cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
KIRC	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	21.01	4.55e-70	1	0.69	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	20.93	1.17e-69	0.99	0.69	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	20.93	1.17e-69	0.99	0.69	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	20.6	4.44e-68	0.98	0.68	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	20.55	7.17e-68	0.97	0.68	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	20.55	7.17e-68	0.97	0.68	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	20.53	9.47e-68	1	0.68	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	20.46	1.99e-67	0.97	0.68	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	20.46	1.99e-67	0.97	0.68	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	20.42	2.96e-67	0.98	0.68	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	20.42	2.96e-67	0.98	0.68	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	20.22	2.65e-66	0.96	0.68	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	20.19	3.82e-66	0.99	0.68	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	20.18	4.39e-66	0.98	0.68	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	20.17	4.96e-66	0.96	0.68	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	20.1	9.73e-66	0.99	0.68	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	20.08	1.26e-65	0.95	0.67	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	20.02	2.35e-65	0.96	0.67	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	20.02	2.59e-65	0.96	0.67	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	19.99	3.32e-65	0.95	0.67	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	19.49	8.56e-63	0.95	0.66	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	19.49	8.56e-63	0.95	0.66	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	19.33	4.57e-62	0.95	0.66	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
KIRC	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	18.91	4.49e-60	0.92	0.65	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	18.78	1.87e-59	1.12	0.65	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	18.75	2.46e-59	1.12	0.65	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-18.05	5.06e-56	-0.95	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-18.05	5.06e-56	-0.95	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-18.02	6.88e-56	-0.96	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-18.02	6.88e-56	-0.96	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-17.84	5.08e-55	-0.95	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-17.84	5.08e-55	-0.95	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-17.84	5.08e-55	-0.95	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-17.84	5.08e-55	-0.95	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	17.81	7.15e-55	0.95	0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	17.81	7.15e-55	0.95	0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-17.24	3.23e-52	-0.94	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-17.24	3.23e-52	-0.94	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-17.21	4.14e-52	-0.92	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-17.21	4.14e-52	-0.92	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-17.15	7.89e-52	-0.93	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-17.15	7.89e-52	-0.93	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-17.13	9.82e-52	-0.94	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-17.13	9.82e-52	-0.94	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-17.09	1.48e-51	-0.93	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-17.09	1.48e-51	-0.93	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-16.92	9e-51	-0.93	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-16.92	9e-51	-0.93	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	16.79	3.63e-50	0.92	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	16.79	3.63e-50	0.92	0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	16.74	6.3e-50	0.85	0.61	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-16.48	9.64e-49	-0.92	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-16.48	9.64e-49	-0.92	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	16.36	3.64e-48	0.94	0.6	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	16.34	4.4e-48	0.94	0.6	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	16.27	9.24e-48	0.93	0.6	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	16.21	1.67e-47	0.93	0.59	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-16.19	2.12e-47	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-16.19	2.12e-47	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	16.17	2.6e-47	0.93	0.59	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	16.17	2.6e-47	0.93	0.59	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	16.17	2.6e-47	0.93	0.59	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	16.16	2.84e-47	0.92	0.59	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	16.15	3.31e-47	0.93	0.59	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	16.12	4.52e-47	0.92	0.59	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	16.12	4.52e-47	0.92	0.59	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	16.12	4.52e-47	0.92	0.59	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	16.08	6.59e-47	0.91	0.59	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	16.07	7.36e-47	0.91	0.59	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	16.07	7.55e-47	0.91	0.59	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	16.06	8.39e-47	0.91	0.59	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	16.03	1.2e-46	0.92	0.59	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	16.03	1.2e-46	0.92	0.59	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	16.03	1.2e-46	0.92	0.59	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	16.03	1.2e-46	0.92	0.59	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	16.03	1.2e-46	0.92	0.59	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	16.02	1.3e-46	0.91	0.59	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	16.01	1.46e-46	0.91	0.59	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	16.01	1.47e-46	0.91	0.59	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	16.01	1.48e-46	0.91	0.59	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	16.01	1.48e-46	0.91	0.59	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	16	1.65e-46	0.91	0.59	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	15.98	1.87e-46	0.92	0.59	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-15.98	1.88e-46	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-15.98	1.88e-46	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-15.94	3.12e-46	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-15.94	3.12e-46	-0.92	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	15.93	3.32e-46	0.91	0.59	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-15.83	9.43e-46	-0.91	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-15.83	9.43e-46	-0.91	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	15.79	1.49e-45	0.91	0.58	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-15.77	1.73e-45	-0.89	-0.58	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	15.72	2.88e-45	0.92	0.58	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	15.72	2.88e-45	0.92	0.58	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	15.72	2.88e-45	0.92	0.58	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	15.72	2.88e-45	0.92	0.58	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-15.72	2.98e-45	-0.86	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-15.72	2.98e-45	-0.86	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-15.62	8.08e-45	-0.88	-0.58	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-15.62	8.08e-45	-0.88	-0.58	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	15.62	8.83e-45	0.89	0.58	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	15.62	8.83e-45	0.89	0.58	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	15.6	9.96e-45	0.89	0.58	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	15.57	1.43e-44	0.89	0.58	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-15.55	1.68e-44	-0.89	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-15.55	1.68e-44	-0.89	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-15.55	1.68e-44	-0.89	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-15.55	1.68e-44	-0.89	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	15.54	1.89e-44	0.88	0.58	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	15.54	1.89e-44	0.88	0.58	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-15.53	2.1e-44	-0.89	-0.58	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-15.44	5.28e-44	-0.89	-0.58	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-15.44	5.28e-44	-0.89	-0.58	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-15.41	7.64e-44	-0.72	-0.57	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	15.38	1.04e-43	0.87	0.57	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	15.22	5.4e-43	0.89	0.57	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	15.22	5.4e-43	0.89	0.57	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	15.16	1.03e-42	0.86	0.57	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-14.98	6.52e-42	-0.84	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-14.98	6.52e-42	-0.84	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-14.59	3.44e-40	-0.84	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-14.59	3.44e-40	-0.84	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	14.39	2.47e-39	0.84	0.55	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-14.31	5.84e-39	-0.94	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-14.31	5.84e-39	-0.94	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-14.21	1.56e-38	-0.67	-0.54	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-14.11	4.45e-38	-0.83	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-14.11	4.45e-38	-0.83	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
KIRC	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-13.97	1.77e-37	-0.66	-0.54	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-13.77	1.35e-36	-0.65	-0.53	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	13.66	3.77e-36	0.65	0.53	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	12.7	4.43e-32	0.72	0.5	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-12.64	7.5e-32	-0.58	-0.5	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-12.64	7.57e-32	-0.58	-0.5	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-12.59	1.26e-31	-0.58	-0.5	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-12.31	1.85e-30	-0.57	-0.49	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-12.22	4.35e-30	-0.56	-0.49	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	12.21	4.59e-30	0.7	0.49	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-12.1	1.34e-29	-0.56	-0.48	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
KIRC	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-12.1	1.34e-29	-0.56	-0.48	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	11.51	3.04e-27	0.33	0.46	Migraine;	chr10:103263177	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	10.83	1.26e-24	0.35	0.44	Migraine;	chr10:103263177	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-10.7	4e-24	-0.35	-0.44	Migraine;	chr10:103415374	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	10.67	5.36e-24	0.32	0.44	Migraine;	chr10:103236031	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-10.6	9.45e-24	-0.35	-0.43	Migraine;	chr10:103254113	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-10.51	2.08e-23	-0.31	-0.43	Migraine;	chr10:103254113	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-10.48	2.74e-23	-0.32	-0.43	Migraine;	chr10:103415374	chr10:103394301~103394322:-
KIRC	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	10.47	2.87e-23	0.34	0.43	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
KIRC	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	10.43	4.27e-23	0.31	0.43	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-10.34	8.96e-23	-0.34	-0.43	Migraine;	chr10:103394332	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-10.33	1.01e-22	-0.31	-0.43	Migraine;	chr10:103365694	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-10.33	1.01e-22	-0.31	-0.43	Migraine;	chr10:103369141	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-10.32	1.05e-22	-0.31	-0.43	Migraine;	chr10:103394332	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-10.3	1.28e-22	-0.31	-0.42	Migraine;	chr10:103315955	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-10.3	1.3e-22	-0.34	-0.42	Migraine;	chr10:103365694	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-10.3	1.3e-22	-0.34	-0.42	Migraine;	chr10:103369141	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-10.3	1.31e-22	-0.31	-0.42	Migraine;	chr10:103338267	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	10.28	1.56e-22	0.34	0.42	Migraine;	chr10:103236031	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-10.27	1.63e-22	-0.34	-0.42	Migraine;	chr10:103338267	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-10.17	3.85e-22	-0.34	-0.42	Migraine;	chr10:103315955	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-10.16	4.24e-22	-0.31	-0.42	Migraine;	chr10:103295206	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-10.16	4.24e-22	-0.31	-0.42	Migraine;	chr10:103296155	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-10.15	4.45e-22	-0.31	-0.42	Migraine;	chr10:103286250	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-10.15	4.45e-22	-0.31	-0.42	Migraine;	chr10:103286932	chr10:103394301~103394322:-
KIRC	cis	rs754133	1	rs754133	MIMAT0004562	hsa-miR-196a-3p	-10.09	7.81e-22	-0.5	-0.42	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54025136	chr12:53991799~53991820:+
KIRC	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-10.07	9.21e-22	-0.34	-0.42	Migraine;	chr10:103286250	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-10.07	9.21e-22	-0.34	-0.42	Migraine;	chr10:103286932	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-10.06	9.92e-22	-0.34	-0.42	Migraine;	chr10:103295206	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-10.06	9.92e-22	-0.34	-0.42	Migraine;	chr10:103296155	chr10:103394341~103394361:-
KIRC	cis	rs754133	0.964	rs4759318	MIMAT0004562	hsa-miR-196a-3p	-10.02	1.4e-21	-0.5	-0.42	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026314	chr12:53991799~53991820:+
KIRC	cis	rs754133	0.891	rs12426399	MIMAT0004562	hsa-miR-196a-3p	-10	1.55e-21	-0.49	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026126	chr12:53991799~53991820:+
KIRC	cis	rs754133	0.964	rs894738	MIMAT0004562	hsa-miR-196a-3p	-9.98	1.96e-21	-0.5	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54023741	chr12:53991799~53991820:+
KIRC	cis	rs754133	0.964	rs894737	MIMAT0004562	hsa-miR-196a-3p	-9.8	8.72e-21	-0.49	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54024359	chr12:53991799~53991820:+
KIRC	cis	rs754133	0.963	rs12319419	MIMAT0004562	hsa-miR-196a-3p	-9.76	1.23e-20	-0.49	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026992	chr12:53991799~53991820:+
KIRC	cis	rs754133	0.964	rs736825	MIMAT0004562	hsa-miR-196a-3p	-9.64	3.1e-20	-0.48	-0.4	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54023792	chr12:53991799~53991820:+
KIRC	cis	rs10021731	0.809	rs35733223	MIMAT0003242	hsa-miR-577	9.11	2.22e-18	0.41	0.38	Optic disc area;	chr4:114566454	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	9.08	2.77e-18	0.41	0.38	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	9.07	3.02e-18	0.41	0.38	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	9.03	4.22e-18	0.41	0.38	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-9	5.33e-18	-0.4	-0.38	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-8.97	6.53e-18	-0.84	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-8.97	6.53e-18	-0.84	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
KIRC	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	8.97	6.58e-18	0.4	0.38	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-8.97	6.64e-18	-0.4	-0.38	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	8.96	7.24e-18	0.4	0.38	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
KIRC	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-8.82	2.18e-17	-0.82	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-8.82	2.18e-17	-0.82	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
KIRC	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-8.77	3.14e-17	-0.39	-0.37	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.756	rs1460783	MIMAT0003242	hsa-miR-577	-8.73	4.11e-17	-0.4	-0.37	Optic disc area;	chr4:114540109	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	8.73	4.14e-17	0.39	0.37	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-8.69	5.87e-17	-0.39	-0.37	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	8.66	7.19e-17	0.38	0.37	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-8.64	8.53e-17	-0.39	-0.37	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-8.63	9.06e-17	-0.38	-0.37	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	8.58	1.31e-16	0.38	0.36	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.756	rs1460782	MIMAT0003242	hsa-miR-577	-8.55	1.61e-16	-0.39	-0.36	Optic disc area;	chr4:114540002	chr4:114656774~114656794:+
KIRC	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	8.55	1.67e-16	0.91	0.36	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
KIRC	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-8.52	2.05e-16	-0.8	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-8.52	2.05e-16	-0.8	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
KIRC	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	8.51	2.18e-16	0.38	0.36	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
KIRC	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-8.48	2.79e-16	-0.8	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
KIRC	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-8.48	2.79e-16	-0.8	-0.36	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
KIRC	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-8.38	5.68e-16	-0.38	-0.36	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-8.38	5.68e-16	-0.38	-0.36	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-8.38	5.68e-16	-0.38	-0.36	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	8.25	1.47e-15	0.39	0.35	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	8.25	1.47e-15	0.39	0.35	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	8.25	1.57e-15	0.39	0.35	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	8.25	1.57e-15	0.39	0.35	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	8.25	1.57e-15	0.39	0.35	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	8.25	1.57e-15	0.39	0.35	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.83	rs28870381	MIMAT0003242	hsa-miR-577	8.24	1.66e-15	0.4	0.35	Optic disc area;	chr4:114557343	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-8.21	2.01e-15	-0.38	-0.35	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	8.2	2.24e-15	0.39	0.35	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	8.2	2.24e-15	0.39	0.35	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	8.2	2.24e-15	0.39	0.35	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	8.2	2.24e-15	0.39	0.35	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.83	rs4834421	MIMAT0003242	hsa-miR-577	8.17	2.68e-15	0.4	0.35	Optic disc area;	chr4:114572686	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.83	rs12648883	MIMAT0003242	hsa-miR-577	-8.17	2.71e-15	-0.4	-0.35	Optic disc area;	chr4:114576504	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	8.17	2.81e-15	0.25	0.35	Migraine;	chr10:103238157	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	8.15	3.09e-15	0.39	0.35	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	8.15	3.09e-15	0.39	0.35	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	8.15	3.09e-15	0.39	0.35	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	8.15	3.09e-15	0.39	0.35	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	8.15	3.09e-15	0.39	0.35	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.83	rs1460785	MIMAT0003242	hsa-miR-577	8.14	3.48e-15	0.39	0.35	Optic disc area;	chr4:114545757	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.83	rs17622401	MIMAT0003242	hsa-miR-577	8.13	3.76e-15	0.4	0.35	Optic disc area;	chr4:114571551	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.793	rs12650568	MIMAT0003242	hsa-miR-577	8.11	4.2e-15	0.39	0.35	Optic disc area;	chr4:114578461	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	8.11	4.21e-15	0.38	0.35	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	8.11	4.21e-15	0.38	0.35	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	8.11	4.21e-15	0.38	0.35	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
KIRC	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-8.09	4.92e-15	-0.53	-0.35	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
KIRC	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	8.08	5.08e-15	0.39	0.35	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	8.07	5.65e-15	0.38	0.34	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	8.05	6.34e-15	0.38	0.34	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	8.05	6.34e-15	0.38	0.34	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	8.05	6.34e-15	0.38	0.34	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	8.05	6.34e-15	0.38	0.34	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	8.05	6.34e-15	0.38	0.34	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.718	rs12505597	MIMAT0003242	hsa-miR-577	-8.04	6.89e-15	-0.36	-0.34	Optic disc area;	chr4:114527954	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-8.01	8.59e-15	-0.36	-0.34	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
KIRC	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-8	9.14e-15	-0.53	-0.34	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
KIRC	cis	rs10021731	0.83	rs28734840	MIMAT0003242	hsa-miR-577	8	9.15e-15	0.39	0.34	Optic disc area;	chr4:114575934	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	7.98	1.11e-14	0.22	0.34	Migraine;	chr10:103238157	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-7.97	1.19e-14	-0.25	-0.34	Migraine;	chr10:103283532	chr10:103394341~103394361:-
KIRC	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-7.96	1.24e-14	-0.36	-0.34	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.798	rs34581144	MIMAT0003242	hsa-miR-577	7.95	1.33e-14	0.39	0.34	Optic disc area;	chr4:114583571	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.83	rs1460784	MIMAT0003242	hsa-miR-577	7.93	1.49e-14	0.39	0.34	Optic disc area;	chr4:114541947	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-7.93	1.57e-14	-0.25	-0.34	Migraine;	chr10:103284207	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	7.92	1.66e-14	0.38	0.34	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.692	rs12108281	MIMAT0003242	hsa-miR-577	-7.91	1.79e-14	-0.36	-0.34	Optic disc area;	chr4:114522147	chr4:114656774~114656794:+
KIRC	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-7.91	1.82e-14	-0.52	-0.34	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
KIRC	cis	rs10021731	0.692	rs10021252	MIMAT0003242	hsa-miR-577	-7.91	1.82e-14	-0.36	-0.34	Optic disc area;	chr4:114515190	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.744	rs6814022	MIMAT0003242	hsa-miR-577	-7.91	1.83e-14	-0.36	-0.34	Optic disc area;	chr4:114528667	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	7.9	1.89e-14	0.37	0.34	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.718	rs7655989	MIMAT0003242	hsa-miR-577	-7.89	2.08e-14	-0.35	-0.34	Optic disc area;	chr4:114528134	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-7.89	2.09e-14	-0.36	-0.34	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-7.89	2.1e-14	-0.36	-0.34	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-7.88	2.18e-14	-0.35	-0.34	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-7.88	2.18e-14	-0.35	-0.34	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-7.86	2.46e-14	-0.35	-0.34	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-7.83	3.21e-14	-0.35	-0.34	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-7.83	3.21e-14	-0.35	-0.34	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-7.83	3.21e-14	-0.35	-0.34	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-7.83	3.21e-14	-0.35	-0.34	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	7.82	3.27e-14	0.37	0.34	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.668	rs7698363	MIMAT0003242	hsa-miR-577	-7.81	3.49e-14	-0.35	-0.34	Optic disc area;	chr4:114492418	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	7.81	3.57e-14	0.37	0.34	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.692	rs1599316	MIMAT0003242	hsa-miR-577	-7.81	3.69e-14	-0.35	-0.34	Optic disc area;	chr4:114490702	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1585446	MIMAT0003242	hsa-miR-577	-7.81	3.69e-14	-0.35	-0.34	Optic disc area;	chr4:114490871	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs2199311	MIMAT0003242	hsa-miR-577	-7.81	3.69e-14	-0.35	-0.34	Optic disc area;	chr4:114492288	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	7.81	3.71e-14	0.21	0.33	Migraine;	chr10:103241753	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-7.8	3.97e-14	-0.35	-0.33	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
KIRC	cis	rs11614913	0.509	rs12300425	MIMAT0004562	hsa-miR-196a-3p	-7.78	4.31e-14	-0.41	-0.33	Waist circumference adjusted for body mass index;	chr12:54001298	chr12:53991799~53991820:+
KIRC	cis	rs10021731	0.718	rs6839599	MIMAT0003242	hsa-miR-577	-7.78	4.32e-14	-0.35	-0.33	Optic disc area;	chr4:114494754	chr4:114656774~114656794:+
KIRC	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	7.77	4.69e-14	0.52	0.33	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
KIRC	cis	rs10021731	0.692	rs13105714	MIMAT0003242	hsa-miR-577	-7.76	5.01e-14	-0.35	-0.33	Optic disc area;	chr4:114511171	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs958771	MIMAT0003242	hsa-miR-577	-7.76	5.12e-14	-0.35	-0.33	Optic disc area;	chr4:114514506	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-7.76	5.18e-14	-0.35	-0.33	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs10002657	MIMAT0003242	hsa-miR-577	-7.75	5.32e-14	-0.35	-0.33	Optic disc area;	chr4:114483120	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs1599317	MIMAT0003242	hsa-miR-577	-7.75	5.55e-14	-0.35	-0.33	Optic disc area;	chr4:114503010	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-7.74	5.83e-14	-0.23	-0.33	Migraine;	chr10:103241568	chr10:103394341~103394361:-
KIRC	cis	rs10021731	0.718	rs1460779	MIMAT0003242	hsa-miR-577	7.74	5.86e-14	0.35	0.33	Optic disc area;	chr4:114528894	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13127822	MIMAT0003242	hsa-miR-577	-7.73	6.31e-14	-0.35	-0.33	Optic disc area;	chr4:114493024	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-7.73	6.5e-14	-0.35	-0.33	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs11724670	MIMAT0003242	hsa-miR-577	-7.72	6.59e-14	-0.35	-0.33	Optic disc area;	chr4:114482122	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs10516602	MIMAT0003242	hsa-miR-577	-7.72	6.76e-14	-0.35	-0.33	Optic disc area;	chr4:114486174	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.693	rs7686100	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114511670	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs7690858	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114511804	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4295329	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114511945	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs4409027	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114511985	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4413472	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114512090	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs11936113	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114512224	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs11936150	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114512391	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs28361366	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114512809	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs28656197	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114512821	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs2199314	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114513555	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-7.72	6.8e-14	-0.35	-0.33	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs993460	MIMAT0003242	hsa-miR-577	-7.72	6.87e-14	-0.35	-0.33	Optic disc area;	chr4:114510521	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1460772	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114487028	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-7.71	7.14e-14	-0.35	-0.33	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4409025	MIMAT0003242	hsa-miR-577	-7.71	7.2e-14	-0.35	-0.33	Optic disc area;	chr4:114511785	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4409026	MIMAT0003242	hsa-miR-577	-7.71	7.2e-14	-0.35	-0.33	Optic disc area;	chr4:114511787	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1824490	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114529766	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs1824489	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114529776	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2100782	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114530452	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	7.7	7.56e-14	0.34	0.33	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.521	rs116635794	MIMAT0003242	hsa-miR-577	-7.7	7.7e-14	-0.35	-0.33	Optic disc area;	chr4:114520865	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-7.7	7.79e-14	-0.24	-0.33	Migraine;	chr10:103273871	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	7.7	7.83e-14	0.37	0.33	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-7.7	7.85e-14	-0.21	-0.33	Migraine;	chr10:103262005	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs2054304	MIMAT0003242	hsa-miR-577	-7.68	9.09e-14	-0.35	-0.33	Optic disc area;	chr4:114495902	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-7.68	9.1e-14	-0.35	-0.33	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7689158	MIMAT0003242	hsa-miR-577	-7.68	9.17e-14	-0.35	-0.33	Optic disc area;	chr4:114495770	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-7.68	9.19e-14	-0.35	-0.33	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-7.68	9.19e-14	-0.35	-0.33	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	7.67	9.29e-14	0.34	0.33	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13103719	MIMAT0003242	hsa-miR-577	7.67	9.29e-14	0.34	0.33	Optic disc area;	chr4:114532620	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.681	rs13109008	MIMAT0003242	hsa-miR-577	7.67	9.29e-14	0.34	0.33	Optic disc area;	chr4:114532769	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13109803	MIMAT0003242	hsa-miR-577	7.67	9.29e-14	0.34	0.33	Optic disc area;	chr4:114532837	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7440658	MIMAT0003242	hsa-miR-577	7.67	9.29e-14	0.34	0.33	Optic disc area;	chr4:114533303	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-7.67	9.8e-14	-0.34	-0.33	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-7.66	1.06e-13	-0.34	-0.33	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-7.66	1.06e-13	-0.34	-0.33	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-7.65	1.09e-13	-0.34	-0.33	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-7.65	1.09e-13	-0.34	-0.33	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-7.65	1.09e-13	-0.34	-0.33	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-7.65	1.09e-13	-0.34	-0.33	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-7.65	1.09e-13	-0.34	-0.33	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-7.65	1.13e-13	-0.34	-0.33	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-7.65	1.13e-13	-0.34	-0.33	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-7.65	1.13e-13	-0.34	-0.33	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
KIRC	cis	rs10021731	1	rs10021731	MIMAT0003242	hsa-miR-577	7.64	1.16e-13	0.36	0.33	Optic disc area;	chr4:114560759	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-7.64	1.17e-13	-0.34	-0.33	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-7.64	1.17e-13	-0.34	-0.33	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-7.64	1.17e-13	-0.34	-0.33	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-7.64	1.2e-13	-0.21	-0.33	Migraine;	chr10:103278698	chr10:103394301~103394322:-
KIRC	cis	rs10021731	1	rs4834419	MIMAT0003242	hsa-miR-577	7.64	1.22e-13	0.36	0.33	Optic disc area;	chr4:114548870	chr4:114656774~114656794:+
KIRC	cis	rs10021731	1	rs1599323	MIMAT0003242	hsa-miR-577	7.64	1.22e-13	0.36	0.33	Optic disc area;	chr4:114549176	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-7.63	1.23e-13	-0.21	-0.33	Migraine;	chr10:103284400	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	7.63	1.25e-13	0.2	0.33	Migraine;	chr10:103237257	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs7686774	MIMAT0003242	hsa-miR-577	-7.63	1.26e-13	-0.35	-0.33	Optic disc area;	chr4:114480357	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7687413	MIMAT0003242	hsa-miR-577	-7.63	1.26e-13	-0.35	-0.33	Optic disc area;	chr4:114480417	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.644	rs7665675	MIMAT0003242	hsa-miR-577	-7.63	1.26e-13	-0.35	-0.33	Optic disc area;	chr4:114480704	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7692571	MIMAT0003242	hsa-miR-577	-7.63	1.26e-13	-0.35	-0.33	Optic disc area;	chr4:114480792	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs11724674	MIMAT0003242	hsa-miR-577	-7.63	1.26e-13	-0.35	-0.33	Optic disc area;	chr4:114482175	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7698790	MIMAT0003242	hsa-miR-577	7.62	1.34e-13	0.34	0.33	Optic disc area;	chr4:114492647	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-7.61	1.47e-13	-0.35	-0.33	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-7.6	1.55e-13	-0.21	-0.33	Migraine;	chr10:103241568	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-7.6	1.6e-13	-0.34	-0.33	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-7.6	1.6e-13	-0.34	-0.33	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-7.6	1.6e-13	-0.34	-0.33	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs12512563	MIMAT0003242	hsa-miR-577	-7.58	1.73e-13	-0.35	-0.33	Optic disc area;	chr4:114493973	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.6	rs12504927	MIMAT0003242	hsa-miR-577	-7.58	1.73e-13	-0.35	-0.33	Optic disc area;	chr4:114493975	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.645	rs13147121	MIMAT0003242	hsa-miR-577	-7.58	1.73e-13	-0.35	-0.33	Optic disc area;	chr4:114493994	chr4:114656774~114656794:+
KIRC	cis	rs10021731	1	rs6533801	MIMAT0003242	hsa-miR-577	7.58	1.8e-13	0.36	0.33	Optic disc area;	chr4:114553199	chr4:114656774~114656794:+
KIRC	cis	rs10021731	1	rs13104222	MIMAT0003242	hsa-miR-577	7.58	1.82e-13	0.36	0.33	Optic disc area;	chr4:114549757	chr4:114656774~114656794:+
KIRC	cis	rs10021731	1	rs11098258	MIMAT0003242	hsa-miR-577	7.57	1.88e-13	0.36	0.33	Optic disc area;	chr4:114564528	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.692	rs13147488	MIMAT0003242	hsa-miR-577	-7.57	1.98e-13	-0.34	-0.33	Optic disc area;	chr4:114494051	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs7676684	MIMAT0003242	hsa-miR-577	7.56	2.07e-13	0.34	0.33	Optic disc area;	chr4:114492371	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-7.56	2.07e-13	-0.23	-0.33	Migraine;	chr10:103262005	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	7.55	2.13e-13	0.23	0.33	Migraine;	chr10:103244344	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	7.55	2.17e-13	0.2	0.33	Migraine;	chr10:103248169	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	7.55	2.17e-13	0.2	0.33	Migraine;	chr10:103249329	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-7.55	2.26e-13	-0.34	-0.33	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-7.53	2.57e-13	-0.21	-0.32	Migraine;	chr10:103395309	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	7.52	2.74e-13	0.22	0.32	Migraine;	chr10:103240612	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-7.51	2.85e-13	-0.21	-0.32	Migraine;	chr10:103299551	chr10:103394301~103394322:-
KIRC	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-7.5	3.03e-13	-0.51	-0.32	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
KIRC	cis	rs10021731	0.692	rs6840798	MIMAT0003242	hsa-miR-577	-7.5	3.07e-13	-0.34	-0.32	Optic disc area;	chr4:114495078	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs6817762	MIMAT0003242	hsa-miR-577	-7.5	3.07e-13	-0.34	-0.32	Optic disc area;	chr4:114495098	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-7.5	3.17e-13	-0.23	-0.32	Migraine;	chr10:103270083	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-7.49	3.2e-13	-0.21	-0.32	Migraine;	chr10:103395888	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs62309866	MIMAT0003242	hsa-miR-577	-7.47	3.72e-13	-0.34	-0.32	Optic disc area;	chr4:114479583	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.718	rs7685549	MIMAT0003242	hsa-miR-577	-7.47	3.72e-13	-0.34	-0.32	Optic disc area;	chr4:114479772	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-7.47	3.85e-13	-0.23	-0.32	Migraine;	chr10:103299082	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	7.46	3.96e-13	0.36	0.32	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	7.44	4.7e-13	0.2	0.32	Migraine;	chr10:103261506	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-7.44	4.76e-13	-0.2	-0.32	Migraine;	chr10:103317367	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-7.44	4.76e-13	-0.2	-0.32	Migraine;	chr10:103319682	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.668	rs13112732	MIMAT0003242	hsa-miR-577	-7.43	4.88e-13	-0.34	-0.32	Optic disc area;	chr4:114483845	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-7.43	4.92e-13	-0.21	-0.32	Migraine;	chr10:103270083	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-7.43	4.94e-13	-0.22	-0.32	Migraine;	chr10:103283532	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	7.43	4.99e-13	0.34	0.32	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-7.43	5.12e-13	-0.23	-0.32	Migraine;	chr10:103279822	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-7.43	5.15e-13	-0.22	-0.32	Migraine;	chr10:103395309	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	7.41	5.71e-13	0.35	0.32	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	7.41	5.77e-13	0.35	0.32	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-7.41	5.85e-13	-0.2	-0.32	Migraine;	chr10:103309363	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-7.4	6.19e-13	-0.23	-0.32	Migraine;	chr10:103293219	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-7.39	6.4e-13	-0.22	-0.32	Migraine;	chr10:103395888	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-7.39	6.63e-13	-0.22	-0.32	Migraine;	chr10:103317367	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-7.39	6.63e-13	-0.22	-0.32	Migraine;	chr10:103319682	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-7.38	6.93e-13	-0.2	-0.32	Migraine;	chr10:103384531	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	7.38	6.97e-13	0.35	0.32	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.668	rs1599322	MIMAT0003242	hsa-miR-577	-7.38	7.05e-13	-0.33	-0.32	Optic disc area;	chr4:114531895	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs55968476	MIMAT0003242	hsa-miR-577	-7.38	7.05e-13	-0.33	-0.32	Optic disc area;	chr4:114532478	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-7.37	7.23e-13	-0.22	-0.32	Migraine;	chr10:103299551	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-7.37	7.33e-13	-0.2	-0.32	Migraine;	chr10:103367951	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-7.37	7.35e-13	-0.2	-0.32	Migraine;	chr10:103353944	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-7.37	7.35e-13	-0.2	-0.32	Migraine;	chr10:103356299	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-7.37	7.35e-13	-0.2	-0.32	Migraine;	chr10:103358705	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	7.37	7.49e-13	0.37	0.32	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	7.37	7.49e-13	0.37	0.32	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.668	rs28651771	MIMAT0003242	hsa-miR-577	-7.37	7.65e-13	-0.33	-0.32	Optic disc area;	chr4:114501291	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	7.37	7.73e-13	0.35	0.32	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.692	rs62309904	MIMAT0003242	hsa-miR-577	-7.36	7.9e-13	-0.33	-0.32	Optic disc area;	chr4:114514011	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	7.36	7.92e-13	0.35	0.32	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	7.36	8.01e-13	0.37	0.32	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-7.36	8.02e-13	-0.23	-0.32	Migraine;	chr10:103289348	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-7.36	8.02e-13	-0.23	-0.32	Migraine;	chr10:103292867	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-7.36	8.02e-13	-0.23	-0.32	Migraine;	chr10:103293183	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-7.36	8.13e-13	-0.22	-0.32	Migraine;	chr10:103309363	chr10:103394341~103394361:-
KIRC	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-7.35	8.5e-13	-0.2	-0.32	Migraine;	chr10:103273985	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-7.34	8.99e-13	-0.2	-0.32	Migraine;	chr10:103386935	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.1e-13	-0.2	-0.32	Migraine;	chr10:103367521	chr10:103394301~103394322:-
KIRC	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.1e-13	-0.2	-0.32	Migraine;	chr10:103273258	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.13e-13	-0.2	-0.32	Migraine;	chr10:103348698	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.13e-13	-0.2	-0.32	Migraine;	chr10:103358719	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.45e-13	-0.21	-0.32	Migraine;	chr10:103284207	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	7.32	1.02e-12	0.35	0.32	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-7.32	1.03e-12	-0.22	-0.32	Migraine;	chr10:103367951	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-7.32	1.03e-12	-0.22	-0.32	Migraine;	chr10:103353944	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-7.32	1.03e-12	-0.22	-0.32	Migraine;	chr10:103356299	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-7.32	1.03e-12	-0.22	-0.32	Migraine;	chr10:103358705	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	7.32	1.04e-12	0.22	0.32	Migraine;	chr10:103261506	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-7.32	1.05e-12	-0.22	-0.32	Migraine;	chr10:103384531	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-7.29	1.27e-12	-0.22	-0.32	Migraine;	chr10:103386935	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-7.29	1.28e-12	-0.22	-0.32	Migraine;	chr10:103367521	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-7.29	1.28e-12	-0.22	-0.32	Migraine;	chr10:103348698	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-7.29	1.28e-12	-0.22	-0.32	Migraine;	chr10:103358719	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-7.28	1.32e-12	-0.21	-0.31	Migraine;	chr10:103273871	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	7.28	1.33e-12	0.34	0.31	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	7.28	1.33e-12	0.34	0.31	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	7.28	1.33e-12	0.34	0.31	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-7.26	1.57e-12	-0.22	-0.31	Migraine;	chr10:103379204	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-7.23	1.88e-12	-0.34	-0.31	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-7.22	2e-12	-0.2	-0.31	Migraine;	chr10:103299082	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	7.22	2.04e-12	0.2	0.31	Migraine;	chr10:103240612	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	7.21	2.23e-12	0.22	0.31	Migraine;	chr10:103367830	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-7.2	2.27e-12	-0.2	-0.31	Migraine;	chr10:103379204	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.668	rs62309894	MIMAT0003242	hsa-miR-577	-7.18	2.62e-12	-0.33	-0.31	Optic disc area;	chr4:114504575	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.668	rs2199313	MIMAT0003242	hsa-miR-577	-7.18	2.7e-12	-0.33	-0.31	Optic disc area;	chr4:114513488	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-7.17	2.79e-12	-0.2	-0.31	Migraine;	chr10:103297804	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	7.17	2.84e-12	0.21	0.31	Migraine;	chr10:103241753	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	7.16	2.96e-12	0.2	0.31	Migraine;	chr10:103244344	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-7.16	2.99e-12	-0.33	-0.31	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	7.15	3.19e-12	0.36	0.31	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
KIRC	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-7.14	3.56e-12	-0.2	-0.31	Migraine;	chr10:103279291	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	7.13	3.74e-12	0.34	0.31	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	7.13	3.78e-12	0.2	0.31	Migraine;	chr10:103367830	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	7.11	4.29e-12	0.38	0.31	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	7.1	4.64e-12	0.19	0.31	Migraine;	chr10:103242040	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	7.09	4.91e-12	0.33	0.31	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.706	rs1380931	MIMAT0003242	hsa-miR-577	-7.07	5.33e-12	-0.32	-0.31	Optic disc area;	chr4:114506853	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-7.05	6.31e-12	-0.2	-0.31	Migraine;	chr10:103279822	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	7.04	6.7e-12	0.34	0.31	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-7.03	6.89e-12	-0.21	-0.31	Migraine;	chr10:103297804	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	7.03	7.08e-12	0.34	0.3	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-7.03	7.3e-12	-0.22	-0.3	Migraine;	chr10:103284400	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-7.02	7.36e-12	-0.19	-0.3	Migraine;	chr10:103305652	chr10:103394301~103394322:-
KIRC	cis	rs754133	0.507	rs10876531	MIMAT0004562	hsa-miR-196a-3p	-7.01	7.94e-12	-0.4	-0.3	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54049934	chr12:53991799~53991820:+
KIRC	cis	rs10021731	0.668	rs13103537	MIMAT0003242	hsa-miR-577	-6.99	9.07e-12	-0.32	-0.3	Optic disc area;	chr4:114495092	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	6.98	9.58e-12	0.21	0.3	Migraine;	chr10:103237257	chr10:103394341~103394361:-
KIRC	cis	rs10021731	0.729	rs17047190	MIMAT0003242	hsa-miR-577	6.98	9.69e-12	0.34	0.3	Optic disc area;	chr4:114536699	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	6.94	1.25e-11	0.34	0.3	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	6.94	1.25e-11	0.34	0.3	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
KIRC	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	6.92	1.47e-11	0.36	0.3	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
KIRC	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	6.85	2.31e-11	0.21	0.3	Migraine;	chr10:103248169	chr10:103394341~103394361:-
KIRC	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	6.85	2.31e-11	0.21	0.3	Migraine;	chr10:103249329	chr10:103394341~103394361:-
KIRC	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-6.84	2.47e-11	-0.55	-0.3	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
KIRC	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-6.77	3.85e-11	-0.19	-0.29	Migraine;	chr10:103289348	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-6.77	3.85e-11	-0.19	-0.29	Migraine;	chr10:103292867	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-6.77	3.85e-11	-0.19	-0.29	Migraine;	chr10:103293183	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-6.76	3.9e-11	-0.18	-0.29	Migraine;	chr10:103307280	chr10:103394301~103394322:-
KIRC	cis	rs10021731	0.725	rs1551742	MIMAT0003242	hsa-miR-577	6.75	4.29e-11	0.32	0.29	Optic disc area;	chr4:114485894	chr4:114656774~114656794:+
KIRC	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-6.74	4.5e-11	-0.19	-0.29	Migraine;	chr10:103389790	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-6.74	4.55e-11	-0.19	-0.29	Migraine;	chr10:103293219	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-6.73	4.7e-11	-0.19	-0.29	Migraine;	chr10:103375562	chr10:103394301~103394322:-
KIRC	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	6.7	5.86e-11	0.2	0.29	Migraine;	chr10:103242040	chr10:103394341~103394361:-
KIRC	cis	rs10021731	0.691	rs2126027	MIMAT0003242	hsa-miR-577	-6.7	5.88e-11	-0.32	-0.29	Optic disc area;	chr4:114533510	chr4:114656774~114656794:+
KIRC	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-6.7	6.01e-11	-0.54	-0.29	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
KIRC	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-6.69	6.31e-11	-0.2	-0.29	Migraine;	chr10:103278698	chr10:103394341~103394361:-
KIRC	cis	rs10021731	0.725	rs2126026	MIMAT0003242	hsa-miR-577	-6.68	6.69e-11	-0.32	-0.29	Optic disc area;	chr4:114533531	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	6.66	7.63e-11	0.32	0.29	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
KIRC	cis	rs7894407	0.504	rs7089271	MIMAT0005951	hsa-miR-1307-3p	-6.63	8.87e-11	-0.19	-0.29	White matter hyperintensity burden;	chr10:103417157	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-6.62	9.48e-11	-0.29	-0.29	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	6.62	9.57e-11	0.31	0.29	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
KIRC	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-6.6	1.09e-10	-0.52	-0.29	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
KIRC	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-6.6	1.09e-10	-0.52	-0.29	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
KIRC	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	6.58	1.25e-10	0.34	0.29	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	6.58	1.25e-10	0.34	0.29	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
KIRC	cis	rs6120849	0.754	rs6120828	MIMAT0004772	hsa-miR-499a-3p	-6.57	1.29e-10	-0.41	-0.29	Protein C levels;	chr20:35086657	chr20:34990445~34990466:+
KIRC	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	6.54	1.55e-10	0.18	0.29	Migraine;	chr10:103347713	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	6.54	1.62e-10	0.3	0.29	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	6.53	1.65e-10	0.31	0.29	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	6.51	1.93e-10	0.18	0.28	Migraine;	chr10:103402122	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	6.5	2.07e-10	0.3	0.28	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	6.5	2.07e-10	0.3	0.28	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs12503513	MIMAT0003242	hsa-miR-577	6.49	2.1e-10	0.31	0.28	Optic disc area;	chr4:114534996	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.725	rs7667556	MIMAT0003242	hsa-miR-577	6.49	2.1e-10	0.31	0.28	Optic disc area;	chr4:114535359	chr4:114656774~114656794:+
KIRC	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	6.49	2.19e-10	0.35	0.28	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
KIRC	cis	rs10021731	0.628	rs6533791	MIMAT0003242	hsa-miR-577	-6.47	2.36e-10	-0.32	-0.28	Optic disc area;	chr4:114491869	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	6.47	2.46e-10	0.29	0.28	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	6.47	2.48e-10	0.29	0.28	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	6.47	2.48e-10	0.29	0.28	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	6.47	2.48e-10	0.29	0.28	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	6.47	2.48e-10	0.29	0.28	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	6.46	2.56e-10	0.29	0.28	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.659	rs13105730	MIMAT0003242	hsa-miR-577	-6.45	2.78e-10	-0.31	-0.28	Optic disc area;	chr4:114490021	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs6087667	MIMAT0004772	hsa-miR-499a-3p	-6.44	2.82e-10	-0.4	-0.28	Protein C levels;	chr20:35064084	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.707	rs6088694	MIMAT0004772	hsa-miR-499a-3p	-6.44	2.82e-10	-0.4	-0.28	Protein C levels;	chr20:35064568	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	6.44	2.88e-10	0.29	0.28	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	6.44	2.88e-10	0.29	0.28	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	6.44	2.88e-10	0.29	0.28	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
KIRC	cis	rs6120849	0.707	rs6088703	MIMAT0004772	hsa-miR-499a-3p	-6.43	3.02e-10	-0.41	-0.28	Protein C levels;	chr20:35088246	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs6839694	MIMAT0003242	hsa-miR-577	-6.42	3.19e-10	-0.31	-0.28	Optic disc area;	chr4:114502041	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	6.42	3.24e-10	0.29	0.28	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	6.42	3.24e-10	0.29	0.28	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	6.42	3.24e-10	0.29	0.28	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	6.42	3.24e-10	0.29	0.28	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	6.42	3.34e-10	0.29	0.28	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs922199	MIMAT0003242	hsa-miR-577	-6.41	3.39e-10	-0.31	-0.28	Optic disc area;	chr4:114485362	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.725	rs13103327	MIMAT0003242	hsa-miR-577	6.41	3.41e-10	0.31	0.28	Optic disc area;	chr4:114532551	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.659	rs28564476	MIMAT0003242	hsa-miR-577	-6.4	3.63e-10	-0.31	-0.28	Optic disc area;	chr4:114484592	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	6.4	3.67e-10	0.29	0.28	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	6.4	3.67e-10	0.29	0.28	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	6.4	3.67e-10	0.29	0.28	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	6.4	3.67e-10	0.29	0.28	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	6.4	3.67e-10	0.29	0.28	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
KIRC	cis	rs6120849	0.707	rs6120826	MIMAT0004772	hsa-miR-499a-3p	-6.4	3.75e-10	-0.4	-0.28	Protein C levels;	chr20:35084028	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.691	rs6849064	MIMAT0003242	hsa-miR-577	-6.4	3.76e-10	-0.31	-0.28	Optic disc area;	chr4:114483807	chr4:114656774~114656794:+
KIRC	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	6.39	3.83e-10	0.35	0.28	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
KIRC	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	6.39	3.86e-10	0.35	0.28	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
KIRC	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	6.39	3.86e-10	0.35	0.28	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
KIRC	cis	rs10021731	0.725	rs66806558	MIMAT0003242	hsa-miR-577	6.39	3.87e-10	0.31	0.28	Optic disc area;	chr4:114515499	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.725	rs13103303	MIMAT0003242	hsa-miR-577	6.39	3.89e-10	0.31	0.28	Optic disc area;	chr4:114532477	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs6088678	MIMAT0004772	hsa-miR-499a-3p	6.39	3.91e-10	0.4	0.28	Protein C levels;	chr20:35019748	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.691	rs7654273	MIMAT0003242	hsa-miR-577	-6.39	4e-10	-0.31	-0.28	Optic disc area;	chr4:114501231	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	6.38	4.15e-10	0.29	0.28	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	6.38	4.15e-10	0.29	0.28	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	6.38	4.15e-10	0.29	0.28	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	6.38	4.15e-10	0.29	0.28	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	6.38	4.15e-10	0.29	0.28	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs62309917	MIMAT0003242	hsa-miR-577	6.38	4.18e-10	0.31	0.28	Optic disc area;	chr4:114522432	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	6.38	4.27e-10	0.29	0.28	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs6839138	MIMAT0003242	hsa-miR-577	-6.37	4.47e-10	-0.31	-0.28	Optic disc area;	chr4:114501793	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs6120819	MIMAT0004772	hsa-miR-499a-3p	-6.36	4.76e-10	-0.4	-0.28	Protein C levels;	chr20:35065235	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6120797	MIMAT0004772	hsa-miR-499a-3p	-6.35	4.9e-10	-0.4	-0.28	Protein C levels;	chr20:35018199	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6119560	MIMAT0004772	hsa-miR-499a-3p	-6.35	4.9e-10	-0.4	-0.28	Protein C levels;	chr20:35019174	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs12641633	MIMAT0003242	hsa-miR-577	6.35	4.92e-10	0.31	0.28	Optic disc area;	chr4:114488186	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.725	rs4833457	MIMAT0003242	hsa-miR-577	6.35	4.92e-10	0.31	0.28	Optic disc area;	chr4:114490891	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-6.34	5.35e-10	-0.3	-0.28	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
KIRC	cis	rs6120849	0.707	rs3746444	MIMAT0004772	hsa-miR-499a-3p	-6.34	5.4e-10	-0.4	-0.28	Protein C levels;	chr20:34990448	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs1885116	MIMAT0004772	hsa-miR-499a-3p	-6.34	5.4e-10	-0.4	-0.28	Protein C levels;	chr20:35012757	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs1885117	MIMAT0004772	hsa-miR-499a-3p	-6.34	5.4e-10	-0.4	-0.28	Protein C levels;	chr20:35012937	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6120793	MIMAT0004772	hsa-miR-499a-3p	-6.34	5.4e-10	-0.4	-0.28	Protein C levels;	chr20:35016604	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs17319032	MIMAT0004772	hsa-miR-499a-3p	-6.34	5.41e-10	-0.4	-0.28	Protein C levels;	chr20:35055493	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6088686	MIMAT0004772	hsa-miR-499a-3p	-6.33	5.51e-10	-0.4	-0.28	Protein C levels;	chr20:35035634	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6120804	MIMAT0004772	hsa-miR-499a-3p	-6.33	5.51e-10	-0.4	-0.28	Protein C levels;	chr20:35035898	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6087666	MIMAT0004772	hsa-miR-499a-3p	-6.33	5.72e-10	-0.4	-0.28	Protein C levels;	chr20:35052439	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6120813	MIMAT0004772	hsa-miR-499a-3p	-6.33	5.72e-10	-0.4	-0.28	Protein C levels;	chr20:35054309	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs6850121	MIMAT0003242	hsa-miR-577	-6.32	5.9e-10	-0.3	-0.28	Optic disc area;	chr4:114484294	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs11167253	MIMAT0004772	hsa-miR-499a-3p	-6.32	6.02e-10	-0.4	-0.28	Protein C levels;	chr20:35026646	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.707	rs6120799	MIMAT0004772	hsa-miR-499a-3p	-6.32	6.02e-10	-0.4	-0.28	Protein C levels;	chr20:35027152	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6088682	MIMAT0004772	hsa-miR-499a-3p	-6.32	6.02e-10	-0.4	-0.28	Protein C levels;	chr20:35027899	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs13433216	MIMAT0004772	hsa-miR-499a-3p	-6.32	6.02e-10	-0.4	-0.28	Protein C levels;	chr20:35028498	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs3746446	MIMAT0004772	hsa-miR-499a-3p	-6.31	6.25e-10	-0.4	-0.28	Protein C levels;	chr20:34986962	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	6.31	6.34e-10	0.34	0.28	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	6.31	6.48e-10	0.28	0.28	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
KIRC	cis	rs6120849	0.617	rs12480442	MIMAT0004772	hsa-miR-499a-3p	-6.31	6.52e-10	-0.4	-0.28	Protein C levels;	chr20:35060585	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs12502750	MIMAT0003242	hsa-miR-577	6.3	6.55e-10	0.3	0.28	Optic disc area;	chr4:114499194	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	6.29	7.13e-10	0.29	0.28	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
KIRC	cis	rs10021731	0.725	rs7665770	MIMAT0003242	hsa-miR-577	-6.28	7.56e-10	-0.3	-0.28	Optic disc area;	chr4:114508383	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs7268266	MIMAT0004772	hsa-miR-499a-3p	-6.28	7.66e-10	-0.39	-0.27	Protein C levels;	chr20:34994086	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs11931563	MIMAT0003242	hsa-miR-577	6.27	7.98e-10	0.3	0.27	Optic disc area;	chr4:114496527	chr4:114656774~114656794:+
KIRC	cis	rs10021731	0.691	rs10015704	MIMAT0003242	hsa-miR-577	-6.27	8.03e-10	-0.3	-0.27	Optic disc area;	chr4:114507972	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	6.27	8.04e-10	0.28	0.27	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
KIRC	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	6.27	8.07e-10	0.34	0.27	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
KIRC	cis	rs6120849	0.754	rs6120812	MIMAT0004772	hsa-miR-499a-3p	-6.27	8.09e-10	-0.39	-0.27	Protein C levels;	chr20:35041624	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.707	rs6088690	MIMAT0004772	hsa-miR-499a-3p	-6.27	8.09e-10	-0.39	-0.27	Protein C levels;	chr20:35045523	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs6088691	MIMAT0004772	hsa-miR-499a-3p	-6.27	8.09e-10	-0.39	-0.27	Protein C levels;	chr20:35045955	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.518	rs11696652	MIMAT0004772	hsa-miR-499a-3p	-6.27	8.09e-10	-0.39	-0.27	Protein C levels;	chr20:35049257	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.707	rs6120798	MIMAT0004772	hsa-miR-499a-3p	-6.27	8.21e-10	-0.39	-0.27	Protein C levels;	chr20:35023019	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.708	rs6087659	MIMAT0004772	hsa-miR-499a-3p	-6.26	8.58e-10	-0.4	-0.27	Protein C levels;	chr20:35018580	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs7674990	MIMAT0003242	hsa-miR-577	6.25	8.9e-10	0.3	0.27	Optic disc area;	chr4:114506467	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	6.25	9.07e-10	0.28	0.27	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
KIRC	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-6.23	1.04e-09	-0.19	-0.27	Migraine;	chr10:103305652	chr10:103394341~103394361:-
KIRC	cis	rs6120849	0.754	rs36003887	MIMAT0004772	hsa-miR-499a-3p	-6.23	1.04e-09	-0.39	-0.27	Protein C levels;	chr20:35001304	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs8501	MIMAT0004772	hsa-miR-499a-3p	-6.23	1.04e-09	-0.39	-0.27	Protein C levels;	chr20:35002781	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.707	rs752075	MIMAT0004772	hsa-miR-499a-3p	-6.23	1.04e-09	-0.39	-0.27	Protein C levels;	chr20:35003788	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs752448	MIMAT0004772	hsa-miR-499a-3p	-6.23	1.04e-09	-0.39	-0.27	Protein C levels;	chr20:35004445	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	6.22	1.11e-09	0.29	0.27	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs36096691	MIMAT0003242	hsa-miR-577	6.19	1.28e-09	0.3	0.27	Optic disc area;	chr4:114509770	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-6.18	1.37e-09	-0.32	-0.27	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
KIRC	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-6.17	1.41e-09	-0.19	-0.27	Migraine;	chr10:103389790	chr10:103394341~103394361:-
KIRC	cis	rs6120849	0.754	rs3818253	MIMAT0004772	hsa-miR-499a-3p	-6.17	1.44e-09	-0.39	-0.27	Protein C levels;	chr20:35009073	chr20:34990445~34990466:+
KIRC	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-6.17	1.48e-09	-0.19	-0.27	Migraine;	chr10:103375562	chr10:103394341~103394361:-
KIRC	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	6.16	1.54e-09	0.32	0.27	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.754	rs6120788	MIMAT0004772	hsa-miR-499a-3p	-6.16	1.58e-09	-0.39	-0.27	Protein C levels;	chr20:34995913	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.754	rs3746436	MIMAT0004772	hsa-miR-499a-3p	-6.16	1.58e-09	-0.39	-0.27	Protein C levels;	chr20:34998390	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	6.14	1.69e-09	0.29	0.27	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	6.14	1.69e-09	0.29	0.27	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
KIRC	cis	rs10021731	0.725	rs1460770	MIMAT0003242	hsa-miR-577	-6.14	1.75e-09	-0.29	-0.27	Optic disc area;	chr4:114484189	chr4:114656774~114656794:+
KIRC	cis	rs2284932	0.556	rs2014766	MIMAT0016895	hsa-miR-2355-5p	6.14	1.77e-09	0.31	0.27	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207126660	chr2:207110043~207110063:-
KIRC	cis	rs6120849	0.754	rs6120790	MIMAT0004772	hsa-miR-499a-3p	-6.12	1.97e-09	-0.38	-0.27	Protein C levels;	chr20:35011287	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.725	rs72676244	MIMAT0003242	hsa-miR-577	6.11	2.1e-09	0.3	0.27	Optic disc area;	chr4:114479168	chr4:114656774~114656794:+
KIRC	cis	rs6120849	0.754	rs3746435	MIMAT0004772	hsa-miR-499a-3p	-6.1	2.14e-09	-0.39	-0.27	Protein C levels;	chr20:34999395	chr20:34990445~34990466:+
KIRC	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	6.09	2.26e-09	0.48	0.27	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
KIRC	cis	rs6120849	0.754	rs6088667	MIMAT0004772	hsa-miR-499a-3p	-6.08	2.42e-09	-0.38	-0.27	Protein C levels;	chr20:34978919	chr20:34990445~34990466:+
KIRC	cis	rs10021731	0.718	rs7698391	MIMAT0003242	hsa-miR-577	-6.08	2.47e-09	-0.28	-0.27	Optic disc area;	chr4:114492457	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	6.05	2.96e-09	0.28	0.27	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	6.04	3.11e-09	0.27	0.27	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
KIRC	cis	rs2284932	0.533	rs918282	MIMAT0016895	hsa-miR-2355-5p	6.03	3.35e-09	0.31	0.26	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127274	chr2:207110043~207110063:-
KIRC	cis	rs2284932	0.533	rs16839275	MIMAT0016895	hsa-miR-2355-5p	6.02	3.54e-09	0.31	0.26	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127431	chr2:207110043~207110063:-
KIRC	cis	rs7072216	0.77	rs7897357	MIMAT0005878	hsa-miR-1287-5p	5.99	4.11e-09	0.28	0.26	Metabolite levels;	chr10:98403840	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-5.97	4.59e-09	-0.31	-0.26	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-5.97	4.59e-09	-0.31	-0.26	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-5.97	4.59e-09	-0.31	-0.26	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.77	rs7896828	MIMAT0005878	hsa-miR-1287-5p	5.96	4.79e-09	0.27	0.26	Metabolite levels;	chr10:98410750	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-5.96	4.84e-09	-0.31	-0.26	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.77	rs942810	MIMAT0005878	hsa-miR-1287-5p	5.95	5.05e-09	0.28	0.26	Metabolite levels;	chr10:98408103	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-5.95	5.08e-09	-0.27	-0.26	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
KIRC	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-5.95	5.24e-09	-0.31	-0.26	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-5.94	5.4e-09	-0.31	-0.26	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-5.94	5.4e-09	-0.31	-0.26	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-5.93	5.78e-09	-0.29	-0.26	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
KIRC	cis	rs7072216	0.77	rs7909131	MIMAT0005878	hsa-miR-1287-5p	5.92	6.07e-09	0.27	0.26	Metabolite levels;	chr10:98411714	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	5.92	6.21e-09	0.26	0.26	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
KIRC	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-5.91	6.38e-09	-0.31	-0.26	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.9	6.82e-09	0.29	0.26	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-5.9	7.01e-09	-0.29	-0.26	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-5.89	7.07e-09	-0.29	-0.26	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
KIRC	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	5.89	7.26e-09	0.27	0.26	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	5.85	9.2e-09	0.25	0.26	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
KIRC	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-5.84	9.45e-09	-0.36	-0.26	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
KIRC	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-5.84	9.61e-09	-0.31	-0.26	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-5.84	9.61e-09	-0.31	-0.26	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.77	rs1737	MIMAT0026738	hsa-miR-1287-3p	5.83	9.94e-09	0.25	0.26	Metabolite levels;	chr10:98416609	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	5.82	1.05e-08	0.26	0.26	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	5.81	1.17e-08	0.26	0.26	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
KIRC	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	5.8	1.18e-08	0.41	0.26	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
KIRC	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	5.79	1.27e-08	0.26	0.26	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	5.78	1.33e-08	0.26	0.25	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	5.76	1.47e-08	0.27	0.25	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
KIRC	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-5.76	1.5e-08	-0.35	-0.25	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
KIRC	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	5.76	1.5e-08	0.18	0.25	Migraine;	chr10:103402122	chr10:103394341~103394361:-
KIRC	cis	rs7894407	0.504	rs7089271	MIMAT0022727	hsa-miR-1307-5p	-5.76	1.5e-08	-0.18	-0.25	White matter hyperintensity burden;	chr10:103417157	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.691	rs10786419	MIMAT0005878	hsa-miR-1287-5p	5.75	1.55e-08	0.28	0.25	Metabolite levels;	chr10:98421183	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-5.72	1.9e-08	-0.27	-0.25	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	5.69	2.18e-08	0.26	0.25	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	5.69	2.18e-08	0.26	0.25	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	5.69	2.18e-08	0.26	0.25	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	5.69	2.19e-08	0.27	0.25	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	5.68	2.31e-08	0.26	0.25	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	5.67	2.48e-08	0.26	0.25	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	5.65	2.8e-08	0.26	0.25	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	5.65	2.8e-08	0.26	0.25	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
KIRC	cis	rs6120849	0.663	rs13041792	MIMAT0004772	hsa-miR-499a-3p	-5.65	2.8e-08	-0.35	-0.25	Protein C levels;	chr20:34957252	chr20:34990445~34990466:+
KIRC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-5.64	2.97e-08	-0.58	-0.25	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
KIRC	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-5.63	3.01e-08	-0.17	-0.25	Migraine;	chr10:103273258	chr10:103394341~103394361:-
KIRC	cis	rs6120849	0.615	rs11167248	MIMAT0004772	hsa-miR-499a-3p	-5.63	3.04e-08	-0.35	-0.25	Protein C levels;	chr20:34950918	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.586	rs2025096	MIMAT0004772	hsa-miR-499a-3p	-5.62	3.24e-08	-0.35	-0.25	Protein C levels;	chr20:34952197	chr20:34990445~34990466:+
KIRC	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-5.62	3.28e-08	-0.17	-0.25	Migraine;	chr10:103307280	chr10:103394341~103394361:-
KIRC	cis	rs6120849	0.663	rs11698868	MIMAT0004772	hsa-miR-499a-3p	-5.61	3.39e-08	-0.35	-0.25	Protein C levels;	chr20:34962143	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.663	rs6119548	MIMAT0004772	hsa-miR-499a-3p	-5.61	3.39e-08	-0.35	-0.25	Protein C levels;	chr20:34964809	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.663	rs6088662	MIMAT0004772	hsa-miR-499a-3p	-5.61	3.47e-08	-0.35	-0.25	Protein C levels;	chr20:34959830	chr20:34990445~34990466:+
KIRC	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-5.61	3.48e-08	-0.29	-0.25	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.621	rs3750604	MIMAT0026738	hsa-miR-1287-3p	5.56	4.41e-08	0.28	0.25	Metabolite levels;	chr10:98415824	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	5.54	4.89e-08	0.25	0.24	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
KIRC	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-5.53	5.21e-08	-0.17	-0.24	Migraine;	chr10:103273985	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.922	rs59667296	MIMAT0005878	hsa-miR-1287-5p	5.51	5.99e-08	0.25	0.24	Metabolite levels;	chr10:98386556	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-5.5	6.19e-08	-0.29	-0.24	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
KIRC	cis	rs2284932	0.875	rs1320929	MIMAT0017950	hsa-miR-2355-3p	5.49	6.43e-08	0.26	0.24	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207136098	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-5.48	6.77e-08	-0.25	-0.24	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
KIRC	cis	rs3746446	0.678	rs6120777	MIMAT0004772	hsa-miR-499a-3p	-5.48	6.87e-08	-0.36	-0.24	Congenital left-sided heart lesions;	chr20:34972369	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	5.48	6.99e-08	0.25	0.24	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
KIRC	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.47	7.2e-08	-0.29	-0.24	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-5.47	7.26e-08	-0.29	-0.24	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-5.46	7.65e-08	-0.29	-0.24	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-5.46	7.65e-08	-0.29	-0.24	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-5.46	7.65e-08	-0.29	-0.24	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-5.46	7.65e-08	-0.29	-0.24	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-5.45	8.19e-08	-0.28	-0.24	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-5.45	8.19e-08	-0.28	-0.24	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-5.43	8.72e-08	-0.26	-0.24	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
KIRC	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-5.43	8.8e-08	-0.28	-0.24	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
KIRC	cis	rs2284932	0.556	rs6727168	MIMAT0016895	hsa-miR-2355-5p	-5.43	9.14e-08	-0.27	-0.24	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207124746	chr2:207110043~207110063:-
KIRC	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.42	9.54e-08	-0.34	-0.24	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-5.4	1.03e-07	-0.28	-0.24	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-5.4	1.03e-07	-0.28	-0.24	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
KIRC	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-5.39	1.1e-07	-0.17	-0.24	Migraine;	chr10:103279291	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	5.38	1.15e-07	0.26	0.24	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
KIRC	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-5.38	1.17e-07	-0.28	-0.24	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
KIRC	cis	rs2284932	1	rs2284932	MIMAT0017950	hsa-miR-2355-3p	5.38	1.19e-07	0.26	0.24	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207147785	chr2:207109999~207110020:-
KIRC	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	5.35	1.33e-07	0.16	0.24	Migraine;	chr10:103347713	chr10:103394341~103394361:-
KIRC	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-5.35	1.38e-07	-0.28	-0.24	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-5.33	1.49e-07	-0.28	-0.24	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	5.32	1.6e-07	0.24	0.24	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
KIRC	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-5.3	1.74e-07	-0.28	-0.23	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-5.29	1.88e-07	-0.28	-0.23	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	5.28	1.94e-07	0.28	0.23	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-5.27	2.03e-07	-0.28	-0.23	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-5.27	2.09e-07	-0.34	-0.23	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.573	rs3746429	MIMAT0004772	hsa-miR-499a-3p	5.25	2.34e-07	0.38	0.23	Protein C levels;	chr20:35115804	chr20:34990445~34990466:+
KIRC	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.22	2.65e-07	-0.33	-0.23	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-5.21	2.78e-07	-0.33	-0.23	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.691	rs10786419	MIMAT0026738	hsa-miR-1287-3p	5.19	3.09e-07	0.24	0.23	Metabolite levels;	chr10:98421183	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.77	rs3830020	MIMAT0026738	hsa-miR-1287-3p	-5.19	3.13e-07	-0.23	-0.23	Metabolite levels;	chr10:98416858	chr10:98395232~98395253:-
KIRC	cis	rs6120849	1	rs6120849	MIMAT0004772	hsa-miR-499a-3p	-5.17	3.5e-07	-0.3	-0.23	Protein C levels;	chr20:35142584	chr20:34990445~34990466:+
KIRC	cis	rs2284932	0.875	rs764487	MIMAT0017950	hsa-miR-2355-3p	5.17	3.52e-07	0.24	0.23	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207136544	chr2:207109999~207110020:-
KIRC	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	5.15	3.84e-07	0.41	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	5.15	3.84e-07	0.41	0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
KIRC	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.12	4.52e-07	-0.3	-0.23	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
KIRC	cis	rs2284932	0.875	rs1320929	MIMAT0016895	hsa-miR-2355-5p	5.11	4.59e-07	0.24	0.23	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207136098	chr2:207110043~207110063:-
KIRC	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-5.09	5.16e-07	-0.27	-0.23	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-5.09	5.16e-07	-0.27	-0.23	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
KIRC	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-5.09	5.16e-07	-0.27	-0.23	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.555	rs2296433	MIMAT0026738	hsa-miR-1287-3p	5.09	5.26e-07	0.25	0.23	Metabolite levels;	chr10:98424305	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.555	rs2296432	MIMAT0026738	hsa-miR-1287-3p	5.09	5.26e-07	0.25	0.23	Metabolite levels;	chr10:98424306	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.77	rs7909131	MIMAT0026738	hsa-miR-1287-3p	5.08	5.28e-07	0.22	0.23	Metabolite levels;	chr10:98411714	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.922	rs942813	MIMAT0005878	hsa-miR-1287-5p	5.08	5.31e-07	0.23	0.23	Metabolite levels;	chr10:98393851	chr10:98395271~98395292:-
KIRC	cis	rs6120849	0.951	rs6120848	MIMAT0004772	hsa-miR-499a-3p	-5.08	5.41e-07	-0.31	-0.23	Protein C levels;	chr20:35140875	chr20:34990445~34990466:+
KIRC	cis	rs2284932	0.533	rs918282	MIMAT0017950	hsa-miR-2355-3p	5.08	5.52e-07	0.26	0.23	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127274	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.922	rs6584191	MIMAT0005878	hsa-miR-1287-5p	5.07	5.56e-07	0.23	0.23	Metabolite levels;	chr10:98392298	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-5.07	5.72e-07	-0.27	-0.22	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
KIRC	cis	rs2284932	0.533	rs16839275	MIMAT0017950	hsa-miR-2355-3p	5.07	5.76e-07	0.26	0.22	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207127431	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.881	rs2147895	MIMAT0005878	hsa-miR-1287-5p	5.05	6.22e-07	0.23	0.22	Metabolite levels;	chr10:98388551	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.922	rs4539242	MIMAT0005878	hsa-miR-1287-5p	5.04	6.65e-07	0.23	0.22	Metabolite levels;	chr10:98388301	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.881	rs2147896	MIMAT0005878	hsa-miR-1287-5p	5.04	6.65e-07	0.23	0.22	Metabolite levels;	chr10:98388419	chr10:98395271~98395292:-
KIRC	cis	rs2284932	0.556	rs2014766	MIMAT0017950	hsa-miR-2355-3p	5.04	6.73e-07	0.26	0.22	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207126660	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.77	rs942810	MIMAT0026738	hsa-miR-1287-3p	5.03	6.84e-07	0.22	0.22	Metabolite levels;	chr10:98408103	chr10:98395232~98395253:-
KIRC	cis	rs2284932	0.556	rs6727168	MIMAT0017950	hsa-miR-2355-3p	-5.02	7.22e-07	-0.25	-0.22	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207124746	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.922	rs4488133	MIMAT0005878	hsa-miR-1287-5p	-5.01	7.68e-07	-0.23	-0.22	Metabolite levels;	chr10:98399379	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.881	rs7916469	MIMAT0005878	hsa-miR-1287-5p	4.97	9.17e-07	0.23	0.22	Metabolite levels;	chr10:98388896	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.922	rs10786415	MIMAT0005878	hsa-miR-1287-5p	4.97	9.36e-07	0.23	0.22	Metabolite levels;	chr10:98391509	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.922	rs942814	MIMAT0005878	hsa-miR-1287-5p	4.97	9.36e-07	0.23	0.22	Metabolite levels;	chr10:98391548	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.881	rs2182168	MIMAT0005878	hsa-miR-1287-5p	4.96	9.66e-07	0.23	0.22	Metabolite levels;	chr10:98388596	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.881	rs755126	MIMAT0005878	hsa-miR-1287-5p	4.96	9.93e-07	0.23	0.22	Metabolite levels;	chr10:98389194	chr10:98395271~98395292:-
KIRC	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-4.94	1.08e-06	-0.26	-0.22	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
KIRC	cis	rs7072216	1	rs7072216	MIMAT0005878	hsa-miR-1287-5p	4.94	1.09e-06	0.23	0.22	Metabolite levels;	chr10:98397096	chr10:98395271~98395292:-
KIRC	cis	rs1950626	0.796	rs7152870	MIMAT0026557	hsa-miR-412-5p	4.92	1.2e-06	0.27	0.22	Pelvic organ prolapse (moderate/severe);	chr14:100923650	chr14:101065465~101065487:+
KIRC	cis	rs9807989	0.507	rs1420097	MIMAT0019927	hsa-miR-4772-3p	4.91	1.23e-06	0.25	0.22	Asthma;	chr2:102392894	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	4.91	1.26e-06	0.21	0.22	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
KIRC	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-4.9	1.32e-06	-0.29	-0.22	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
KIRC	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-4.9	1.32e-06	-0.29	-0.22	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
KIRC	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-4.9	1.32e-06	-0.29	-0.22	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
KIRC	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-4.9	1.32e-06	-0.29	-0.22	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
KIRC	cis	rs7072216	0.881	rs10883084	MIMAT0005878	hsa-miR-1287-5p	4.9	1.34e-06	0.23	0.22	Metabolite levels;	chr10:98391432	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.77	rs7897357	MIMAT0026738	hsa-miR-1287-3p	4.89	1.35e-06	0.21	0.22	Metabolite levels;	chr10:98403840	chr10:98395232~98395253:-
KIRC	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-4.89	1.36e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-4.89	1.36e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
KIRC	cis	rs7072216	0.881	rs2274247	MIMAT0005878	hsa-miR-1287-5p	4.88	1.42e-06	0.22	0.22	Metabolite levels;	chr10:98390391	chr10:98395271~98395292:-
KIRC	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-4.88	1.45e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-4.88	1.45e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
KIRC	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-4.88	1.45e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-4.88	1.45e-06	-0.37	-0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
KIRC	cis	rs7072216	0.652	rs11189600	MIMAT0026738	hsa-miR-1287-3p	-4.87	1.49e-06	-0.22	-0.22	Metabolite levels;	chr10:98419517	chr10:98395232~98395253:-
KIRC	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	4.87	1.51e-06	0.35	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	4.87	1.51e-06	0.35	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
KIRC	cis	rs2284932	1	rs2284932	MIMAT0016895	hsa-miR-2355-5p	4.86	1.63e-06	0.24	0.22	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207147785	chr2:207110043~207110063:-
KIRC	cis	rs7072216	0.922	rs2296438	MIMAT0005878	hsa-miR-1287-5p	4.85	1.67e-06	0.22	0.22	Metabolite levels;	chr10:98387138	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	4.84	1.74e-06	0.25	0.22	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
KIRC	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	4.84	1.75e-06	0.14	0.22	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
KIRC	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	4.84	1.77e-06	0.15	0.22	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
KIRC	cis	rs6120849	0.707	rs3746448	MIMAT0004772	hsa-miR-499a-3p	-4.83	1.85e-06	-0.35	-0.21	Protein C levels;	chr20:34985176	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	4.82	1.89e-06	0.25	0.21	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
KIRC	cis	rs6703335	0.735	rs12129652	MIMAT0019761	hsa-miR-4677-3p	4.82	1.89e-06	0.21	0.21	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243412167	chr1:243346225~243346246:+
KIRC	cis	rs7072216	0.881	rs6584192	MIMAT0005878	hsa-miR-1287-5p	4.82	1.91e-06	0.22	0.21	Metabolite levels;	chr10:98392616	chr10:98395271~98395292:-
KIRC	cis	rs6703335	0.735	rs10927011	MIMAT0019761	hsa-miR-4677-3p	-4.81	2.03e-06	-0.21	-0.21	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243415810	chr1:243346225~243346246:+
KIRC	cis	rs1950626	0.833	rs35436326	MIMAT0026557	hsa-miR-412-5p	-4.81	2.06e-06	-0.26	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100929811	chr14:101065465~101065487:+
KIRC	cis	rs7072216	0.881	rs2182169	MIMAT0005878	hsa-miR-1287-5p	4.79	2.23e-06	0.22	0.21	Metabolite levels;	chr10:98388247	chr10:98395271~98395292:-
KIRC	cis	rs1950626	0.833	rs12892225	MIMAT0026557	hsa-miR-412-5p	-4.77	2.4e-06	-0.26	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100949076	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.75	rs72700530	MIMAT0026557	hsa-miR-412-5p	-4.77	2.5e-06	-0.26	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100963122	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs35151884	MIMAT0026557	hsa-miR-412-5p	-4.76	2.56e-06	-0.26	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100927859	chr14:101065465~101065487:+
KIRC	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	4.76	2.61e-06	0.14	0.21	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
KIRC	cis	rs2284932	0.875	rs764487	MIMAT0016895	hsa-miR-2355-5p	4.74	2.79e-06	0.23	0.21	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207136544	chr2:207110043~207110063:-
KIRC	cis	rs7072216	0.922	rs7097824	MIMAT0005878	hsa-miR-1287-5p	4.73	2.92e-06	0.22	0.21	Metabolite levels;	chr10:98392042	chr10:98395271~98395292:-
KIRC	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-4.73	3e-06	-0.28	-0.21	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
KIRC	cis	rs7072216	0.881	rs1079179	MIMAT0005878	hsa-miR-1287-5p	4.71	3.3e-06	0.22	0.21	Metabolite levels;	chr10:98389589	chr10:98395271~98395292:-
KIRC	cis	rs1950626	0.751	rs12883799	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100930513	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs67456801	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100932832	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs1951025	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100939685	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.827	rs35829821	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100943426	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs34463495	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100944849	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs12891189	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100949186	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs72700524	MIMAT0026557	hsa-miR-412-5p	-4.7	3.44e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100950972	chr14:101065465~101065487:+
KIRC	cis	rs1163656	0.572	rs1402349	MIMAT0003287	hsa-miR-618	-4.7	3.44e-06	-0.28	-0.21	Dental caries;	chr12:80919985	chr12:80935796~80935818:-
KIRC	cis	rs1950626	0.75	rs35820579	MIMAT0026557	hsa-miR-412-5p	-4.68	3.74e-06	-0.26	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100969178	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs2400963	MIMAT0026557	hsa-miR-412-5p	-4.67	3.85e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100929369	chr14:101065465~101065487:+
KIRC	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	4.67	3.89e-06	0.23	0.21	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
KIRC	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-4.67	3.93e-06	-0.36	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-4.67	3.93e-06	-0.36	-0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
KIRC	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-4.66	4.09e-06	-0.23	-0.21	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
KIRC	cis	rs1950626	0.787	rs34857222	MIMAT0026557	hsa-miR-412-5p	-4.65	4.28e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100925017	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.833	rs12897114	MIMAT0026557	hsa-miR-412-5p	-4.65	4.28e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100928803	chr14:101065465~101065487:+
KIRC	cis	rs7072216	0.881	rs2147897	MIMAT0005878	hsa-miR-1287-5p	-4.65	4.36e-06	-0.21	-0.21	Metabolite levels;	chr10:98388056	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.922	rs942813	MIMAT0026738	hsa-miR-1287-3p	4.65	4.38e-06	0.2	0.21	Metabolite levels;	chr10:98393851	chr10:98395232~98395253:-
KIRC	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	4.65	4.39e-06	0.14	0.21	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
KIRC	cis	rs1950626	0.75	rs34144313	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100964879	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.705	rs34991312	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100968830	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.75	rs34061904	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100969637	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.75	rs34228453	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100973984	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.662	rs72700538	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100975574	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.75	rs12895798	MIMAT0026557	hsa-miR-412-5p	-4.63	4.61e-06	-0.25	-0.21	Pelvic organ prolapse (moderate/severe);	chr14:100976456	chr14:101065465~101065487:+
KIRC	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-4.6	5.46e-06	-0.23	-0.2	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-4.6	5.46e-06	-0.23	-0.2	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-4.6	5.46e-06	-0.23	-0.2	Asthma;	chr2:102394452	chr2:102432336~102432357:+
KIRC	cis	rs6703335	1	rs10927013	MIMAT0019761	hsa-miR-4677-3p	-4.58	5.87e-06	-0.2	-0.2	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243425854	chr1:243346225~243346246:+
KIRC	cis	rs7072216	0.881	rs4345897	MIMAT0005878	hsa-miR-1287-5p	4.58	5.89e-06	0.21	0.2	Metabolite levels;	chr10:98387303	chr10:98395271~98395292:-
KIRC	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	4.58	5.95e-06	0.23	0.2	Asthma;	chr2:102393077	chr2:102432336~102432357:+
KIRC	cis	rs9527	0.59	rs1475642	MIMAT0005951	hsa-miR-1307-3p	-4.56	6.5e-06	-0.14	-0.2	Arsenic metabolism;	chr10:102786426	chr10:103394301~103394322:-
KIRC	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-4.55	6.66e-06	-0.29	-0.2	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
KIRC	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-4.55	6.8e-06	-0.14	-0.2	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
KIRC	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.25e-06	-0.23	-0.2	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.25e-06	-0.23	-0.2	Asthma;	chr2:102388870	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.25e-06	-0.23	-0.2	Asthma;	chr2:102389644	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.25e-06	-0.23	-0.2	Asthma;	chr2:102389988	chr2:102432336~102432357:+
KIRC	cis	rs7894407	0.856	rs7093667	MIMAT0022727	hsa-miR-1307-5p	-4.5	8.38e-06	-0.15	-0.2	White matter hyperintensity burden;	chr10:103320818	chr10:103394341~103394361:-
KIRC	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	4.5	8.42e-06	0.28	0.2	Asthma;	chr2:102344364	chr2:102432300~102432321:+
KIRC	cis	rs6703335	0.687	rs4658560	MIMAT0019761	hsa-miR-4677-3p	4.5	8.44e-06	0.2	0.2	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243355389	chr1:243346225~243346246:+
KIRC	cis	rs6120849	0.662	rs6060300	MIMAT0004772	hsa-miR-499a-3p	-4.5	8.62e-06	-0.28	-0.2	Protein C levels;	chr20:35193167	chr20:34990445~34990466:+
KIRC	cis	rs953492	0.863	rs2490395	MIMAT0019761	hsa-miR-4677-3p	-4.49	8.91e-06	-0.2	-0.2	Diastolic blood pressure;	chr1:243295620	chr1:243346225~243346246:+
KIRC	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	4.48	9.31e-06	0.23	0.2	Asthma;	chr2:102374909	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.922	rs4539242	MIMAT0026738	hsa-miR-1287-3p	4.48	9.45e-06	0.19	0.2	Metabolite levels;	chr10:98388301	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.881	rs2147896	MIMAT0026738	hsa-miR-1287-3p	4.48	9.45e-06	0.19	0.2	Metabolite levels;	chr10:98388419	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.922	rs6584191	MIMAT0026738	hsa-miR-1287-3p	4.47	9.83e-06	0.19	0.2	Metabolite levels;	chr10:98392298	chr10:98395232~98395253:-
KIRC	cis	rs7894407	0.76	rs4917386	MIMAT0022727	hsa-miR-1307-5p	4.47	9.95e-06	0.15	0.2	White matter hyperintensity burden;	chr10:103247771	chr10:103394341~103394361:-
KIRC	cis	rs953492	0.932	rs2783972	MIMAT0019761	hsa-miR-4677-3p	-4.45	1.05e-05	-0.2	-0.2	Diastolic blood pressure;	chr1:243318129	chr1:243346225~243346246:+
KIRC	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	4.44	1.11e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.881	rs11189591	MIMAT0005878	hsa-miR-1287-5p	4.44	1.13e-05	0.2	0.2	Metabolite levels;	chr10:98395539	chr10:98395271~98395292:-
KIRC	cis	rs6120849	0.951	rs55670307	MIMAT0004772	hsa-miR-499a-3p	-4.43	1.15e-05	-0.27	-0.2	Protein C levels;	chr20:35132691	chr20:34990445~34990466:+
KIRC	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.15e-05	-0.23	-0.2	Asthma;	chr2:102379885	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.922	rs10786415	MIMAT0026738	hsa-miR-1287-3p	4.43	1.16e-05	0.19	0.2	Metabolite levels;	chr10:98391509	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.922	rs942814	MIMAT0026738	hsa-miR-1287-3p	4.43	1.16e-05	0.19	0.2	Metabolite levels;	chr10:98391548	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.922	rs4488133	MIMAT0026738	hsa-miR-1287-3p	-4.43	1.18e-05	-0.19	-0.2	Metabolite levels;	chr10:98399379	chr10:98395232~98395253:-
KIRC	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	4.42	1.2e-05	0.22	0.2	Asthma;	chr2:102401592	chr2:102432336~102432357:+
KIRC	cis	rs1950626	0.671	rs34675695	MIMAT0026557	hsa-miR-412-5p	-4.42	1.22e-05	-0.24	-0.2	Pelvic organ prolapse (moderate/severe);	chr14:100981576	chr14:101065465~101065487:+
KIRC	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	4.41	1.26e-05	0.12	0.2	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
KIRC	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	4.41	1.28e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	4.41	1.28e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	4.41	1.28e-05	0.22	0.2	Asthma;	chr2:102438096	chr2:102432336~102432357:+
KIRC	cis	rs7894407	0.856	rs10883855	MIMAT0022727	hsa-miR-1307-5p	-4.41	1.28e-05	-0.14	-0.2	White matter hyperintensity burden;	chr10:103332690	chr10:103394341~103394361:-
KIRC	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	4.41	1.29e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
KIRC	cis	rs6708413	0.528	rs7567885	MIMAT0019927	hsa-miR-4772-3p	4.41	1.3e-05	0.25	0.2	Crohn's disease;Inflammatory bowel disease;	chr2:102492393	chr2:102432336~102432357:+
KIRC	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-4.41	1.3e-05	-0.13	-0.2	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	4.4	1.31e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
KIRC	cis	rs7917772	0.508	rs2252147	MIMAT0005951	hsa-miR-1307-3p	-4.4	1.32e-05	-0.15	-0.2	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102708017	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.4e-05	-0.22	-0.2	Asthma;	chr2:102374753	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.41e-05	-0.22	-0.2	Asthma;	chr2:102381819	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.41e-05	-0.22	-0.2	Asthma;	chr2:102382514	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.41e-05	-0.22	-0.2	Asthma;	chr2:102382943	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.41e-05	-0.22	-0.2	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.41e-05	-0.22	-0.2	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
KIRC	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	4.39	1.42e-05	0.12	0.2	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.42e-05	-0.22	-0.2	Asthma;	chr2:102381261	chr2:102432336~102432357:+
KIRC	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	4.39	1.42e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	4.38	1.46e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.881	rs7082192	MIMAT0005878	hsa-miR-1287-5p	4.37	1.5e-05	0.2	0.2	Metabolite levels;	chr10:98392087	chr10:98395271~98395292:-
KIRC	cis	rs953492	1	rs2783971	MIMAT0019761	hsa-miR-4677-3p	-4.37	1.52e-05	-0.19	-0.2	Diastolic blood pressure;	chr1:243311234	chr1:243346225~243346246:+
KIRC	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.37	1.55e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	4.37	1.55e-05	0.13	0.2	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.36	1.58e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	4.36	1.59e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
KIRC	cis	rs1950626	0.716	rs34572720	MIMAT0026557	hsa-miR-412-5p	-4.36	1.6e-05	-0.24	-0.19	Pelvic organ prolapse (moderate/severe);	chr14:100980813	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.716	rs34158896	MIMAT0026557	hsa-miR-412-5p	-4.36	1.6e-05	-0.24	-0.19	Pelvic organ prolapse (moderate/severe);	chr14:100981036	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.75	rs35683125	MIMAT0026557	hsa-miR-412-5p	-4.36	1.6e-05	-0.24	-0.19	Pelvic organ prolapse (moderate/severe);	chr14:100988413	chr14:101065465~101065487:+
KIRC	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	4.34	1.72e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
KIRC	cis	rs768090	0.798	rs2284933	MIMAT0017950	hsa-miR-2355-3p	4.34	1.73e-05	0.2	0.19	Hemoglobin concentration;Hematocrit;	chr2:207134297	chr2:207109999~207110020:-
KIRC	cis	rs7072216	0.666	rs11189592	MIMAT0005878	hsa-miR-1287-5p	4.34	1.75e-05	0.22	0.19	Metabolite levels;	chr10:98395885	chr10:98395271~98395292:-
KIRC	cis	rs953492	0.83	rs2636321	MIMAT0019761	hsa-miR-4677-3p	-4.34	1.76e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243301114	chr1:243346225~243346246:+
KIRC	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-4.34	1.77e-05	-0.22	-0.19	Asthma;	chr2:102403325	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.78e-05	-0.22	-0.19	Asthma;	chr2:102402540	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.78e-05	-0.22	-0.19	Asthma;	chr2:102402571	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.78e-05	-0.22	-0.19	Asthma;	chr2:102399227	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.901	rs6088739	MIMAT0004772	hsa-miR-499a-3p	-4.33	1.79e-05	-0.25	-0.19	Protein C levels;	chr20:35160921	chr20:34990445~34990466:+
KIRC	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.82e-05	-0.22	-0.19	Asthma;	chr2:102446466	chr2:102432336~102432357:+
KIRC	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	4.33	1.84e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-4.33	1.84e-05	-0.22	-0.19	Asthma;	chr2:102403679	chr2:102432336~102432357:+
KIRC	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	4.32	1.86e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.32	1.86e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.922	rs59667296	MIMAT0026738	hsa-miR-1287-3p	4.32	1.88e-05	0.18	0.19	Metabolite levels;	chr10:98386556	chr10:98395232~98395253:-
KIRC	cis	rs6703335	0.696	rs10927003	MIMAT0019761	hsa-miR-4677-3p	-4.32	1.89e-05	-0.19	-0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243381548	chr1:243346225~243346246:+
KIRC	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	4.32	1.9e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
KIRC	cis	rs6703335	1	rs2039839	MIMAT0019761	hsa-miR-4677-3p	-4.32	1.91e-05	-0.18	-0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243435368	chr1:243346225~243346246:+
KIRC	cis	rs7072216	0.881	rs755126	MIMAT0026738	hsa-miR-1287-3p	4.31	1.99e-05	0.19	0.19	Metabolite levels;	chr10:98389194	chr10:98395232~98395253:-
KIRC	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	4.31	1.99e-05	0.22	0.19	Asthma;	chr2:102374328	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-4.31	2e-05	-0.22	-0.19	Asthma;	chr2:102404807	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-4.31	2e-05	-0.22	-0.19	Asthma;	chr2:102407218	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-4.31	2e-05	-0.22	-0.19	Asthma;	chr2:102446780	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.881	rs2147895	MIMAT0026738	hsa-miR-1287-3p	4.31	2.01e-05	0.19	0.19	Metabolite levels;	chr10:98388551	chr10:98395232~98395253:-
KIRC	cis	rs6703335	0.687	rs10754803	MIMAT0019761	hsa-miR-4677-3p	-4.3	2.03e-05	-0.19	-0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243349745	chr1:243346225~243346246:+
KIRC	cis	rs953492	0.83	rs2484639	MIMAT0019761	hsa-miR-4677-3p	-4.3	2.1e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243299065	chr1:243346225~243346246:+
KIRC	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-4.29	2.11e-05	-0.12	-0.19	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.29	2.12e-05	0.22	0.19	Asthma;	chr2:102394777	chr2:102432336~102432357:+
KIRC	cis	rs7072216	0.881	rs7916469	MIMAT0026738	hsa-miR-1287-3p	4.29	2.13e-05	0.18	0.19	Metabolite levels;	chr10:98388896	chr10:98395232~98395253:-
KIRC	cis	rs953492	0.932	rs2636323	MIMAT0019761	hsa-miR-4677-3p	-4.29	2.16e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243318254	chr1:243346225~243346246:+
KIRC	cis	rs953492	0.831	rs2802723	MIMAT0019761	hsa-miR-4677-3p	-4.29	2.2e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243335010	chr1:243346225~243346246:+
KIRC	cis	rs9527	0.662	rs4919686	MIMAT0005951	hsa-miR-1307-3p	4.28	2.26e-05	0.14	0.19	Arsenic metabolism;	chr10:102832492	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.881	rs10883084	MIMAT0026738	hsa-miR-1287-3p	4.28	2.3e-05	0.18	0.19	Metabolite levels;	chr10:98391432	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.881	rs2182168	MIMAT0026738	hsa-miR-1287-3p	4.28	2.3e-05	0.18	0.19	Metabolite levels;	chr10:98388596	chr10:98395232~98395253:-
KIRC	cis	rs6120849	0.802	rs6087681	MIMAT0004772	hsa-miR-499a-3p	-4.28	2.3e-05	-0.25	-0.19	Protein C levels;	chr20:35165093	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.802	rs6087682	MIMAT0004772	hsa-miR-499a-3p	-4.28	2.3e-05	-0.25	-0.19	Protein C levels;	chr20:35165094	chr20:34990445~34990466:+
KIRC	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	4.27	2.35e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
KIRC	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	4.27	2.35e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
KIRC	cis	rs6120849	0.901	rs13037296	MIMAT0004772	hsa-miR-499a-3p	-4.27	2.38e-05	-0.25	-0.19	Protein C levels;	chr20:35161425	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.881	rs2274247	MIMAT0026738	hsa-miR-1287-3p	4.26	2.41e-05	0.18	0.19	Metabolite levels;	chr10:98390391	chr10:98395232~98395253:-
KIRC	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-4.26	2.42e-05	-0.21	-0.19	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
KIRC	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-4.26	2.43e-05	-0.22	-0.19	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.851	rs13040631	MIMAT0004772	hsa-miR-499a-3p	-4.26	2.43e-05	-0.25	-0.19	Protein C levels;	chr20:35159911	chr20:34990445~34990466:+
KIRC	cis	rs1950626	0.743	rs1956734	MIMAT0026557	hsa-miR-412-5p	4.26	2.44e-05	0.23	0.19	Pelvic organ prolapse (moderate/severe);	chr14:100933493	chr14:101065465~101065487:+
KIRC	cis	rs768090	0.541	rs1263621	MIMAT0017950	hsa-miR-2355-3p	4.26	2.44e-05	0.2	0.19	Hemoglobin concentration;Hematocrit;	chr2:207118472	chr2:207109999~207110020:-
KIRC	cis	rs6120849	0.901	rs6088735	MIMAT0004772	hsa-miR-499a-3p	-4.26	2.48e-05	-0.25	-0.19	Protein C levels;	chr20:35157873	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.901	rs6088737	MIMAT0004772	hsa-miR-499a-3p	-4.26	2.48e-05	-0.25	-0.19	Protein C levels;	chr20:35158135	chr20:34990445~34990466:+
KIRC	cis	rs6703335	0.841	rs10803140	MIMAT0019761	hsa-miR-4677-3p	-4.24	2.64e-05	-0.18	-0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243410087	chr1:243346225~243346246:+
KIRC	cis	rs7072216	1	rs7072216	MIMAT0026738	hsa-miR-1287-3p	4.24	2.66e-05	0.18	0.19	Metabolite levels;	chr10:98397096	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.881	rs2182169	MIMAT0026738	hsa-miR-1287-3p	4.24	2.68e-05	0.18	0.19	Metabolite levels;	chr10:98388247	chr10:98395232~98395253:-
KIRC	cis	rs768090	0.812	rs7589607	MIMAT0017950	hsa-miR-2355-3p	4.24	2.69e-05	0.21	0.19	Hemoglobin concentration;Hematocrit;	chr2:207124821	chr2:207109999~207110020:-
KIRC	cis	rs4927850	1	rs7627706	MIMAT0003235	hsa-miR-570-3p	4.24	2.71e-05	0.22	0.19	Pancreatic cancer;	chr3:196026482	chr3:195699460~195699481:+
KIRC	cis	rs4927850	0.881	rs7630489	MIMAT0003235	hsa-miR-570-3p	4.24	2.71e-05	0.22	0.19	Pancreatic cancer;	chr3:196026530	chr3:195699460~195699481:+
KIRC	cis	rs4927850	1	rs7627868	MIMAT0003235	hsa-miR-570-3p	4.24	2.71e-05	0.22	0.19	Pancreatic cancer;	chr3:196026602	chr3:195699460~195699481:+
KIRC	cis	rs6120849	0.901	rs6060273	MIMAT0004772	hsa-miR-499a-3p	-4.24	2.74e-05	-0.25	-0.19	Protein C levels;	chr20:35156520	chr20:34990445~34990466:+
KIRC	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-4.23	2.78e-05	-0.2	-0.19	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	4.23	2.79e-05	0.19	0.19	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
KIRC	cis	rs7072216	0.881	rs6584192	MIMAT0026738	hsa-miR-1287-3p	4.22	2.87e-05	0.18	0.19	Metabolite levels;	chr10:98392616	chr10:98395232~98395253:-
KIRC	cis	rs7917772	0.505	rs61869211	MIMAT0005951	hsa-miR-1307-3p	-4.22	2.9e-05	-0.14	-0.19	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102690079	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.881	rs2147897	MIMAT0026738	hsa-miR-1287-3p	-4.22	2.92e-05	-0.18	-0.19	Metabolite levels;	chr10:98388056	chr10:98395232~98395253:-
KIRC	cis	rs7894407	0.76	rs1163072	MIMAT0022727	hsa-miR-1307-5p	4.22	2.96e-05	0.14	0.19	White matter hyperintensity burden;	chr10:103264621	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.545	rs35756290	MIMAT0005951	hsa-miR-1307-3p	4.21	2.99e-05	0.14	0.19	Arsenic metabolism;	chr10:102825815	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.922	rs7097824	MIMAT0026738	hsa-miR-1287-3p	4.2	3.24e-05	0.18	0.19	Metabolite levels;	chr10:98392042	chr10:98395232~98395253:-
KIRC	cis	rs7917772	0.565	rs61869210	MIMAT0005951	hsa-miR-1307-3p	-4.19	3.25e-05	-0.14	-0.19	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102677418	chr10:103394301~103394322:-
KIRC	cis	rs7072216	0.881	rs1079179	MIMAT0026738	hsa-miR-1287-3p	4.19	3.35e-05	0.18	0.19	Metabolite levels;	chr10:98389589	chr10:98395232~98395253:-
KIRC	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	4.19	3.35e-05	0.25	0.19	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
KIRC	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-4.18	3.42e-05	-0.12	-0.19	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
KIRC	cis	rs953492	0.863	rs2802722	MIMAT0019761	hsa-miR-4677-3p	-4.18	3.5e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243335231	chr1:243346225~243346246:+
KIRC	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	4.18	3.5e-05	0.13	0.19	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
KIRC	cis	rs9527	0.615	rs11191401	MIMAT0005951	hsa-miR-1307-3p	4.18	3.52e-05	0.13	0.19	Arsenic metabolism;	chr10:102813646	chr10:103394301~103394322:-
KIRC	cis	rs6120849	0.901	rs6060266	MIMAT0004772	hsa-miR-499a-3p	-4.18	3.53e-05	-0.25	-0.19	Protein C levels;	chr20:35145275	chr20:34990445~34990466:+
KIRC	cis	rs6120849	0.901	rs6058193	MIMAT0004772	hsa-miR-499a-3p	-4.18	3.53e-05	-0.25	-0.19	Protein C levels;	chr20:35146661	chr20:34990445~34990466:+
KIRC	cis	rs75358501	0.551	rs10171736	MIMAT0014995	hsa-miR-3130-5p	-4.17	3.6e-05	-0.29	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783276~206783296:-
KIRC	cis	rs75358501	0.551	rs10171736	MIMAT0014995_1	hsa-miR-3130-5p	-4.17	3.6e-05	-0.29	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783246~206783266:+
KIRC	cis	rs953492	0.932	rs2490391	MIMAT0019761	hsa-miR-4677-3p	-4.17	3.66e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243306367	chr1:243346225~243346246:+
KIRC	cis	rs7072216	0.687	rs7097625	MIMAT0005878	hsa-miR-1287-5p	4.16	3.7e-05	0.2	0.19	Metabolite levels;	chr10:98399165	chr10:98395271~98395292:-
KIRC	cis	rs7917772	0.69	rs11191369	MIMAT0005951	hsa-miR-1307-3p	-4.16	3.72e-05	-0.12	-0.19	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102697699	chr10:103394301~103394322:-
KIRC	cis	rs953492	0.932	rs2932634	MIMAT0019761	hsa-miR-4677-3p	-4.16	3.74e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243307151	chr1:243346225~243346246:+
KIRC	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	4.16	3.78e-05	0.12	0.19	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
KIRC	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-4.16	3.79e-05	-0.21	-0.19	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
KIRC	cis	rs6120849	0.901	rs6088733	MIMAT0004772	hsa-miR-499a-3p	-4.16	3.8e-05	-0.24	-0.19	Protein C levels;	chr20:35157101	chr20:34990445~34990466:+
KIRC	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-4.16	3.83e-05	-0.22	-0.19	Asthma;	chr2:102368164	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.91e-05	-0.21	-0.19	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
KIRC	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	4.15	3.92e-05	0.12	0.19	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
KIRC	cis	rs4988958	0.565	rs885088	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.95e-05	-0.21	-0.19	Asthma (childhood onset);	chr2:102422584	chr2:102432336~102432357:+
KIRC	cis	rs7894407	0.892	rs10883859	MIMAT0022727	hsa-miR-1307-5p	4.15	3.99e-05	0.14	0.19	White matter hyperintensity burden;	chr10:103368377	chr10:103394341~103394361:-
KIRC	cis	rs59072704	0.843	rs12031783	MIMAT0019761	hsa-miR-4677-3p	4.14	4.07e-05	0.25	0.19	Monocyte count;	chr1:244335446	chr1:243346225~243346246:+
KIRC	cis	rs953492	0.83	rs2451669	MIMAT0019761	hsa-miR-4677-3p	-4.14	4.07e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243329822	chr1:243346225~243346246:+
KIRC	cis	rs482700	0.876	rs518645	MIMAT0003242	hsa-miR-577	-4.14	4.07e-05	-0.22	-0.19	Stromal-cell-derived factor 1 alpha levels;	chr4:115120708	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	4.14	4.11e-05	0.2	0.19	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
KIRC	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-4.14	4.12e-05	-0.21	-0.19	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.901	rs6088738	MIMAT0004772	hsa-miR-499a-3p	4.14	4.18e-05	0.24	0.19	Protein C levels;	chr20:35159528	chr20:34990445~34990466:+
KIRC	cis	rs768090	0.812	rs763865	MIMAT0017950	hsa-miR-2355-3p	4.13	4.28e-05	0.21	0.18	Hemoglobin concentration;Hematocrit;	chr2:207124506	chr2:207109999~207110020:-
KIRC	cis	rs9527	0.662	rs10786714	MIMAT0005951	hsa-miR-1307-3p	4.13	4.3e-05	0.13	0.18	Arsenic metabolism;	chr10:102838849	chr10:103394301~103394322:-
KIRC	cis	rs482700	0.876	rs559420	MIMAT0003242	hsa-miR-577	-4.12	4.52e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115137324	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-4.12	4.53e-05	-0.21	-0.18	Asthma;	chr2:102369915	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.901	rs11696967	MIMAT0004772	hsa-miR-499a-3p	-4.11	4.56e-05	-0.24	-0.18	Protein C levels;	chr20:35155806	chr20:34990445~34990466:+
KIRC	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-4.11	4.71e-05	-0.21	-0.18	Asthma;	chr2:102369762	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.729	rs10170583	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102358304	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102359712	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102360736	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102361051	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102361270	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102361999	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102363164	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102364083	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102364846	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102365634	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.8e-05	-0.21	-0.18	Asthma;	chr2:102410644	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.95e-05	-0.21	-0.18	Asthma;	chr2:102423717	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.901	rs6060278	MIMAT0004772	hsa-miR-499a-3p	-4.09	5e-05	-0.24	-0.18	Protein C levels;	chr20:35165459	chr20:34990445~34990466:+
KIRC	cis	rs7072216	0.881	rs11189591	MIMAT0026738	hsa-miR-1287-3p	4.09	5.06e-05	0.18	0.18	Metabolite levels;	chr10:98395539	chr10:98395232~98395253:-
KIRC	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.07e-05	-0.21	-0.18	Asthma;	chr2:102426252	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6710528	MIMAT0019927	hsa-miR-4772-3p	4.09	5.08e-05	0.21	0.18	Asthma;	chr2:102399682	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.12e-05	-0.21	-0.18	Asthma;	chr2:102419875	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.12e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.12e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.12e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.12e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.14e-05	-0.21	-0.18	Asthma;	chr2:102423587	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.15e-05	-0.21	-0.18	Asthma;	chr2:102427407	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.15e-05	-0.21	-0.18	Asthma;	chr2:102427715	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.15e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-4.09	5.15e-05	-0.21	-0.18	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
KIRC	cis	rs7894407	0.76	rs1163085	MIMAT0022727	hsa-miR-1307-5p	-4.08	5.18e-05	-0.14	-0.18	White matter hyperintensity burden;	chr10:103279484	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.837	rs580538	MIMAT0003242	hsa-miR-577	-4.08	5.19e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115133613	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.21e-05	-0.21	-0.18	Asthma;	chr2:102419319	chr2:102432336~102432357:+
KIRC	cis	rs953492	0.871	rs2484640	MIMAT0019761	hsa-miR-4677-3p	-4.08	5.27e-05	-0.18	-0.18	Diastolic blood pressure;	chr1:243299115	chr1:243346225~243346246:+
KIRC	cis	rs482700	0.837	rs503251	MIMAT0003242	hsa-miR-577	-4.07	5.41e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115128287	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.799	rs534277	MIMAT0003242	hsa-miR-577	-4.07	5.41e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115129355	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.881	rs7082192	MIMAT0026738	hsa-miR-1287-3p	4.07	5.59e-05	0.18	0.18	Metabolite levels;	chr10:98392087	chr10:98395232~98395253:-
KIRC	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-4.06	5.73e-05	-0.21	-0.18	Asthma;	chr2:102358590	chr2:102432336~102432357:+
KIRC	cis	rs10492002	0.636	rs17736448	MIMAT0003287	hsa-miR-618	4.05	5.86e-05	0.19	0.18	Response to antidepressant treatment (citalopram);	chr12:81116390	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.636	rs61934932	MIMAT0003287	hsa-miR-618	4.05	5.86e-05	0.19	0.18	Response to antidepressant treatment (citalopram);	chr12:81117248	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.596	rs7305347	MIMAT0003287	hsa-miR-618	4.05	5.86e-05	0.19	0.18	Response to antidepressant treatment (citalopram);	chr12:81119115	chr12:80935796~80935818:-
KIRC	cis	rs482700	0.876	rs1615663	MIMAT0003242	hsa-miR-577	-4.05	6.03e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115133728	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.876	rs545996	MIMAT0003242	hsa-miR-577	-4.05	6.03e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115135328	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.731	rs471196	MIMAT0003242	hsa-miR-577	-4.05	6.03e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115136889	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.876	rs497135	MIMAT0003242	hsa-miR-577	-4.05	6.03e-05	-0.22	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115137386	chr4:114656774~114656794:+
KIRC	cis	rs1018697	1	rs7080587	MIMAT0005951	hsa-miR-1307-3p	4.04	6.11e-05	0.12	0.18	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394301~103394322:-
KIRC	cis	rs74233809	1	rs11191580	MIMAT0022727	hsa-miR-1307-5p	4.04	6.26e-05	0.21	0.18	Birth weight;	chr10:103146454	chr10:103394341~103394361:-
KIRC	cis	rs6120849	0.901	rs6060270	MIMAT0004772	hsa-miR-499a-3p	-4.04	6.29e-05	-0.24	-0.18	Protein C levels;	chr20:35149011	chr20:34990445~34990466:+
KIRC	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	4.03	6.37e-05	0.19	0.18	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
KIRC	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.38e-05	-0.2	-0.18	Asthma;	chr2:102415109	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.38e-05	-0.2	-0.18	Asthma;	chr2:102417501	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.38e-05	-0.2	-0.18	Asthma;	chr2:102418383	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.4e-05	-0.2	-0.18	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	4.03	6.43e-05	0.2	0.18	Asthma;	chr2:102377873	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs13021177	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.44e-05	-0.2	-0.18	Asthma;	chr2:102440033	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.56e-05	-0.2	-0.18	Asthma;	chr2:102411180	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.56e-05	-0.2	-0.18	Asthma;	chr2:102411191	chr2:102432336~102432357:+
KIRC	cis	rs2237579	0.584	rs17727433	MIMAT0026625	hsa-miR-653-3p	4.03	6.57e-05	0.22	0.18	Body mass index;	chr7:93513117	chr7:93482784~93482805:-
KIRC	cis	rs9527	0.615	rs10883781	MIMAT0005951	hsa-miR-1307-3p	4.03	6.58e-05	0.13	0.18	Arsenic metabolism;	chr10:102821373	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.59e-05	-0.2	-0.18	Asthma;	chr2:102418659	chr2:102432336~102432357:+
KIRC	cis	rs11083840	0.535	rs931647	MIMAT0003886	hsa-miR-769-5p	4.02	6.68e-05	0.2	0.18	Inflammatory bowel disease;Ulcerative colitis;	chr19:46640111	chr19:46018961~46018982:+
KIRC	cis	rs11651753	0.636	rs12602494	MIMAT0000253	hsa-miR-10a-5p	4.02	6.74e-05	0.21	0.18	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47960241	chr17:48579904~48579926:-
KIRC	cis	rs9527	0.662	rs10883783	MIMAT0005951	hsa-miR-1307-3p	4.01	6.92e-05	0.13	0.18	Arsenic metabolism;	chr10:102831395	chr10:103394301~103394322:-
KIRC	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-4.01	6.98e-05	-0.2	-0.18	Asthma;	chr2:102415289	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-4.01	6.98e-05	-0.2	-0.18	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
KIRC	cis	rs9303542	0.625	rs8073963	MIMAT0000253	hsa-miR-10a-5p	-4.01	7.14e-05	-0.22	-0.18	Epithelial ovarian cancer;Ovarian cancer;	chr17:48532556	chr17:48579904~48579926:-
KIRC	cis	rs990171	0.538	rs2075193	MIMAT0019927	hsa-miR-4772-3p	4.01	7.16e-05	0.23	0.18	Lymphocyte counts;	chr2:102501568	chr2:102432336~102432357:+
KIRC	cis	rs7594645	0.59	rs73068058	MIMAT0014995	hsa-miR-3130-5p	4.01	7.17e-05	0.4	0.18	Episodic memory;	chr2:206752613	chr2:206783276~206783296:-
KIRC	cis	rs7594645	0.59	rs73068058	MIMAT0014995_1	hsa-miR-3130-5p	4.01	7.17e-05	0.4	0.18	Episodic memory;	chr2:206752613	chr2:206783246~206783266:+
KIRC	cis	rs9527	0.662	rs4919687	MIMAT0005951	hsa-miR-1307-3p	4	7.27e-05	0.13	0.18	Arsenic metabolism;	chr10:102835491	chr10:103394301~103394322:-
KIRC	cis	rs482700	0.836	rs477208	MIMAT0003242	hsa-miR-577	-4	7.3e-05	-0.21	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115095273	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs13131643	MIMAT0003242	hsa-miR-577	-4	7.3e-05	-0.21	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115102671	chr4:114656774~114656794:+
KIRC	cis	rs59072704	0.843	rs12028532	MIMAT0019761	hsa-miR-4677-3p	-4	7.32e-05	-0.24	-0.18	Monocyte count;	chr1:244335303	chr1:243346225~243346246:+
KIRC	cis	rs9807989	0.839	rs7603730	MIMAT0019927	hsa-miR-4772-3p	-4	7.33e-05	-0.21	-0.18	Asthma;	chr2:102357911	chr2:102432336~102432357:+
KIRC	cis	rs6703335	1	rs6703335	MIMAT0019761	hsa-miR-4677-3p	4	7.38e-05	0.18	0.18	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243445665	chr1:243346225~243346246:+
KIRC	cis	rs953492	1	rs953492	MIMAT0019761	hsa-miR-4677-3p	-4	7.48e-05	-0.18	-0.18	Diastolic blood pressure;	chr1:243307890	chr1:243346225~243346246:+
KIRC	cis	rs4927850	1	rs7614767	MIMAT0003235	hsa-miR-570-3p	3.99	7.52e-05	0.21	0.18	Pancreatic cancer;	chr3:196026580	chr3:195699460~195699481:+
KIRC	cis	rs7072216	0.666	rs2274248	MIMAT0005878	hsa-miR-1287-5p	3.99	7.61e-05	0.2	0.18	Metabolite levels;	chr10:98388785	chr10:98395271~98395292:-
KIRC	cis	rs7142881	0.815	rs6571438	MIMAT0003293	hsa-miR-624-5p	3.98	7.88e-05	0.25	0.18	Response to iloperidone treatment (QT prolongation);	chr14:31610803	chr14:31014706~31014727:-
KIRC	cis	rs482700	0.836	rs506851	MIMAT0003242	hsa-miR-577	3.98	8e-05	0.21	0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115094365	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.507	rs4479442	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.04e-05	-0.2	-0.18	Asthma;	chr2:102437614	chr2:102432336~102432357:+
KIRC	cis	rs6120849	0.901	rs6058194	MIMAT0004772	hsa-miR-499a-3p	-3.98	8.09e-05	-0.24	-0.18	Protein C levels;	chr20:35152028	chr20:34990445~34990466:+
KIRC	cis	rs7917772	0.507	rs2778036	MIMAT0005951	hsa-miR-1307-3p	-3.97	8.16e-05	-0.14	-0.18	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102725968	chr10:103394301~103394322:-
KIRC	cis	rs9527	0.662	rs743575	MIMAT0005951	hsa-miR-1307-3p	3.97	8.27e-05	0.13	0.18	Arsenic metabolism;	chr10:102835149	chr10:103394301~103394322:-
KIRC	cis	rs74233809	1	rs11191472	MIMAT0022727	hsa-miR-1307-5p	-3.97	8.3e-05	-0.21	-0.18	Birth weight;	chr10:102947259	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.836	rs6533834	MIMAT0003242	hsa-miR-577	-3.97	8.34e-05	-0.21	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115106675	chr4:114656774~114656794:+
KIRC	cis	rs9527	0.615	rs4919685	MIMAT0005951	hsa-miR-1307-3p	3.97	8.38e-05	0.13	0.18	Arsenic metabolism;	chr10:102827605	chr10:103394301~103394322:-
KIRC	cis	rs12701220	0.744	rs10499317	MIMAT0004702	hsa-miR-339-3p	3.96	8.6e-05	0.25	0.18	Bronchopulmonary dysplasia;	chr7:972467	chr7:1022955~1022977:-
KIRC	cis	rs3764400	0.567	rs9890691	MIMAT0000438	hsa-miR-152-3p	-3.96	8.67e-05	-0.29	-0.18	Body mass index;	chr17:48115574	chr17:48037174~48037194:-
KIRC	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.7e-05	-0.2	-0.18	Asthma;	chr2:102432614	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.7e-05	-0.2	-0.18	Asthma;	chr2:102433405	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.73e-05	-0.2	-0.18	Asthma;	chr2:102431747	chr2:102432336~102432357:+
KIRC	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.73e-05	-0.2	-0.18	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.73e-05	-0.2	-0.18	Asthma;	chr2:102432120	chr2:102432336~102432357:+
KIRC	cis	rs9303542	0.625	rs9905940	MIMAT0000253	hsa-miR-10a-5p	-3.96	8.73e-05	-0.22	-0.18	Epithelial ovarian cancer;Ovarian cancer;	chr17:48536740	chr17:48579904~48579926:-
KIRC	cis	rs482700	0.641	rs483240	MIMAT0003242	hsa-miR-577	-3.96	8.75e-05	-0.21	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115091828	chr4:114656774~114656794:+
KIRC	cis	rs10492002	0.557	rs7973522	MIMAT0003287	hsa-miR-618	3.95	8.84e-05	0.19	0.18	Response to antidepressant treatment (citalopram);	chr12:81095362	chr12:80935796~80935818:-
KIRC	cis	rs74233809	1	rs10883806	MIMAT0022727	hsa-miR-1307-5p	-3.95	8.99e-05	-0.21	-0.18	Birth weight;	chr10:102953319	chr10:103394341~103394361:-
KIRC	cis	rs11083840	0.504	rs12974594	MIMAT0003886	hsa-miR-769-5p	3.95	9.12e-05	0.19	0.18	Inflammatory bowel disease;Ulcerative colitis;	chr19:46641393	chr19:46018961~46018982:+
KIRC	cis	rs4851551	0.543	rs35918372	MIMAT0019926	hsa-miR-4772-5p	3.95	9.16e-05	0.45	0.18	Blood protein levels;	chr2:102202803	chr2:102432300~102432321:+
KIRC	cis	rs6681460	0.649	rs1415984	MIMAT0014979	hsa-miR-3117-3p	-3.94	9.42e-05	-0.21	-0.18	Presence of antiphospholipid antibodies;	chr1:66536434	chr1:66628485~66628505:+
KIRC	cis	rs10492002	0.636	rs11614641	MIMAT0003287	hsa-miR-618	3.94	9.43e-05	0.19	0.18	Response to antidepressant treatment (citalopram);	chr12:81119546	chr12:80935796~80935818:-
KIRC	cis	rs9303542	0.559	rs2326012	MIMAT0000253	hsa-miR-10a-5p	3.94	9.46e-05	0.22	0.18	Epithelial ovarian cancer;Ovarian cancer;	chr17:48541219	chr17:48579904~48579926:-
KIRC	cis	rs12701220	0.689	rs12701824	MIMAT0004702	hsa-miR-339-3p	3.94	9.47e-05	0.29	0.18	Bronchopulmonary dysplasia;	chr7:1062728	chr7:1022955~1022977:-
KIRC	cis	rs9303542	0.625	rs7207109	MIMAT0000253	hsa-miR-10a-5p	3.94	9.53e-05	0.23	0.18	Epithelial ovarian cancer;Ovarian cancer;	chr17:48530455	chr17:48579904~48579926:-
KIRC	cis	rs9527	0.641	rs4919684	MIMAT0005951	hsa-miR-1307-3p	3.93	9.59e-05	0.13	0.18	Arsenic metabolism;	chr10:102827267	chr10:103394301~103394322:-
KIRC	cis	rs74233809	1	rs10509759	MIMAT0022727	hsa-miR-1307-5p	-3.93	9.62e-05	-0.21	-0.18	Birth weight;	chr10:102929908	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.876	rs477506	MIMAT0003242	hsa-miR-577	-3.93	9.63e-05	-0.21	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115138175	chr4:114656774~114656794:+
KIRC	cis	rs9527	0.662	rs10786714	MIMAT0022727	hsa-miR-1307-5p	3.93	9.64e-05	0.14	0.18	Arsenic metabolism;	chr10:102838849	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.922	rs2296438	MIMAT0026738	hsa-miR-1287-3p	3.93	9.85e-05	0.17	0.18	Metabolite levels;	chr10:98387138	chr10:98395232~98395253:-
KIRC	cis	rs2871473	1	rs1030024	MIMAT0019926	hsa-miR-4772-5p	3.92	9.94e-05	0.26	0.18	Blood protein levels;	chr2:102489310	chr2:102432300~102432321:+
KIRC	cis	rs74233809	1	rs78260931	MIMAT0022727	hsa-miR-1307-5p	-3.92	9.99e-05	-0.21	-0.18	Birth weight;	chr10:102962205	chr10:103394341~103394361:-
KIRC	cis	rs10492002	0.5	rs2525839	MIMAT0003287	hsa-miR-618	-3.92	0.000101	-0.19	-0.18	Response to antidepressant treatment (citalopram);	chr12:81138848	chr12:80935796~80935818:-
KIRC	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-3.91	0.000104	-0.2	-0.18	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
KIRC	cis	rs12701220	0.725	rs13242971	MIMAT0004702	hsa-miR-339-3p	3.91	0.000105	0.27	0.18	Bronchopulmonary dysplasia;	chr7:1015879	chr7:1022955~1022977:-
KIRC	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-3.91	0.000106	-0.2	-0.18	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
KIRC	cis	rs9903692	0.505	rs208008	MIMAT0000438	hsa-miR-152-3p	-3.9	0.000108	-0.28	-0.18	Pulse pressure;	chr17:48153476	chr17:48037174~48037194:-
KIRC	cis	rs482700	0.699	rs509777	MIMAT0003242	hsa-miR-577	-3.9	0.000108	-0.2	-0.18	Stromal-cell-derived factor 1 alpha levels;	chr4:115091901	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.2	-0.18	Asthma;	chr2:102412435	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.2	-0.18	Asthma;	chr2:102412461	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.2	-0.18	Asthma;	chr2:102412524	chr2:102432336~102432357:+
KIRC	cis	rs1018697	0.966	rs10748832	MIMAT0022727	hsa-miR-1307-5p	3.9	0.000109	0.12	0.17	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394341~103394361:-
KIRC	cis	rs6703335	0.632	rs10927025	MIMAT0019761	hsa-miR-4677-3p	3.9	0.000111	0.18	0.17	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243475916	chr1:243346225~243346246:+
KIRC	cis	rs9807989	0.801	rs72823663	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102352278	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs67088699	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102352291	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.773	rs5010059	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102352366	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs11688559	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353453	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs11688568	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353489	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs11688573	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353511	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs11689730	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353524	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs11695627	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353645	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs7558339	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353783	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs7608638	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102353829	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102354290	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102354299	chr2:102432336~102432357:+
KIRC	cis	rs9807989	1	rs9807989	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102354740	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs9808453	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102354846	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs4851565	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102355021	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.765	rs9807962	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102355204	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs12413046	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000111	-0.21	-0.17	Birth weight;	chr10:103111447	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs10883832	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000111	-0.21	-0.17	Birth weight;	chr10:103111522	chr10:103394341~103394361:-
KIRC	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000111	-0.2	-0.17	Asthma;	chr2:102370999	chr2:102432336~102432357:+
KIRC	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-3.89	0.000114	-0.26	-0.17	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
KIRC	cis	rs7894407	1	rs7894407	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000114	0.13	0.17	White matter hyperintensity burden;	chr10:103416422	chr10:103394341~103394361:-
KIRC	cis	rs7894407	0.634	rs755577	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000115	0.15	0.17	White matter hyperintensity burden;	chr10:103464309	chr10:103394341~103394361:-
KIRC	cis	rs894344	0.584	rs11985416	MIMAT0004551	hsa-miR-30d-3p	3.89	0.000115	0.18	0.17	Systolic blood pressure;	chr8:134621762	chr8:134804879~134804900:-
KIRC	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-3.89	0.000116	-0.21	-0.17	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.881	rs4345897	MIMAT0026738	hsa-miR-1287-3p	3.88	0.000117	0.17	0.17	Metabolite levels;	chr10:98387303	chr10:98395232~98395253:-
KIRC	cis	rs7917772	0.715	rs7077678	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000118	-0.11	-0.17	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102678808	chr10:103394301~103394322:-
KIRC	cis	rs482700	0.796	rs511198	MIMAT0003242	hsa-miR-577	-3.88	0.000118	-0.21	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115093936	chr4:114656774~114656794:+
KIRC	cis	rs74233809	1	rs12411886	MIMAT0022727	hsa-miR-1307-5p	-3.88	0.000119	-0.21	-0.17	Birth weight;	chr10:102925542	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs11191560	MIMAT0022727	hsa-miR-1307-5p	-3.88	0.00012	-0.2	-0.17	Birth weight;	chr10:103109281	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.876	rs509423	MIMAT0003242	hsa-miR-577	-3.88	0.000121	-0.21	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115140173	chr4:114656774~114656794:+
KIRC	cis	rs6504340	0.793	rs12946855	MIMAT0000253	hsa-miR-10a-5p	3.88	0.000121	0.23	0.17	Primary tooth development (number of teeth);	chr17:48530668	chr17:48579904~48579926:-
KIRC	cis	rs7072216	0.687	rs4551689	MIMAT0005878	hsa-miR-1287-5p	-3.87	0.000122	-0.18	-0.17	Metabolite levels;	chr10:98397836	chr10:98395271~98395292:-
KIRC	cis	rs7894407	0.634	rs755577	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000122	0.13	0.17	White matter hyperintensity burden;	chr10:103464309	chr10:103394301~103394322:-
KIRC	cis	rs74233809	1	rs17115213	MIMAT0022727	hsa-miR-1307-5p	-3.87	0.000124	-0.2	-0.17	Birth weight;	chr10:102921386	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.699	rs569917	MIMAT0003242	hsa-miR-577	-3.87	0.000125	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115092099	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.669	rs567227	MIMAT0003242	hsa-miR-577	-3.87	0.000125	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115092356	chr4:114656774~114656794:+
KIRC	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-3.87	0.000126	-0.25	-0.17	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
KIRC	cis	rs12701220	0.894	rs12701406	MIMAT0004702	hsa-miR-339-3p	3.86	0.000126	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1010647	chr7:1022955~1022977:-
KIRC	cis	rs12701220	0.894	rs12539012	MIMAT0004702	hsa-miR-339-3p	3.86	0.000126	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1012497	chr7:1022955~1022977:-
KIRC	cis	rs12701220	0.894	rs13224488	MIMAT0004702	hsa-miR-339-3p	3.86	0.000126	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1012717	chr7:1022955~1022977:-
KIRC	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.000127	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
KIRC	cis	rs4927850	1	rs7630875	MIMAT0003235	hsa-miR-570-3p	3.86	0.000127	0.2	0.17	Pancreatic cancer;	chr3:196026895	chr3:195699460~195699481:+
KIRC	cis	rs9303542	0.625	rs6504340	MIMAT0000253	hsa-miR-10a-5p	-3.86	0.000127	-0.21	-0.17	Epithelial ovarian cancer;Ovarian cancer;	chr17:48539657	chr17:48579904~48579926:-
KIRC	cis	rs11651753	0.636	rs4793731	MIMAT0000253	hsa-miR-10a-5p	3.86	0.000129	0.2	0.17	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47956327	chr17:48579904~48579926:-
KIRC	cis	rs11651753	0.636	rs4793733	MIMAT0000253	hsa-miR-10a-5p	3.86	0.000129	0.2	0.17	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47956616	chr17:48579904~48579926:-
KIRC	cis	rs11651753	0.636	rs35280206	MIMAT0000253	hsa-miR-10a-5p	3.86	0.000129	0.2	0.17	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47957645	chr17:48579904~48579926:-
KIRC	cis	rs6681460	0.649	rs967325	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.00013	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66538039	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-3.86	0.00013	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.699	rs504346	MIMAT0003242	hsa-miR-577	-3.86	0.000131	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115092454	chr4:114656774~114656794:+
KIRC	cis	rs7594645	1	rs73070048	MIMAT0014995	hsa-miR-3130-5p	3.85	0.000132	0.39	0.17	Episodic memory;	chr2:206776670	chr2:206783276~206783296:-
KIRC	cis	rs7594645	1	rs73070048	MIMAT0014995_1	hsa-miR-3130-5p	3.85	0.000132	0.39	0.17	Episodic memory;	chr2:206776670	chr2:206783246~206783266:+
KIRC	cis	rs74233809	1	rs79082900	MIMAT0022727	hsa-miR-1307-5p	-3.85	0.000133	-0.21	-0.17	Birth weight;	chr10:103117545	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.948	rs12690826	MIMAT0004702	hsa-miR-339-3p	3.85	0.000133	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1041982	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.622	rs12779263	MIMAT0022727	hsa-miR-1307-5p	3.85	0.000133	0.13	0.17	Arsenic metabolism;	chr10:103126776	chr10:103394341~103394361:-
KIRC	cis	rs990171	0.538	rs2072508	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000134	-0.22	-0.17	Lymphocyte counts;	chr2:102501883	chr2:102432336~102432357:+
KIRC	cis	rs6703335	0.87	rs10803142	MIMAT0019761	hsa-miR-4677-3p	3.85	0.000135	0.17	0.17	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243434932	chr1:243346225~243346246:+
KIRC	cis	rs10492002	0.52	rs2701788	MIMAT0003287	hsa-miR-618	-3.84	0.000137	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81125954	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.52	rs2574746	MIMAT0003287	hsa-miR-618	-3.84	0.000137	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81125969	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.52	rs2574741	MIMAT0003287	hsa-miR-618	-3.84	0.000137	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81128065	chr12:80935796~80935818:-
KIRC	cis	rs768090	0.886	rs3791995	MIMAT0017950	hsa-miR-2355-3p	3.84	0.000138	0.19	0.17	Hemoglobin concentration;Hematocrit;	chr2:207145629	chr2:207109999~207110020:-
KIRC	cis	rs953492	0.831	rs2783966	MIMAT0019761	hsa-miR-4677-3p	-3.84	0.000138	-0.17	-0.17	Diastolic blood pressure;	chr1:243336645	chr1:243346225~243346246:+
KIRC	cis	rs10492002	0.522	rs12809234	MIMAT0003287	hsa-miR-618	3.84	0.000138	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81103740	chr12:80935796~80935818:-
KIRC	cis	rs12701220	0.901	rs12701708	MIMAT0004702	hsa-miR-339-3p	3.84	0.00014	0.25	0.17	Bronchopulmonary dysplasia;	chr7:1050697	chr7:1022955~1022977:-
KIRC	cis	rs10492002	0.522	rs1882258	MIMAT0003287	hsa-miR-618	3.84	0.00014	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81104925	chr12:80935796~80935818:-
KIRC	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-3.84	0.00014	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.876	rs537164	MIMAT0003242	hsa-miR-577	-3.84	0.00014	-0.21	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115129710	chr4:114656774~114656794:+
KIRC	cis	rs10492002	0.597	rs7306808	MIMAT0003287	hsa-miR-618	3.84	0.000141	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81107695	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.506	rs7297387	MIMAT0003287	hsa-miR-618	3.84	0.000141	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81108854	chr12:80935796~80935818:-
KIRC	cis	rs74233809	1	rs11191505	MIMAT0022727	hsa-miR-1307-5p	-3.84	0.000142	-0.2	-0.17	Birth weight;	chr10:103007134	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs7074395	MIMAT0022727	hsa-miR-1307-5p	-3.83	0.000143	-0.13	-0.17	Arsenic metabolism;	chr10:103085171	chr10:103394341~103394361:-
KIRC	cis	rs7594645	0.59	rs879472	MIMAT0014995	hsa-miR-3130-5p	-3.83	0.000144	-0.38	-0.17	Episodic memory;	chr2:206787058	chr2:206783276~206783296:-
KIRC	cis	rs7594645	0.59	rs879472	MIMAT0014995_1	hsa-miR-3130-5p	-3.83	0.000144	-0.38	-0.17	Episodic memory;	chr2:206787058	chr2:206783246~206783266:+
KIRC	cis	rs990171	0.538	rs4851016	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000147	-0.21	-0.17	Lymphocyte counts;	chr2:102503941	chr2:102432336~102432357:+
KIRC	cis	rs12701220	0.744	rs2030958	MIMAT0004702	hsa-miR-339-3p	3.83	0.000148	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1036374	chr7:1022955~1022977:-
KIRC	cis	rs1018697	0.966	rs1475643	MIMAT0022727	hsa-miR-1307-5p	3.83	0.000148	0.12	0.17	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394341~103394361:-
KIRC	cis	rs768090	0.886	rs3791994	MIMAT0017950	hsa-miR-2355-3p	3.82	0.000149	0.19	0.17	Hemoglobin concentration;Hematocrit;	chr2:207145195	chr2:207109999~207110020:-
KIRC	cis	rs6988306	0.521	rs634588	MIMAT0030020	hsa-miR-7705	3.82	0.00015	0.3	0.17	Bronchopulmonary dysplasia;	chr8:101586184	chr8:100703002~100703024:-
KIRC	cis	rs990171	0.538	rs11690932	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000151	-0.21	-0.17	Lymphocyte counts;	chr2:102502570	chr2:102432336~102432357:+
KIRC	cis	rs10492002	0.508	rs2574733	MIMAT0003287	hsa-miR-618	-3.82	0.000153	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81135426	chr12:80935796~80935818:-
KIRC	cis	rs482700	0.8	rs505967	MIMAT0003242	hsa-miR-577	-3.81	0.000154	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115094450	chr4:114656774~114656794:+
KIRC	cis	rs990171	0.538	rs4851015	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000155	-0.22	-0.17	Lymphocyte counts;	chr2:102503897	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.649	rs4655494	MIMAT0014979	hsa-miR-3117-3p	-3.81	0.000157	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66537193	chr1:66628485~66628505:+
KIRC	cis	rs10492002	0.596	rs11608692	MIMAT0003287	hsa-miR-618	3.81	0.000157	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81101897	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.596	rs11608718	MIMAT0003287	hsa-miR-618	3.81	0.000157	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81102007	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.557	rs34246226	MIMAT0003287	hsa-miR-618	3.81	0.000157	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81102245	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.52	rs2525843	MIMAT0003287	hsa-miR-618	-3.81	0.00016	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81136021	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.52	rs2525842	MIMAT0003287	hsa-miR-618	-3.81	0.00016	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81136165	chr12:80935796~80935818:-
KIRC	cis	rs2675399	0.716	rs4667235	MIMAT0022706	hsa-miR-561-5p	-3.8	0.000162	-0.21	-0.17	Obesity-related traits;	chr2:188655075	chr2:188297517~188297538:+
KIRC	cis	rs12701220	0.948	rs10275712	MIMAT0004702	hsa-miR-339-3p	3.8	0.000163	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1043282	chr7:1022955~1022977:-
KIRC	cis	rs6681460	0.649	rs1856315	MIMAT0014979	hsa-miR-3117-3p	-3.8	0.000163	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66539546	chr1:66628485~66628505:+
KIRC	cis	rs9807989	0.839	rs6749114	MIMAT0019927	hsa-miR-4772-3p	-3.8	0.000163	-0.2	-0.17	Asthma;	chr2:102351127	chr2:102432336~102432357:+
KIRC	cis	rs9527	0.622	rs12779263	MIMAT0005951	hsa-miR-1307-3p	3.8	0.000164	0.12	0.17	Arsenic metabolism;	chr10:103126776	chr10:103394301~103394322:-
KIRC	cis	rs990171	0.566	rs10172588	MIMAT0019927	hsa-miR-4772-3p	-3.8	0.000166	-0.22	-0.17	Lymphocyte counts;	chr2:102486838	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs11191555	MIMAT0022727	hsa-miR-1307-5p	-3.8	0.000166	-0.2	-0.17	Birth weight;	chr10:103097766	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs11191557	MIMAT0022727	hsa-miR-1307-5p	-3.8	0.000166	-0.2	-0.17	Birth weight;	chr10:103104857	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs11191558	MIMAT0022727	hsa-miR-1307-5p	-3.8	0.000166	-0.2	-0.17	Birth weight;	chr10:103104921	chr10:103394341~103394361:-
KIRC	cis	rs10492002	0.613	rs11114762	MIMAT0003287	hsa-miR-618	3.79	0.000166	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81099128	chr12:80935796~80935818:-
KIRC	cis	rs9807989	0.773	rs72823661	MIMAT0019927	hsa-miR-4772-3p	-3.79	0.000167	-0.2	-0.17	Asthma;	chr2:102352256	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-3.79	0.000168	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
KIRC	cis	rs3764400	0.567	rs4995899	MIMAT0000438	hsa-miR-152-3p	3.79	0.00017	0.28	0.17	Body mass index;	chr17:48073368	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs16951519	MIMAT0000438	hsa-miR-152-3p	3.79	0.00017	0.28	0.17	Body mass index;	chr17:48074929	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs12946143	MIMAT0000438	hsa-miR-152-3p	3.79	0.00017	0.28	0.17	Body mass index;	chr17:48077581	chr17:48037174~48037194:-
KIRC	cis	rs990171	0.538	rs4851012	MIMAT0019927	hsa-miR-4772-3p	3.79	0.000171	0.21	0.17	Lymphocyte counts;	chr2:102499456	chr2:102432336~102432357:+
KIRC	cis	rs3764400	0.517	rs7224461	MIMAT0000438	hsa-miR-152-3p	-3.78	0.000175	-0.28	-0.17	Body mass index;	chr17:48126068	chr17:48037174~48037194:-
KIRC	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-3.78	0.000176	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
KIRC	cis	rs10492002	0.636	rs1435968	MIMAT0003287	hsa-miR-618	3.78	0.000176	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81136877	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.522	rs11114765	MIMAT0003287	hsa-miR-618	-3.78	0.000176	-0.18	-0.17	Response to antidepressant treatment (citalopram);	chr12:81100495	chr12:80935796~80935818:-
KIRC	cis	rs12701220	0.894	rs10263252	MIMAT0004702	hsa-miR-339-3p	3.78	0.000177	0.25	0.17	Bronchopulmonary dysplasia;	chr7:1010313	chr7:1022955~1022977:-
KIRC	cis	rs10492002	0.636	rs34334790	MIMAT0003287	hsa-miR-618	3.78	0.000178	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81122814	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.636	rs35713634	MIMAT0003287	hsa-miR-618	3.78	0.000178	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81122818	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.597	rs12815528	MIMAT0003287	hsa-miR-618	3.78	0.000178	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81126418	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.636	rs10492006	MIMAT0003287	hsa-miR-618	3.78	0.000178	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81126959	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.596	rs73149275	MIMAT0003287	hsa-miR-618	3.78	0.000178	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81128275	chr12:80935796~80935818:-
KIRC	cis	rs11083840	0.535	rs10424552	MIMAT0003886	hsa-miR-769-5p	-3.78	0.000179	-0.18	-0.17	Inflammatory bowel disease;Ulcerative colitis;	chr19:46640522	chr19:46018961~46018982:+
KIRC	cis	rs10492002	0.522	rs10862240	MIMAT0003287	hsa-miR-618	3.78	0.00018	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81101847	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.545	rs12299448	MIMAT0003287	hsa-miR-618	3.77	0.00018	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81102693	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.522	rs10862241	MIMAT0003287	hsa-miR-618	3.77	0.00018	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81102979	chr12:80935796~80935818:-
KIRC	cis	rs6681460	0.649	rs1947083	MIMAT0014979	hsa-miR-3117-3p	-3.77	0.00018	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66539118	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.535	rs6588204	MIMAT0014979	hsa-miR-3117-3p	-3.77	0.000182	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66525325	chr1:66628485~66628505:+
KIRC	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000182	-0.2	-0.17	Asthma;	chr2:102351751	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000182	-0.2	-0.17	Asthma;	chr2:102351752	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs7593935	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000183	-0.21	-0.17	Lymphocyte counts;	chr2:102501669	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs2075192	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000183	-0.21	-0.17	Lymphocyte counts;	chr2:102501769	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.511	rs2072509	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000183	-0.21	-0.17	Lymphocyte counts;	chr2:102501878	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs2075190	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000183	-0.21	-0.17	Lymphocyte counts;	chr2:102502100	chr2:102432336~102432357:+
KIRC	cis	rs6708413	0.501	rs2075189	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000183	-0.21	-0.17	Crohn's disease;Inflammatory bowel disease;	chr2:102502230	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.576	rs6588203	MIMAT0014979	hsa-miR-3117-3p	-3.77	0.000183	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66525168	chr1:66628485~66628505:+
KIRC	cis	rs3764400	0.507	rs56161855	MIMAT0000438	hsa-miR-152-3p	3.77	0.000185	0.26	0.17	Body mass index;	chr17:48211287	chr17:48037174~48037194:-
KIRC	cis	rs990171	0.538	rs2075187	MIMAT0019927	hsa-miR-4772-3p	3.77	0.000185	0.22	0.17	Lymphocyte counts;	chr2:102503852	chr2:102432336~102432357:+
KIRC	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	3.77	0.000185	0.38	0.17	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
KIRC	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	3.77	0.000185	0.38	0.17	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
KIRC	cis	rs990171	0.538	rs11682754	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.000188	-0.21	-0.17	Lymphocyte counts;	chr2:102500636	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs6728288	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.000188	-0.21	-0.17	Lymphocyte counts;	chr2:102500809	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs6741235	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.000188	-0.21	-0.17	Lymphocyte counts;	chr2:102500824	chr2:102432336~102432357:+
KIRC	cis	rs482700	0.796	rs530974	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115094742	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.689	rs559307	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115096055	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.758	rs514133	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115098009	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.758	rs510657	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115098369	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs482641	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115101369	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs557687	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115102348	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs562874	MIMAT0003242	hsa-miR-577	-3.76	0.000189	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115102349	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.00019	-0.2	-0.17	Asthma;	chr2:102351825	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.00019	-0.2	-0.17	Asthma;	chr2:102351896	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.00019	-0.2	-0.17	Asthma;	chr2:102351902	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.608	rs10889624	MIMAT0014979	hsa-miR-3117-3p	-3.76	0.000191	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66540124	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-3.76	0.000193	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
KIRC	cis	rs12701220	0.541	rs12535516	MIMAT0004702	hsa-miR-339-3p	3.76	0.000194	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1074804	chr7:1022955~1022977:-
KIRC	cis	rs3764400	0.508	rs2240121	MIMAT0000438	hsa-miR-152-3p	3.75	0.000195	0.28	0.17	Body mass index;	chr17:48074960	chr17:48037174~48037194:-
KIRC	cis	rs10492002	0.636	rs2107416	MIMAT0003287	hsa-miR-618	3.75	0.000197	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81138503	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.636	rs2107415	MIMAT0003287	hsa-miR-618	3.75	0.000197	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81139299	chr12:80935796~80935818:-
KIRC	cis	rs6681460	0.649	rs6691033	MIMAT0014979	hsa-miR-3117-3p	-3.75	0.000198	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66541746	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.649	rs10889625	MIMAT0014979	hsa-miR-3117-3p	-3.75	2e-04	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66541552	chr1:66628485~66628505:+
KIRC	cis	rs990171	0.538	rs2075191	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000201	-0.2	-0.17	Lymphocyte counts;	chr2:102501840	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs4851566	MIMAT0019927	hsa-miR-4772-3p	-3.74	0.000207	-0.2	-0.17	Asthma;	chr2:102356339	chr2:102432336~102432357:+
KIRC	cis	rs929843	1	rs929843	MIMAT0000431	hsa-miR-140-5p	-3.73	0.000211	-0.21	-0.17	Menarche (age at onset);	chr16:70011845	chr16:69933103~69933124:+
KIRC	cis	rs990171	0.538	rs2075188	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000212	-0.21	-0.17	Lymphocyte counts;	chr2:102503773	chr2:102432336~102432357:+
KIRC	cis	rs9527	0.615	rs7917295	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000212	0.12	0.17	Arsenic metabolism;	chr10:102941430	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs12412038	MIMAT0022727	hsa-miR-1307-5p	-3.73	0.000212	-0.2	-0.17	Birth weight;	chr10:103096405	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.758	rs562049	MIMAT0003242	hsa-miR-577	-3.73	0.000213	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115103577	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs3114034	MIMAT0003242	hsa-miR-577	-3.73	0.000214	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115106857	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs537144	MIMAT0003242	hsa-miR-577	-3.73	0.000214	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115107633	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.796	rs476739	MIMAT0003242	hsa-miR-577	-3.73	0.000214	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115108392	chr4:114656774~114656794:+
KIRC	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102350776	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102350953	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102350970	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102350971	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs6734742	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102351397	chr2:102432336~102432357:+
KIRC	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000215	-0.19	-0.17	Asthma;	chr2:102351398	chr2:102432336~102432357:+
KIRC	cis	rs9527	0.662	rs4919687	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000217	0.13	0.17	Arsenic metabolism;	chr10:102835491	chr10:103394341~103394361:-
KIRC	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-3.73	0.000217	-0.19	-0.17	Asthma;	chr2:102351547	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-3.73	0.000218	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
KIRC	cis	rs10492002	0.596	rs17736095	MIMAT0003287	hsa-miR-618	3.73	0.000218	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81101115	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.596	rs12811480	MIMAT0003287	hsa-miR-618	3.73	0.000218	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81101405	chr12:80935796~80935818:-
KIRC	cis	rs9527	0.569	rs10883801	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000218	0.12	0.17	Arsenic metabolism;	chr10:102918130	chr10:103394341~103394361:-
KIRC	cis	rs3764400	0.567	rs741058	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Body mass index;	chr17:48127991	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs2109983	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Body mass index;	chr17:48129786	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.517	rs7209042	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Body mass index;	chr17:48130430	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs8071879	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Body mass index;	chr17:48140095	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs2325804	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Body mass index;	chr17:48141183	chr17:48037174~48037194:-
KIRC	cis	rs9903692	0.505	rs208009	MIMAT0000438	hsa-miR-152-3p	-3.72	0.00022	-0.27	-0.17	Pulse pressure;	chr17:48152329	chr17:48037174~48037194:-
KIRC	cis	rs12701220	0.847	rs10272002	MIMAT0004702	hsa-miR-339-3p	3.72	0.000221	0.25	0.17	Bronchopulmonary dysplasia;	chr7:1007979	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.615	rs10883800	MIMAT0022727	hsa-miR-1307-5p	3.72	0.000221	0.12	0.17	Arsenic metabolism;	chr10:102911455	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.615	rs7073295	MIMAT0022727	hsa-miR-1307-5p	3.72	0.000221	0.12	0.17	Arsenic metabolism;	chr10:102912476	chr10:103394341~103394361:-
KIRC	cis	rs2564921	0.704	rs35671032	MIMAT0004584	hsa-let-7g-3p	3.72	0.000221	0.09	0.17	Height;	chr3:52972039	chr3:52268280~52268300:-
KIRC	cis	rs12701220	0.689	rs12536282	MIMAT0004702	hsa-miR-339-3p	3.72	0.000222	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1076014	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.59	rs7067663	MIMAT0022727	hsa-miR-1307-5p	3.72	0.000222	0.12	0.17	Arsenic metabolism;	chr10:103123893	chr10:103394341~103394361:-
KIRC	cis	rs990171	0.538	rs12995030	MIMAT0019927	hsa-miR-4772-3p	-3.72	0.000225	-0.2	-0.17	Lymphocyte counts;	chr2:102500007	chr2:102432336~102432357:+
KIRC	cis	rs4851551	0.867	rs3917299	MIMAT0019926	hsa-miR-4772-5p	3.71	0.000228	0.45	0.17	Blood protein levels;	chr2:102169626	chr2:102432300~102432321:+
KIRC	cis	rs9903692	0.505	rs208005	MIMAT0000438	hsa-miR-152-3p	-3.71	0.000229	-0.27	-0.17	Pulse pressure;	chr17:48162623	chr17:48037174~48037194:-
KIRC	cis	rs12701220	0.744	rs35588238	MIMAT0004702	hsa-miR-339-3p	3.71	0.000231	0.24	0.17	Bronchopulmonary dysplasia;	chr7:972370	chr7:1022955~1022977:-
KIRC	cis	rs10492002	0.596	rs10862238	MIMAT0003287	hsa-miR-618	3.71	0.000232	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81100151	chr12:80935796~80935818:-
KIRC	cis	rs9527	0.662	rs743575	MIMAT0022727	hsa-miR-1307-5p	3.71	0.000233	0.13	0.17	Arsenic metabolism;	chr10:102835149	chr10:103394341~103394361:-
KIRC	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-3.71	0.000233	-0.23	-0.17	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
KIRC	cis	rs12701220	0.803	rs12701432	MIMAT0004702	hsa-miR-339-3p	3.71	0.000234	0.24	0.17	Bronchopulmonary dysplasia;	chr7:1012817	chr7:1022955~1022977:-
KIRC	cis	rs8114671	0.74	rs3761141	MIMAT0004772	hsa-miR-499a-3p	-3.71	0.000234	-0.19	-0.17	Height;	chr20:35150021	chr20:34990445~34990466:+
KIRC	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-3.71	0.000236	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
KIRC	cis	rs953492	0.831	rs2783965	MIMAT0019761	hsa-miR-4677-3p	-3.71	0.000236	-0.17	-0.17	Diastolic blood pressure;	chr1:243337095	chr1:243346225~243346246:+
KIRC	cis	rs3764400	0.508	rs978263	MIMAT0000438	hsa-miR-152-3p	-3.7	0.000238	-0.27	-0.17	Body mass index;	chr17:48103302	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs12600980	MIMAT0000438	hsa-miR-152-3p	-3.7	0.000238	-0.27	-0.17	Body mass index;	chr17:48109779	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs8071199	MIMAT0000438	hsa-miR-152-3p	-3.7	0.000238	-0.27	-0.17	Body mass index;	chr17:48117973	chr17:48037174~48037194:-
KIRC	cis	rs9527	0.59	rs10883818	MIMAT0022727	hsa-miR-1307-5p	3.7	0.000239	0.12	0.17	Arsenic metabolism;	chr10:102999829	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.641	rs10786732	MIMAT0022727	hsa-miR-1307-5p	3.7	0.000239	0.12	0.17	Arsenic metabolism;	chr10:103002778	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.689	rs12530960	MIMAT0004702	hsa-miR-339-3p	3.7	0.000239	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1055835	chr7:1022955~1022977:-
KIRC	cis	rs482700	0.876	rs540954	MIMAT0003242	hsa-miR-577	-3.7	0.000239	-0.2	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115112612	chr4:114656774~114656794:+
KIRC	cis	rs10492002	0.547	rs7980266	MIMAT0003287	hsa-miR-618	3.7	0.000241	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81137967	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.522	rs12315512	MIMAT0003287	hsa-miR-618	3.7	0.000243	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81100600	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.522	rs12315517	MIMAT0003287	hsa-miR-618	3.7	0.000243	0.18	0.17	Response to antidepressant treatment (citalopram);	chr12:81100625	chr12:80935796~80935818:-
KIRC	cis	rs990171	0.538	rs12987295	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000243	-0.2	-0.17	Lymphocyte counts;	chr2:102499379	chr2:102432336~102432357:+
KIRC	cis	rs1018697	1	rs7909612	MIMAT0022727	hsa-miR-1307-5p	3.7	0.000243	0.12	0.17	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394341~103394361:-
KIRC	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	3.7	0.000244	0.12	0.17	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
KIRC	cis	rs966423	0.597	rs1233081	MIMAT0004500	hsa-miR-26b-3p	-3.7	0.000244	-0.12	-0.17	Thyroid cancer;	chr2:217435521	chr2:218402692~218402712:+
KIRC	cis	rs6681460	0.649	rs1338184	MIMAT0014979	hsa-miR-3117-3p	3.69	0.000246	0.2	0.17	Presence of antiphospholipid antibodies;	chr1:66539389	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.649	rs967322	MIMAT0014979	hsa-miR-3117-3p	-3.69	0.000247	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66537763	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.568	rs12772775	MIMAT0022727	hsa-miR-1307-5p	3.69	0.000247	0.12	0.17	Arsenic metabolism;	chr10:102943242	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs12220375	MIMAT0022727	hsa-miR-1307-5p	-3.69	0.000248	-0.2	-0.17	Birth weight;	chr10:103141734	chr10:103394341~103394361:-
KIRC	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-3.69	0.00025	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
KIRC	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-3.69	0.00025	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
KIRC	cis	rs10492002	0.52	rs2701791	MIMAT0003287	hsa-miR-618	3.69	0.000251	0.17	0.17	Response to antidepressant treatment (citalopram);	chr12:81133821	chr12:80935796~80935818:-
KIRC	cis	rs6133127	0.554	rs2326497	MIMAT0000101	hsa-miR-103a-3p	-3.69	0.000251	-0.11	-0.17	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4536399	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs2326497	MIMAT0000101_1	hsa-miR-103a-3p	-3.69	0.000251	-0.11	-0.17	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4536399	chr5:168560904~168560926:-
KIRC	cis	rs3764400	0.567	rs2240120	MIMAT0000438	hsa-miR-152-3p	3.69	0.000252	0.28	0.17	Body mass index;	chr17:48064782	chr17:48037174~48037194:-
KIRC	cis	rs894344	0.584	rs2315837	MIMAT0004551	hsa-miR-30d-3p	3.69	0.000252	0.18	0.17	Systolic blood pressure;	chr8:134610098	chr8:134804879~134804900:-
KIRC	cis	rs6504340	0.793	rs56128659	MIMAT0000253	hsa-miR-10a-5p	3.69	0.000253	0.22	0.17	Primary tooth development (number of teeth);	chr17:48544466	chr17:48579904~48579926:-
KIRC	cis	rs74233809	1	rs11191499	MIMAT0022727	hsa-miR-1307-5p	-3.69	0.000253	-0.19	-0.17	Birth weight;	chr10:103004514	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.837	rs528282	MIMAT0003242	hsa-miR-577	-3.69	0.000254	-0.19	-0.17	Stromal-cell-derived factor 1 alpha levels;	chr4:115095018	chr4:114656774~114656794:+
KIRC	cis	rs12701220	0.894	rs12701348	MIMAT0004702	hsa-miR-339-3p	3.69	0.000254	0.24	0.17	Bronchopulmonary dysplasia;	chr7:999821	chr7:1022955~1022977:-
KIRC	cis	rs12701220	0.689	rs12533004	MIMAT0004702	hsa-miR-339-3p	3.68	0.000256	0.26	0.17	Bronchopulmonary dysplasia;	chr7:1055774	chr7:1022955~1022977:-
KIRC	cis	rs74233809	1	rs11191515	MIMAT0022727	hsa-miR-1307-5p	-3.68	0.000257	-0.2	-0.17	Birth weight;	chr10:103016770	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.901	rs12701710	MIMAT0004702	hsa-miR-339-3p	-3.68	0.000258	-0.24	-0.17	Bronchopulmonary dysplasia;	chr7:1050760	chr7:1022955~1022977:-
KIRC	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-3.68	0.000258	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
KIRC	cis	rs9290877	0.965	rs17671434	MIMAT0004502	hsa-miR-28-3p	-3.68	0.000259	-0.18	-0.17	IgE levels;	chr3:188727651	chr3:188688834~188688855:+
KIRC	cis	rs6681460	0.576	rs2859914	MIMAT0014979	hsa-miR-3117-3p	-3.68	0.00026	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66524157	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.634	rs4142763	MIMAT0014979	hsa-miR-3117-3p	-3.68	0.000262	-0.2	-0.17	Presence of antiphospholipid antibodies;	chr1:66532353	chr1:66628485~66628505:+
KIRC	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-3.68	0.000263	-0.19	-0.17	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
KIRC	cis	rs990171	0.513	rs7573566	MIMAT0019927	hsa-miR-4772-3p	-3.68	0.000264	-0.2	-0.17	Lymphocyte counts;	chr2:102498746	chr2:102432336~102432357:+
KIRC	cis	rs7647973	1	rs8897	MIMAT0001618	hsa-miR-191-3p	3.67	0.000265	0.21	0.17	Menarche (age at onset);	chr3:49422974	chr3:49020631~49020652:-
KIRC	cis	rs74233809	1	rs112390216	MIMAT0022727	hsa-miR-1307-5p	-3.67	0.000266	-0.19	-0.17	Birth weight;	chr10:102981274	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.666	rs11189592	MIMAT0026738	hsa-miR-1287-3p	3.67	0.000268	0.17	0.16	Metabolite levels;	chr10:98395885	chr10:98395232~98395253:-
KIRC	cis	rs994533	0.928	rs7594625	MIMAT0004500	hsa-miR-26b-3p	-3.67	0.000269	-0.11	-0.16	Height;	chr2:217428841	chr2:218402692~218402712:+
KIRC	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-3.67	0.000271	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.662	rs10883783	MIMAT0022727	hsa-miR-1307-5p	3.67	0.000272	0.13	0.16	Arsenic metabolism;	chr10:102831395	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.59	rs1881124	MIMAT0004702	hsa-miR-339-3p	3.67	0.000273	0.26	0.16	Bronchopulmonary dysplasia;	chr7:1057130	chr7:1022955~1022977:-
KIRC	cis	rs6708413	0.521	rs6543153	MIMAT0019927	hsa-miR-4772-3p	-3.66	0.000275	-0.2	-0.16	Crohn's disease;Inflammatory bowel disease;	chr2:102497744	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs11191479	MIMAT0022727	hsa-miR-1307-5p	-3.66	0.000275	-0.19	-0.16	Birth weight;	chr10:102963863	chr10:103394341~103394361:-
KIRC	cis	rs7173964	0.967	rs8037894	MIMAT0000458	hsa-miR-190a-5p	3.66	0.000275	0.15	0.16	Fasting blood glucose (BMI interaction);Fasting blood glucose;	chr15:62102065	chr15:62823971~62823992:+
KIRC	cis	rs482700	0.796	rs480693	MIMAT0003242	hsa-miR-577	-3.66	0.000277	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115101590	chr4:114656774~114656794:+
KIRC	cis	rs3764400	0.567	rs1979897	MIMAT0000438	hsa-miR-152-3p	3.66	0.000277	0.27	0.16	Body mass index;	chr17:48232184	chr17:48037174~48037194:-
KIRC	cis	rs10492002	0.596	rs55924813	MIMAT0003287	hsa-miR-618	3.66	0.00028	0.17	0.16	Response to antidepressant treatment (citalopram);	chr12:81133017	chr12:80935796~80935818:-
KIRC	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-3.66	0.00028	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.796	rs490103	MIMAT0003242	hsa-miR-577	-3.66	0.000282	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115105324	chr4:114656774~114656794:+
KIRC	cis	rs990171	0.538	rs4851599	MIMAT0019927	hsa-miR-4772-3p	-3.66	0.000282	-0.2	-0.16	Lymphocyte counts;	chr2:102499561	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.511	rs4851013	MIMAT0019927	hsa-miR-4772-3p	-3.66	0.000282	-0.2	-0.16	Lymphocyte counts;	chr2:102499676	chr2:102432336~102432357:+
KIRC	cis	rs3764400	0.508	rs2240119	MIMAT0000438	hsa-miR-152-3p	-3.66	0.000283	-0.27	-0.16	Body mass index;	chr17:48033806	chr17:48037174~48037194:-
KIRC	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-3.66	0.000283	-0.21	-0.16	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
KIRC	cis	rs3764400	0.567	rs12946208	MIMAT0000438	hsa-miR-152-3p	3.66	0.000284	0.27	0.16	Body mass index;	chr17:48234767	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs3897789	MIMAT0000438	hsa-miR-152-3p	3.66	0.000284	0.27	0.16	Body mass index;	chr17:48235415	chr17:48037174~48037194:-
KIRC	cis	rs2564921	0.73	rs60579898	MIMAT0004584	hsa-let-7g-3p	3.65	0.00029	0.09	0.16	Height;	chr3:53069965	chr3:52268280~52268300:-
KIRC	cis	rs966423	0.54	rs12478966	MIMAT0004500	hsa-miR-26b-3p	3.65	0.000291	0.12	0.16	Thyroid cancer;	chr2:217435840	chr2:218402692~218402712:+
KIRC	cis	rs966423	0.621	rs12473807	MIMAT0004500	hsa-miR-26b-3p	3.65	0.000291	0.12	0.16	Thyroid cancer;	chr2:217435999	chr2:218402692~218402712:+
KIRC	cis	rs74233809	1	rs5011520	MIMAT0022727	hsa-miR-1307-5p	-3.65	0.000291	-0.19	-0.16	Birth weight;	chr10:102937759	chr10:103394341~103394361:-
KIRC	cis	rs8114671	0.647	rs6060267	MIMAT0004772	hsa-miR-499a-3p	-3.65	0.000294	-0.19	-0.16	Height;	chr20:35146209	chr20:34990445~34990466:+
KIRC	cis	rs8114671	0.647	rs6060268	MIMAT0004772	hsa-miR-499a-3p	-3.65	0.000294	-0.19	-0.16	Height;	chr20:35146490	chr20:34990445~34990466:+
KIRC	cis	rs8114671	0.647	rs1415771	MIMAT0004772	hsa-miR-499a-3p	-3.65	0.000294	-0.19	-0.16	Height;	chr20:35146690	chr20:34990445~34990466:+
KIRC	cis	rs3764400	0.567	rs12936369	MIMAT0000438	hsa-miR-152-3p	3.65	0.000294	0.27	0.16	Body mass index;	chr17:48193334	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs36071506	MIMAT0000438	hsa-miR-152-3p	3.65	0.000294	0.27	0.16	Body mass index;	chr17:48202410	chr17:48037174~48037194:-
KIRC	cis	rs8114671	0.647	rs945959	MIMAT0004772	hsa-miR-499a-3p	-3.65	0.000295	-0.19	-0.16	Height;	chr20:35147102	chr20:34990445~34990466:+
KIRC	cis	rs482700	0.876	rs520385	MIMAT0003242	hsa-miR-577	-3.65	0.000295	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115134842	chr4:114656774~114656794:+
KIRC	cis	rs79985863	1	rs12106339	MIMAT0027531	hsa-miR-6815-3p	-3.65	0.000295	-0.33	-0.16	Alzheimer disease and age of onset;	chr21:45486098	chr21:45478306~45478326:+
KIRC	cis	rs990171	0.538	rs11123934	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000296	-0.21	-0.16	Lymphocyte counts;	chr2:102499109	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs77860422	MIMAT0022727	hsa-miR-1307-5p	-3.65	0.000296	-0.19	-0.16	Birth weight;	chr10:102988252	chr10:103394341~103394361:-
KIRC	cis	rs6575836	0.539	rs963924	MIMAT0005899	hsa-miR-1247-5p	3.65	0.000296	0.22	0.16	Tuberculosis;	chr14:101185411	chr14:101560362~101560383:-
KIRC	cis	rs74233809	1	rs10883815	MIMAT0022727	hsa-miR-1307-5p	-3.64	0.000297	-0.19	-0.16	Birth weight;	chr10:102979422	chr10:103394341~103394361:-
KIRC	cis	rs11237982	0.543	rs7129676	MIMAT0004927	hsa-miR-708-3p	3.64	0.000298	0.29	0.16	Verbal declarative memory;	chr11:79700847	chr11:79402032~79402053:-
KIRC	cis	rs9303542	0.559	rs12603976	MIMAT0000253	hsa-miR-10a-5p	3.64	3e-04	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48539801	chr17:48579904~48579926:-
KIRC	cis	rs9303542	0.559	rs12602539	MIMAT0000253	hsa-miR-10a-5p	3.64	3e-04	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48540097	chr17:48579904~48579926:-
KIRC	cis	rs9303542	0.559	rs62066693	MIMAT0000253	hsa-miR-10a-5p	3.64	3e-04	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48540168	chr17:48579904~48579926:-
KIRC	cis	rs74233809	1	rs10883808	MIMAT0022727	hsa-miR-1307-5p	-3.64	0.000302	-0.19	-0.16	Birth weight;	chr10:102961369	chr10:103394341~103394361:-
KIRC	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-3.64	0.000304	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
KIRC	cis	rs3764400	0.567	rs1452662	MIMAT0000438	hsa-miR-152-3p	3.64	0.000306	0.27	0.16	Body mass index;	chr17:48215948	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.564	rs1452663	MIMAT0000438	hsa-miR-152-3p	3.64	0.000306	0.27	0.16	Body mass index;	chr17:48216024	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs16953941	MIMAT0000438	hsa-miR-152-3p	3.64	0.000306	0.27	0.16	Body mass index;	chr17:48218842	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs12939334	MIMAT0000438	hsa-miR-152-3p	3.64	0.000306	0.27	0.16	Body mass index;	chr17:48225307	chr17:48037174~48037194:-
KIRC	cis	rs990171	0.513	rs6543152	MIMAT0019927	hsa-miR-4772-3p	-3.64	0.000308	-0.2	-0.16	Lymphocyte counts;	chr2:102497584	chr2:102432336~102432357:+
KIRC	cis	rs4851551	1	rs3917329	MIMAT0019926	hsa-miR-4772-5p	-3.63	0.00031	-0.41	-0.16	Blood protein levels;	chr2:102179403	chr2:102432300~102432321:+
KIRC	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.00031	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.59	rs10883839	MIMAT0022727	hsa-miR-1307-5p	3.63	0.000312	0.12	0.16	Arsenic metabolism;	chr10:103160584	chr10:103394341~103394361:-
KIRC	cis	rs9527	1	rs9527	MIMAT0005951	hsa-miR-1307-3p	3.63	0.000315	0.12	0.16	Arsenic metabolism;	chr10:102863821	chr10:103394301~103394322:-
KIRC	cis	rs1950626	0.623	rs34448411	MIMAT0026557	hsa-miR-412-5p	-3.63	0.000316	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100962950	chr14:101065465~101065487:+
KIRC	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.00032	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.876	rs487981	MIMAT0003242	hsa-miR-577	-3.62	0.000322	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115131742	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.876	rs1600396	MIMAT0003242	hsa-miR-577	-3.62	0.000322	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115133096	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.876	rs532094	MIMAT0003242	hsa-miR-577	-3.62	0.000322	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115136658	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.876	rs556892	MIMAT0003242	hsa-miR-577	-3.62	0.000322	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115137109	chr4:114656774~114656794:+
KIRC	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000323	-0.16	-0.16	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
KIRC	cis	rs3764400	0.567	rs208012	MIMAT0000438	hsa-miR-152-3p	-3.62	0.000323	-0.26	-0.16	Body mass index;	chr17:48180655	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs208011	MIMAT0000438	hsa-miR-152-3p	-3.62	0.000323	-0.26	-0.16	Body mass index;	chr17:48180983	chr17:48037174~48037194:-
KIRC	cis	rs482700	0.796	rs505277	MIMAT0003242	hsa-miR-577	-3.62	0.000323	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115107652	chr4:114656774~114656794:+
KIRC	cis	rs953492	0.831	rs2783964	MIMAT0019761	hsa-miR-4677-3p	-3.62	0.000324	-0.16	-0.16	Diastolic blood pressure;	chr1:243337362	chr1:243346225~243346246:+
KIRC	cis	rs6504340	0.6	rs2325946	MIMAT0000253	hsa-miR-10a-5p	-3.62	0.000324	-0.2	-0.16	Primary tooth development (number of teeth);	chr17:48507269	chr17:48579904~48579926:-
KIRC	cis	rs9303542	0.571	rs2202895	MIMAT0000253	hsa-miR-10a-5p	-3.62	0.000324	-0.2	-0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48507295	chr17:48579904~48579926:-
KIRC	cis	rs9303542	0.694	rs9906950	MIMAT0000253	hsa-miR-10a-5p	-3.62	0.000325	-0.2	-0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48499805	chr17:48579904~48579926:-
KIRC	cis	rs482700	0.876	rs482283	MIMAT0003242	hsa-miR-577	-3.62	0.000325	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115114361	chr4:114656774~114656794:+
KIRC	cis	rs7072216	0.687	rs10786418	MIMAT0005878	hsa-miR-1287-5p	3.62	0.000326	0.18	0.16	Metabolite levels;	chr10:98397611	chr10:98395271~98395292:-
KIRC	cis	rs6592284	0.726	rs10792851	MIMAT0027410	hsa-miR-6755-5p	3.62	0.000327	0.26	0.16	Cognitive performance;	chr11:86356333	chr11:86278338~86278359:+
KIRC	cis	rs6681460	0.576	rs1338200	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.000328	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66526514	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.73	rs511497	MIMAT0003242	hsa-miR-577	-3.62	0.000329	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115091707	chr4:114656774~114656794:+
KIRC	cis	rs17025426	1	rs17025426	MIMAT0000227	hsa-miR-197-3p	3.61	0.000333	0.22	0.16	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr1:110102705	chr1:109598940~109598961:+
KIRC	cis	rs990171	0.538	rs7591878	MIMAT0019927	hsa-miR-4772-3p	-3.61	0.000334	-0.21	-0.16	Lymphocyte counts;	chr2:102496199	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.674	rs2121051	MIMAT0014979	hsa-miR-3117-3p	-3.61	0.000335	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66551494	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-3.61	0.000336	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.634	rs994396	MIMAT0014979	hsa-miR-3117-3p	-3.61	0.000337	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66546553	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.615	rs2152915	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000339	0.12	0.16	Arsenic metabolism;	chr10:102931975	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.615	rs3897401	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000339	0.12	0.16	Arsenic metabolism;	chr10:102936622	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.615	rs10883804	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000339	0.12	0.16	Arsenic metabolism;	chr10:102946763	chr10:103394341~103394361:-
KIRC	cis	rs7173964	1	rs8038040	MIMAT0000458	hsa-miR-190a-5p	3.61	0.000342	0.15	0.16	Fasting blood glucose (BMI interaction);Fasting blood glucose;	chr15:62102140	chr15:62823971~62823992:+
KIRC	cis	rs12701220	0.739	rs2293523	MIMAT0004702	hsa-miR-339-3p	3.61	0.000342	0.25	0.16	Bronchopulmonary dysplasia;	chr7:1058882	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.615	rs17725614	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000343	0.12	0.16	Arsenic metabolism;	chr10:102925736	chr10:103394341~103394361:-
KIRC	cis	rs4851551	1	rs4851551	MIMAT0019926	hsa-miR-4772-5p	3.61	0.000344	0.45	0.16	Blood protein levels;	chr2:102183770	chr2:102432300~102432321:+
KIRC	cis	rs990171	0.538	rs12712153	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000348	-0.2	-0.16	Lymphocyte counts;	chr2:102495302	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs11687071	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000348	-0.2	-0.16	Lymphocyte counts;	chr2:102495461	chr2:102432336~102432357:+
KIRC	cis	rs1950626	0.743	rs12884454	MIMAT0026557	hsa-miR-412-5p	-3.6	0.000351	-0.21	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100999290	chr14:101065465~101065487:+
KIRC	cis	rs990171	0.538	rs4851017	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000351	-0.2	-0.16	Lymphocyte counts;	chr2:102504310	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs6543155	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000352	-0.21	-0.16	Lymphocyte counts;	chr2:102498436	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs4851014	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000356	-0.2	-0.16	Lymphocyte counts;	chr2:102499817	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.52	rs4851605	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000357	-0.2	-0.16	Lymphocyte counts;	chr2:102504409	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs4851606	MIMAT0019927	hsa-miR-4772-3p	-3.6	0.000357	-0.2	-0.16	Lymphocyte counts;	chr2:102504430	chr2:102432336~102432357:+
KIRC	cis	rs768090	1	rs2284934	MIMAT0017950	hsa-miR-2355-3p	3.59	0.000358	0.19	0.16	Hemoglobin concentration;Hematocrit;	chr2:207134076	chr2:207109999~207110020:-
KIRC	cis	rs990171	0.538	rs6543154	MIMAT0019927	hsa-miR-4772-3p	-3.59	0.000359	-0.21	-0.16	Lymphocyte counts;	chr2:102497875	chr2:102432336~102432357:+
KIRC	cis	rs6681460	0.674	rs4134135	MIMAT0014979	hsa-miR-3117-3p	-3.59	0.000362	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66547045	chr1:66628485~66628505:+
KIRC	cis	rs990171	0.538	rs7566063	MIMAT0019927	hsa-miR-4772-3p	-3.59	0.000365	-0.21	-0.16	Lymphocyte counts;	chr2:102496106	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs12221193	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000369	-0.19	-0.16	Birth weight;	chr10:102905510	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs77180047	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000369	-0.19	-0.16	Birth weight;	chr10:102907000	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs12221064	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000369	-0.19	-0.16	Birth weight;	chr10:102917369	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs77602510	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000369	-0.19	-0.16	Birth weight;	chr10:102922845	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs78821730	MIMAT0022727	hsa-miR-1307-5p	-3.59	0.000369	-0.19	-0.16	Birth weight;	chr10:102924787	chr10:103394341~103394361:-
KIRC	cis	rs6708413	0.52	rs6543151	MIMAT0019927	hsa-miR-4772-3p	-3.59	0.000369	-0.2	-0.16	Crohn's disease;Inflammatory bowel disease;	chr2:102497582	chr2:102432336~102432357:+
KIRC	cis	rs12701220	0.542	rs6957866	MIMAT0004702	hsa-miR-339-3p	3.59	0.000371	0.25	0.16	Bronchopulmonary dysplasia;	chr7:1072038	chr7:1022955~1022977:-
KIRC	cis	rs12701220	0.689	rs6973645	MIMAT0004702	hsa-miR-339-3p	3.59	0.000371	0.25	0.16	Bronchopulmonary dysplasia;	chr7:1072610	chr7:1022955~1022977:-
KIRC	cis	rs768090	0.541	rs1263621	MIMAT0016895	hsa-miR-2355-5p	3.58	0.000372	0.17	0.16	Hemoglobin concentration;Hematocrit;	chr2:207118472	chr2:207110043~207110063:-
KIRC	cis	rs74233809	0.901	rs12416331	MIMAT0022727	hsa-miR-1307-5p	-3.58	0.000374	-0.19	-0.16	Birth weight;	chr10:103169157	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.687	rs7924303	MIMAT0005878	hsa-miR-1287-5p	-3.58	0.000375	-0.17	-0.16	Metabolite levels;	chr10:98396206	chr10:98395271~98395292:-
KIRC	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-3.58	0.000376	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
KIRC	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-3.58	0.000376	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.876	rs537058	MIMAT0003242	hsa-miR-577	-3.58	0.000376	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115142593	chr4:114656774~114656794:+
KIRC	cis	rs59072704	0.92	rs74373761	MIMAT0019761	hsa-miR-4677-3p	-3.58	0.000377	-0.25	-0.16	Monocyte count;	chr1:244333251	chr1:243346225~243346246:+
KIRC	cis	rs990171	0.538	rs6705272	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.000378	-0.2	-0.16	Lymphocyte counts;	chr2:102490110	chr2:102432336~102432357:+
KIRC	cis	rs12999542	1	rs11465597	MIMAT0019926	hsa-miR-4772-5p	-3.58	0.000378	-0.31	-0.16	Serum protein levels (sST2);	chr2:102370753	chr2:102432300~102432321:+
KIRC	cis	rs9527	0.568	rs1926036	MIMAT0022727	hsa-miR-1307-5p	3.58	0.00038	0.12	0.16	Arsenic metabolism;	chr10:103124055	chr10:103394341~103394361:-
KIRC	cis	rs6681460	0.576	rs7354983	MIMAT0014979	hsa-miR-3117-3p	-3.58	0.00038	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66522466	chr1:66628485~66628505:+
KIRC	cis	rs990171	0.538	rs4851600	MIMAT0019927	hsa-miR-4772-3p	3.58	0.00038	0.19	0.16	Lymphocyte counts;	chr2:102499764	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs7591872	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.2	-0.16	Lymphocyte counts;	chr2:102496182	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.538	rs1523201	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000389	-0.21	-0.16	Lymphocyte counts;	chr2:102490605	chr2:102432336~102432357:+
KIRC	cis	rs990171	0.566	rs10175045	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000391	-0.2	-0.16	Lymphocyte counts;	chr2:102486773	chr2:102432336~102432357:+
KIRC	cis	rs9303542	0.694	rs8071207	MIMAT0000253	hsa-miR-10a-5p	-3.57	0.000393	-0.2	-0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48506654	chr17:48579904~48579926:-
KIRC	cis	rs74233809	1	rs11191453	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.000395	-0.19	-0.16	Birth weight;	chr10:102900095	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs11191454	MIMAT0005951	hsa-miR-1307-3p	-3.57	0.000397	-0.17	-0.16	Birth weight;	chr10:102900247	chr10:103394301~103394322:-
KIRC	cis	rs894344	0.584	rs7012866	MIMAT0004551	hsa-miR-30d-3p	3.57	0.000399	0.17	0.16	Systolic blood pressure;	chr8:134604716	chr8:134804879~134804900:-
KIRC	cis	rs9527	0.544	rs11191549	MIMAT0022727	hsa-miR-1307-5p	3.57	4e-04	0.12	0.16	Arsenic metabolism;	chr10:103087040	chr10:103394341~103394361:-
KIRC	cis	rs865686	1	rs680138	MIMAT0004505	hsa-miR-32-3p	3.56	4e-04	0.2	0.16	Breast cancer;	chr9:108120700	chr9:109046231~109046252:-
KIRC	cis	rs6088813	0.635	rs2145082	MIMAT0004772	hsa-miR-499a-3p	3.56	0.000402	0.21	0.16	Height;	chr20:35317523	chr20:34990445~34990466:+
KIRC	cis	rs6681460	0.649	rs1415974	MIMAT0014979	hsa-miR-3117-3p	3.56	0.000402	0.19	0.16	Presence of antiphospholipid antibodies;	chr1:66539820	chr1:66628485~66628505:+
KIRC	cis	rs74233809	1	rs12217501	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000403	-0.19	-0.16	Birth weight;	chr10:103092132	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.687	rs7924209	MIMAT0005878	hsa-miR-1287-5p	3.56	0.000405	0.17	0.16	Metabolite levels;	chr10:98396170	chr10:98395271~98395292:-
KIRC	cis	rs79985863	1	rs73370824	MIMAT0027531	hsa-miR-6815-3p	-3.56	0.000406	-0.33	-0.16	Alzheimer disease and age of onset;	chr21:45487424	chr21:45478306~45478326:+
KIRC	cis	rs74233809	1	rs9633712	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000406	-0.19	-0.16	Birth weight;	chr10:103114004	chr10:103394341~103394361:-
KIRC	cis	rs74233809	0.786	rs11191564	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000406	-0.19	-0.16	Birth weight;	chr10:103118786	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs1060240	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000406	-0.19	-0.16	Birth weight;	chr10:103123580	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs10883835	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000406	-0.19	-0.16	Birth weight;	chr10:103124451	chr10:103394341~103394361:-
KIRC	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-3.56	0.000406	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.662	rs4919686	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000407	0.13	0.16	Arsenic metabolism;	chr10:102832492	chr10:103394341~103394361:-
KIRC	cis	rs11071657	1	rs11635220	MIMAT0026482	hsa-miR-190a-3p	3.56	0.00041	0.17	0.16	Fasting blood glucose;	chr15:62146967	chr15:62824008~62824028:+
KIRC	cis	rs74233809	1	rs12413409	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.00041	-0.19	-0.16	Birth weight;	chr10:102959339	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.796	rs503256	MIMAT0003242	hsa-miR-577	-3.56	0.000412	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115104297	chr4:114656774~114656794:+
KIRC	cis	rs12701220	0.522	rs1881116	MIMAT0004702	hsa-miR-339-3p	3.56	0.000414	0.2	0.16	Bronchopulmonary dysplasia;	chr7:1014322	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.59	rs10509766	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103166577	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs1926037	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103118253	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.567	rs6584539	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103119645	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs2148200	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103120090	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.614	rs2153774	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103121278	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs10883834	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103121645	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.545	rs7915816	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.12	0.16	Arsenic metabolism;	chr10:103121993	chr10:103394341~103394361:-
KIRC	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-3.55	0.000416	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
KIRC	cis	rs3764400	0.567	rs67345313	MIMAT0000438	hsa-miR-152-3p	3.55	0.000416	0.27	0.16	Body mass index;	chr17:48224839	chr17:48037174~48037194:-
KIRC	cis	rs9527	0.64	rs7089061	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000416	0.12	0.16	Arsenic metabolism;	chr10:102963258	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.615	rs7089065	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000416	0.12	0.16	Arsenic metabolism;	chr10:102963265	chr10:103394341~103394361:-
KIRC	cis	rs2237579	0.584	rs17794795	MIMAT0026625	hsa-miR-653-3p	-3.55	0.000417	-0.2	-0.16	Body mass index;	chr7:93511032	chr7:93482784~93482805:-
KIRC	cis	rs10492002	0.636	rs1545083	MIMAT0003287	hsa-miR-618	3.55	0.000417	0.17	0.16	Response to antidepressant treatment (citalopram);	chr12:81133424	chr12:80935796~80935818:-
KIRC	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	3.55	0.000417	0.18	0.16	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
KIRC	cis	rs74233809	1	rs11191502	MIMAT0022727	hsa-miR-1307-5p	-3.55	0.000417	-0.19	-0.16	Birth weight;	chr10:103005737	chr10:103394341~103394361:-
KIRC	cis	rs7221773	0.507	rs9891553	MIMAT0001631	hsa-miR-451a	-3.55	0.000419	-0.06	-0.16	Mean corpuscular volume;	chr17:28986269	chr17:28861403~28861424:-
KIRC	cis	rs994533	0.781	rs11890939	MIMAT0004500	hsa-miR-26b-3p	-3.55	0.000419	-0.12	-0.16	Height;	chr2:217423502	chr2:218402692~218402712:+
KIRC	cis	rs6537837	0.517	rs559479	MIMAT0000227	hsa-miR-197-3p	-3.55	0.00042	-0.13	-0.16	Major depressive disorder;	chr1:109595914	chr1:109598940~109598961:+
KIRC	cis	rs2237579	0.584	rs7808583	MIMAT0026625	hsa-miR-653-3p	-3.55	0.00042	-0.2	-0.16	Body mass index;	chr7:93513584	chr7:93482784~93482805:-
KIRC	cis	rs2237579	0.584	rs11972993	MIMAT0026625	hsa-miR-653-3p	-3.55	0.00042	-0.2	-0.16	Body mass index;	chr7:93514125	chr7:93482784~93482805:-
KIRC	cis	rs1018697	0.966	rs6584526	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000421	0.11	0.16	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394341~103394361:-
KIRC	cis	rs6555855	0.514	rs2338526	MIMAT0003250	hsa-miR-585-3p	3.55	0.000422	0.2	0.16	Menarche (age at onset);	chr5:169298244	chr5:169263616~169263634:-
KIRC	cis	rs9527	0.59	rs11191547	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000422	0.12	0.16	Arsenic metabolism;	chr10:103083391	chr10:103394341~103394361:-
KIRC	cis	rs482700	0.796	rs554840	MIMAT0003242	hsa-miR-577	-3.55	0.000424	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115094428	chr4:114656774~114656794:+
KIRC	cis	rs9527	0.615	rs36045108	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000429	0.12	0.16	Arsenic metabolism;	chr10:102938172	chr10:103394341~103394361:-
KIRC	cis	rs2564921	0.73	rs2564922	MIMAT0004584	hsa-let-7g-3p	-3.55	0.000429	-0.09	-0.16	Height;	chr3:53091453	chr3:52268280~52268300:-
KIRC	cis	rs7200543	0.666	rs34955778	MIMAT0000710	hsa-miR-365a-3p	-3.55	0.000431	-0.15	-0.16	Body mass index;Triglyceride levels;Metabolic traits;Glycerophospholipid levels;	chr16:15045737	chr16:14309340~14309361:+
KIRC	cis	rs1950626	0.699	rs12880855	MIMAT0026557	hsa-miR-412-5p	-3.54	0.000432	-0.21	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:101002045	chr14:101065465~101065487:+
KIRC	cis	rs62066768	0.744	rs502276	MIMAT0019856	hsa-miR-4732-3p	-3.54	0.000432	-0.19	-0.16	Tonsillectomy;	chr17:28520808	chr17:28861668~28861688:-
KIRC	cis	rs7647973	0.89	rs73073004	MIMAT0001618	hsa-miR-191-3p	-3.54	0.000433	-0.23	-0.16	Menarche (age at onset);	chr3:49452587	chr3:49020631~49020652:-
KIRC	cis	rs7072216	0.687	rs7908310	MIMAT0005878	hsa-miR-1287-5p	3.54	0.000436	0.17	0.16	Metabolite levels;	chr10:98396470	chr10:98395271~98395292:-
KIRC	cis	rs7072216	0.687	rs10883087	MIMAT0005878	hsa-miR-1287-5p	3.54	0.000436	0.17	0.16	Metabolite levels;	chr10:98397233	chr10:98395271~98395292:-
KIRC	cis	rs768090	0.886	rs3791994	MIMAT0016895	hsa-miR-2355-5p	3.54	0.000436	0.18	0.16	Hemoglobin concentration;Hematocrit;	chr2:207145195	chr2:207110043~207110063:-
KIRC	cis	rs1950626	0.623	rs2295657	MIMAT0026557	hsa-miR-412-5p	-3.54	0.000437	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100964283	chr14:101065465~101065487:+
KIRC	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000438	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.64	rs35195396	MIMAT0022727	hsa-miR-1307-5p	3.54	0.00044	0.12	0.16	Arsenic metabolism;	chr10:103169013	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.614	rs11191589	MIMAT0022727	hsa-miR-1307-5p	3.54	0.00044	0.12	0.16	Arsenic metabolism;	chr10:103170625	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs3740386	MIMAT0022727	hsa-miR-1307-5p	3.54	0.00044	0.12	0.16	Arsenic metabolism;	chr10:103171294	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs10786741	MIMAT0022727	hsa-miR-1307-5p	3.54	0.00044	0.12	0.16	Arsenic metabolism;	chr10:103179425	chr10:103394341~103394361:-
KIRC	cis	rs11237982	0.587	rs10899663	MIMAT0004927	hsa-miR-708-3p	3.54	0.000441	0.27	0.16	Verbal declarative memory;	chr11:79678191	chr11:79402032~79402053:-
KIRC	cis	rs2237579	0.565	rs10225481	MIMAT0026625	hsa-miR-653-3p	-3.54	0.000442	-0.2	-0.16	Body mass index;	chr7:93512420	chr7:93482784~93482805:-
KIRC	cis	rs2237579	0.584	rs6465386	MIMAT0026625	hsa-miR-653-3p	3.54	0.000444	0.19	0.16	Body mass index;	chr7:93510501	chr7:93482784~93482805:-
KIRC	cis	rs953492	0.765	rs10926981	MIMAT0019761	hsa-miR-4677-3p	-3.54	0.000447	-0.16	-0.16	Diastolic blood pressure;	chr1:243288103	chr1:243346225~243346246:+
KIRC	cis	rs9527	0.59	rs1541213	MIMAT0022727	hsa-miR-1307-5p	3.53	0.00045	0.12	0.16	Arsenic metabolism;	chr10:103125573	chr10:103394341~103394361:-
KIRC	cis	rs733254	0.666	rs7009477	MIMAT0004551	hsa-miR-30d-3p	3.53	0.000455	0.17	0.16	Height;	chr8:134618797	chr8:134804879~134804900:-
KIRC	cis	rs6133127	0.554	rs6139466	MIMAT0000101	hsa-miR-103a-3p	3.53	0.000457	0.1	0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533457	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6139466	MIMAT0000101_1	hsa-miR-103a-3p	3.53	0.000457	0.1	0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533457	chr5:168560904~168560926:-
KIRC	cis	rs6133127	0.554	rs6037864	MIMAT0000101	hsa-miR-103a-3p	3.53	0.000459	0.1	0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4534314	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6037864	MIMAT0000101_1	hsa-miR-103a-3p	3.53	0.000459	0.1	0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4534314	chr5:168560904~168560926:-
KIRC	cis	rs9527	0.59	rs7897663	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000461	0.12	0.16	Arsenic metabolism;	chr10:103145847	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.64	rs6584541	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000461	0.12	0.16	Arsenic metabolism;	chr10:103169367	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs7917650	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000461	0.12	0.16	Arsenic metabolism;	chr10:103177343	chr10:103394341~103394361:-
KIRC	cis	rs10862219	0.528	rs1581347	MIMAT0003287	hsa-miR-618	3.53	0.000461	0.18	0.16	Neuroticism;	chr12:80963299	chr12:80935796~80935818:-
KIRC	cis	rs9527	0.59	rs1935323	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000464	0.12	0.16	Arsenic metabolism;	chr10:103117278	chr10:103394341~103394361:-
KIRC	cis	rs4851551	0.543	rs1997503	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.000465	-0.32	-0.16	Blood protein levels;	chr2:102192775	chr2:102432336~102432357:+
KIRC	cis	rs79985863	1	rs2246749	MIMAT0027531	hsa-miR-6815-3p	3.52	0.000465	0.31	0.16	Alzheimer disease and age of onset;	chr21:45486776	chr21:45478306~45478326:+
KIRC	cis	rs9303542	0.559	rs1042818	MIMAT0000253	hsa-miR-10a-5p	3.52	0.000466	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48542749	chr17:48579904~48579926:-
KIRC	cis	rs9303542	0.559	rs2229302	MIMAT0000253	hsa-miR-10a-5p	3.52	0.000466	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48543040	chr17:48579904~48579926:-
KIRC	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-3.52	0.000469	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
KIRC	cis	rs1950626	0.699	rs12880424	MIMAT0026557	hsa-miR-412-5p	-3.52	0.000469	-0.21	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100993323	chr14:101065465~101065487:+
KIRC	cis	rs768090	0.886	rs3791995	MIMAT0016895	hsa-miR-2355-5p	3.52	0.000471	0.17	0.16	Hemoglobin concentration;Hematocrit;	chr2:207145629	chr2:207110043~207110063:-
KIRC	cis	rs10492002	0.563	rs4516036	MIMAT0003287	hsa-miR-618	3.52	0.000471	0.17	0.16	Response to antidepressant treatment (citalopram);	chr12:81115447	chr12:80935796~80935818:-
KIRC	cis	rs11216831	1	rs11216831	MIMAT0025845	hsa-miR-6716-3p	-3.52	0.000471	-0.4	-0.16	Thiazide-induced adverse metabolic effects in hypertensive patients;	chr11:118246303	chr11:118644048~118644069:+
KIRC	cis	rs9527	0.59	rs2281877	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000472	0.12	0.16	Arsenic metabolism;	chr10:103106305	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs10786738	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000472	0.12	0.16	Arsenic metabolism;	chr10:103109694	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs1807298	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000472	0.12	0.16	Arsenic metabolism;	chr10:103110461	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs2182348	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000472	0.12	0.16	Arsenic metabolism;	chr10:103112927	chr10:103394341~103394361:-
KIRC	cis	rs894344	0.584	rs7011157	MIMAT0004551	hsa-miR-30d-3p	3.52	0.000472	0.17	0.16	Systolic blood pressure;	chr8:134616936	chr8:134804879~134804900:-
KIRC	cis	rs12701220	0.655	rs9638973	MIMAT0004702	hsa-miR-339-3p	3.52	0.000474	0.23	0.16	Bronchopulmonary dysplasia;	chr7:1094042	chr7:1022955~1022977:-
KIRC	cis	rs990171	0.538	rs1403548	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.000475	-0.2	-0.16	Lymphocyte counts;	chr2:102493916	chr2:102432336~102432357:+
KIRC	cis	rs6555855	0.521	rs751346	MIMAT0003250	hsa-miR-585-3p	3.52	0.000475	0.23	0.16	Menarche (age at onset);	chr5:169283363	chr5:169263616~169263634:-
KIRC	cis	rs12701220	0.894	rs34712249	MIMAT0004702	hsa-miR-339-3p	3.52	0.000475	0.24	0.16	Bronchopulmonary dysplasia;	chr7:996998	chr7:1022955~1022977:-
KIRC	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-3.52	0.000476	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
KIRC	cis	rs6725806	1	rs6725806	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.000476	-0.2	-0.16	Blood protein levels;	chr2:102599713	chr2:102432336~102432357:+
KIRC	cis	rs7200543	1	rs7200543	MIMAT0000710	hsa-miR-365a-3p	3.52	0.000477	0.16	0.16	Body mass index;Triglyceride levels;Metabolic traits;Glycerophospholipid levels;	chr16:15036113	chr16:14309340~14309361:+
KIRC	cis	rs11237982	0.587	rs72944361	MIMAT0004926	hsa-miR-708-5p	3.52	0.000477	0.26	0.16	Verbal declarative memory;	chr11:79677841	chr11:79402077~79402099:-
KIRC	cis	rs1950626	0.577	rs61991118	MIMAT0026557	hsa-miR-412-5p	-3.52	0.000478	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100975637	chr14:101065465~101065487:+
KIRC	cis	rs7072216	0.687	rs10883085	MIMAT0005878	hsa-miR-1287-5p	3.52	0.00048	0.16	0.16	Metabolite levels;	chr10:98395856	chr10:98395271~98395292:-
KIRC	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-3.51	0.000483	-0.17	-0.16	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
KIRC	cis	rs3764400	0.507	rs16954324	MIMAT0000438	hsa-miR-152-3p	3.51	0.000484	0.27	0.16	Body mass index;	chr17:48247222	chr17:48037174~48037194:-
KIRC	cis	rs1950626	0.623	rs34603287	MIMAT0026557	hsa-miR-412-5p	-3.51	0.000486	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100967494	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.569	rs4143956	MIMAT0026557	hsa-miR-412-5p	-3.51	0.000486	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100968019	chr14:101065465~101065487:+
KIRC	cis	rs1950626	0.623	rs61991083	MIMAT0026557	hsa-miR-412-5p	-3.51	0.000486	-0.19	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100970098	chr14:101065465~101065487:+
KIRC	cis	rs11237982	0.587	rs10899663	MIMAT0004926	hsa-miR-708-5p	3.51	0.000488	0.25	0.16	Verbal declarative memory;	chr11:79678191	chr11:79402077~79402099:-
KIRC	cis	rs2564921	0.704	rs57916015	MIMAT0004584	hsa-let-7g-3p	3.51	0.000488	0.09	0.16	Height;	chr3:52971094	chr3:52268280~52268300:-
KIRC	cis	rs3764400	0.567	rs2325784	MIMAT0000438	hsa-miR-152-3p	-3.51	0.000488	-0.26	-0.16	Body mass index;	chr17:48134947	chr17:48037174~48037194:-
KIRC	cis	rs3764400	0.567	rs8079616	MIMAT0000438	hsa-miR-152-3p	-3.51	0.000488	-0.26	-0.16	Body mass index;	chr17:48136126	chr17:48037174~48037194:-
KIRC	cis	rs74233809	1	rs34747231	MIMAT0022727	hsa-miR-1307-5p	-3.51	0.000489	-0.19	-0.16	Birth weight;	chr10:103182487	chr10:103394341~103394361:-
KIRC	cis	rs9303542	0.559	rs1042822	MIMAT0000253	hsa-miR-10a-5p	3.51	0.000489	0.21	0.16	Epithelial ovarian cancer;Ovarian cancer;	chr17:48542733	chr17:48579904~48579926:-
KIRC	cis	rs6681460	0.576	rs7354930	MIMAT0014979	hsa-miR-3117-3p	-3.51	0.00049	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66520694	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.576	rs1338194	MIMAT0014979	hsa-miR-3117-3p	-3.51	0.00049	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66520793	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-3.51	0.000492	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
KIRC	cis	rs865686	0.931	rs837983	MIMAT0004505	hsa-miR-32-3p	3.51	0.000492	0.19	0.16	Breast cancer;	chr9:108119173	chr9:109046231~109046252:-
KIRC	cis	rs1018697	1	rs7092346	MIMAT0022727	hsa-miR-1307-5p	3.51	0.000494	0.11	0.16	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.687	rs10883086	MIMAT0005878	hsa-miR-1287-5p	3.51	0.000494	0.17	0.16	Metabolite levels;	chr10:98395986	chr10:98395271~98395292:-
KIRC	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	3.51	0.000499	0.17	0.16	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.641	rs4919684	MIMAT0022727	hsa-miR-1307-5p	3.51	0.000499	0.12	0.16	Arsenic metabolism;	chr10:102827267	chr10:103394341~103394361:-
KIRC	cis	rs2564921	0.704	rs62253649	MIMAT0004584	hsa-let-7g-3p	3.5	0.000499	0.09	0.16	Height;	chr3:52967831	chr3:52268280~52268300:-
KIRC	cis	rs12701220	0.553	rs9639882	MIMAT0004702	hsa-miR-339-3p	3.5	5e-04	0.23	0.16	Bronchopulmonary dysplasia;	chr7:1094095	chr7:1022955~1022977:-
KIRC	cis	rs9527	0.615	rs11191401	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000501	0.12	0.16	Arsenic metabolism;	chr10:102813646	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.894	rs10257744	MIMAT0004702	hsa-miR-339-3p	3.5	0.000501	0.24	0.16	Bronchopulmonary dysplasia;	chr7:1005976	chr7:1022955~1022977:-
KIRC	cis	rs2675399	0.684	rs1851878	MIMAT0022706	hsa-miR-561-5p	-3.5	0.000503	-0.19	-0.16	Obesity-related traits;	chr2:188723339	chr2:188297517~188297538:+
KIRC	cis	rs11237982	0.587	rs10899664	MIMAT0004927	hsa-miR-708-3p	3.5	0.000507	0.26	0.16	Verbal declarative memory;	chr11:79678322	chr11:79402032~79402053:-
KIRC	cis	rs6681460	0.674	rs7543607	MIMAT0014979	hsa-miR-3117-3p	-3.5	0.00051	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66546909	chr1:66628485~66628505:+
KIRC	cis	rs1018697	1	rs7092051	MIMAT0022727	hsa-miR-1307-5p	3.5	0.00051	0.11	0.16	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394341~103394361:-
KIRC	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-3.5	0.00051	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-3.5	0.000512	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.59	rs2274339	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000513	0.12	0.16	Arsenic metabolism;	chr10:103100296	chr10:103394341~103394361:-
KIRC	cis	rs11651753	0.598	rs4794286	MIMAT0000253	hsa-miR-10a-5p	3.5	0.000513	0.18	0.16	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47913231	chr17:48579904~48579926:-
KIRC	cis	rs12701220	0.901	rs12701713	MIMAT0004702	hsa-miR-339-3p	3.5	0.000514	0.23	0.16	Bronchopulmonary dysplasia;	chr7:1050869	chr7:1022955~1022977:-
KIRC	cis	rs12701220	0.894	rs8591	MIMAT0004702	hsa-miR-339-3p	3.5	0.000514	0.23	0.16	Bronchopulmonary dysplasia;	chr7:997163	chr7:1022955~1022977:-
KIRC	cis	rs953492	0.731	rs10803133	MIMAT0019761	hsa-miR-4677-3p	3.5	0.000516	0.16	0.16	Diastolic blood pressure;	chr1:243290712	chr1:243346225~243346246:+
KIRC	cis	rs2564921	0.693	rs2581798	MIMAT0004584	hsa-let-7g-3p	-3.5	0.000517	-0.09	-0.16	Height;	chr3:53073584	chr3:52268280~52268300:-
KIRC	cis	rs9527	0.59	rs10883836	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103131441	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs11191572	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103133380	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs12415199	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103135779	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs34104646	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103136321	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.567	rs11191573	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103137059	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.641	rs34130454	MIMAT0022727	hsa-miR-1307-5p	3.5	0.000518	0.12	0.16	Arsenic metabolism;	chr10:103143881	chr10:103394341~103394361:-
KIRC	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-3.49	0.000518	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
KIRC	cis	rs482700	0.796	rs13106842	MIMAT0003242	hsa-miR-577	-3.49	0.000521	-0.19	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115102678	chr4:114656774~114656794:+
KIRC	cis	rs11071657	1	rs8038542	MIMAT0026482	hsa-miR-190a-3p	3.49	0.000523	0.17	0.16	Fasting blood glucose;	chr15:62145254	chr15:62824008~62824028:+
KIRC	cis	rs9527	1	rs4919690	MIMAT0005951	hsa-miR-1307-3p	-3.49	0.000524	-0.12	-0.16	Arsenic metabolism;	chr10:102856743	chr10:103394301~103394322:-
KIRC	cis	rs9527	0.59	rs7912517	MIMAT0022727	hsa-miR-1307-5p	3.49	0.000526	0.12	0.16	Arsenic metabolism;	chr10:103145772	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs2066322	MIMAT0022727	hsa-miR-1307-5p	3.49	0.000526	0.12	0.16	Arsenic metabolism;	chr10:103149582	chr10:103394341~103394361:-
KIRC	cis	rs2675399	0.7	rs1354906	MIMAT0022706	hsa-miR-561-5p	-3.49	0.000527	-0.19	-0.16	Obesity-related traits;	chr2:188582091	chr2:188297517~188297538:+
KIRC	cis	rs11071657	1	rs8038711	MIMAT0026482	hsa-miR-190a-3p	3.49	0.000528	0.17	0.16	Fasting blood glucose;	chr15:62145350	chr15:62824008~62824028:+
KIRC	cis	rs2277912	1	rs3762567	MIMAT0014995	hsa-miR-3130-5p	3.49	0.000528	0.25	0.16	Height;	chr2:206765614	chr2:206783276~206783296:-
KIRC	cis	rs2277912	1	rs3762567	MIMAT0014995_1	hsa-miR-3130-5p	3.49	0.000528	0.25	0.16	Height;	chr2:206765614	chr2:206783246~206783266:+
KIRC	cis	rs62066768	0.706	rs12944511	MIMAT0019856	hsa-miR-4732-3p	-3.49	0.000529	-0.17	-0.16	Tonsillectomy;	chr17:28514568	chr17:28861668~28861688:-
KIRC	cis	rs9527	0.59	rs1926029	MIMAT0022727	hsa-miR-1307-5p	3.49	0.000531	0.12	0.16	Arsenic metabolism;	chr10:103095913	chr10:103394341~103394361:-
KIRC	cis	rs2277912	1	rs12620432	MIMAT0014995	hsa-miR-3130-5p	3.49	0.000531	0.25	0.16	Height;	chr2:206771794	chr2:206783276~206783296:-
KIRC	cis	rs2277912	1	rs12620432	MIMAT0014995_1	hsa-miR-3130-5p	3.49	0.000531	0.25	0.16	Height;	chr2:206771794	chr2:206783246~206783266:+
KIRC	cis	rs6133127	0.554	rs6139465	MIMAT0000101	hsa-miR-103a-3p	-3.49	0.000532	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533335	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6139465	MIMAT0000101_1	hsa-miR-103a-3p	-3.49	0.000532	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533335	chr5:168560904~168560926:-
KIRC	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-3.49	0.000533	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
KIRC	cis	rs9527	0.544	rs3781280	MIMAT0022727	hsa-miR-1307-5p	3.49	0.000535	0.12	0.16	Arsenic metabolism;	chr10:103104086	chr10:103394341~103394361:-
KIRC	cis	rs2581828	0.646	rs3796351	MIMAT0004584	hsa-let-7g-3p	-3.48	0.000537	-0.1	-0.16	Crohn's disease;	chr3:53122049	chr3:52268280~52268300:-
KIRC	cis	rs7647973	0.71	rs2029591	MIMAT0000440	hsa-miR-191-5p	-3.48	0.000539	-0.12	-0.16	Menarche (age at onset);	chr3:49609548	chr3:49020672~49020694:-
KIRC	cis	rs6133127	0.554	rs6139463	MIMAT0000101	hsa-miR-103a-3p	-3.48	0.000543	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533291	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6139463	MIMAT0000101_1	hsa-miR-103a-3p	-3.48	0.000543	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533291	chr5:168560904~168560926:-
KIRC	cis	rs6133127	0.554	rs6139464	MIMAT0000101	hsa-miR-103a-3p	-3.48	0.000543	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533333	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6139464	MIMAT0000101_1	hsa-miR-103a-3p	-3.48	0.000543	-0.1	-0.16	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533333	chr5:168560904~168560926:-
KIRC	cis	rs1018697	1	rs7080587	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000544	0.11	0.16	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394341~103394361:-
KIRC	cis	rs11621975	0.57	rs61994022	MIMAT0002814	hsa-miR-432-5p	-3.48	0.000547	-0.25	-0.16	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin;	chr14:101789505	chr14:100884496~100884518:+
KIRC	cis	rs3764400	0.567	rs2229369	MIMAT0000438	hsa-miR-152-3p	3.48	0.000547	0.26	0.16	Body mass index;	chr17:48058771	chr17:48037174~48037194:-
KIRC	cis	rs9527	0.59	rs11191578	MIMAT0022727	hsa-miR-1307-5p	3.48	0.000548	0.11	0.16	Arsenic metabolism;	chr10:103142580	chr10:103394341~103394361:-
KIRC	cis	rs7917772	0.69	rs11191369	MIMAT0022727	hsa-miR-1307-5p	-3.48	0.000548	-0.11	-0.16	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102697699	chr10:103394341~103394361:-
KIRC	cis	rs7917772	0.619	rs2251772	MIMAT0005951	hsa-miR-1307-3p	-3.48	0.000551	-0.12	-0.16	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102711161	chr10:103394301~103394322:-
KIRC	cis	rs11651753	0.561	rs4794261	MIMAT0000253	hsa-miR-10a-5p	3.48	0.000552	0.18	0.16	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47904980	chr17:48579904~48579926:-
KIRC	cis	rs11651753	0.561	rs1108833	MIMAT0000253	hsa-miR-10a-5p	3.48	0.000552	0.18	0.16	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47905431	chr17:48579904~48579926:-
KIRC	cis	rs12701220	0.895	rs10262866	MIMAT0004702	hsa-miR-339-3p	3.48	0.000552	0.24	0.16	Bronchopulmonary dysplasia;	chr7:979900	chr7:1022955~1022977:-
KIRC	cis	rs2378353	1	rs2378353	MIMAT0004772	hsa-miR-499a-3p	3.48	0.000552	0.2	0.16	Lobe attachment (rater-scored or self-reported);	chr20:35382659	chr20:34990445~34990466:+
KIRC	cis	rs7173964	1	rs6494307	MIMAT0000458	hsa-miR-190a-5p	-3.48	0.000552	-0.14	-0.16	Fasting blood glucose (BMI interaction);Fasting blood glucose;	chr15:62102491	chr15:62823971~62823992:+
KIRC	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-3.48	0.000552	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-3.48	0.000554	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
KIRC	cis	rs74233809	1	rs11191575	MIMAT0022727	hsa-miR-1307-5p	-3.48	0.000556	-0.18	-0.16	Birth weight;	chr10:103138580	chr10:103394341~103394361:-
KIRC	cis	rs9527	1	rs12416687	MIMAT0005951	hsa-miR-1307-3p	3.47	0.000558	0.12	0.16	Arsenic metabolism;	chr10:102869254	chr10:103394301~103394322:-
KIRC	cis	rs482700	0.699	rs566198	MIMAT0003242	hsa-miR-577	-3.47	0.000558	-0.18	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115092491	chr4:114656774~114656794:+
KIRC	cis	rs11237982	0.543	rs7129676	MIMAT0004926	hsa-miR-708-5p	3.47	0.00056	0.26	0.16	Verbal declarative memory;	chr11:79700847	chr11:79402077~79402099:-
KIRC	cis	rs10492002	0.563	rs10778789	MIMAT0003287	hsa-miR-618	-3.47	0.000561	-0.17	-0.16	Response to antidepressant treatment (citalopram);	chr12:81113973	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.541	rs7302831	MIMAT0003287	hsa-miR-618	-3.47	0.000561	-0.17	-0.16	Response to antidepressant treatment (citalopram);	chr12:81114185	chr12:80935796~80935818:-
KIRC	cis	rs894344	0.584	rs10875385	MIMAT0004551	hsa-miR-30d-3p	3.47	0.000564	0.17	0.16	Systolic blood pressure;	chr8:134617331	chr8:134804879~134804900:-
KIRC	cis	rs10492002	0.563	rs4466902	MIMAT0003287	hsa-miR-618	-3.47	0.000565	-0.17	-0.16	Response to antidepressant treatment (citalopram);	chr12:81116043	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.563	rs4240723	MIMAT0003287	hsa-miR-618	-3.47	0.000565	-0.17	-0.16	Response to antidepressant treatment (citalopram);	chr12:81116673	chr12:80935796~80935818:-
KIRC	cis	rs10492002	0.563	rs5027920	MIMAT0003287	hsa-miR-618	-3.47	0.000565	-0.17	-0.16	Response to antidepressant treatment (citalopram);	chr12:81118979	chr12:80935796~80935818:-
KIRC	cis	rs9527	0.59	rs12414232	MIMAT0022727	hsa-miR-1307-5p	3.47	0.000565	0.11	0.16	Arsenic metabolism;	chr10:103154734	chr10:103394341~103394361:-
KIRC	cis	rs7594645	0.59	rs2359724	MIMAT0014995	hsa-miR-3130-5p	-3.47	0.000567	-0.34	-0.16	Episodic memory;	chr2:206750798	chr2:206783276~206783296:-
KIRC	cis	rs7594645	0.59	rs2359724	MIMAT0014995_1	hsa-miR-3130-5p	-3.47	0.000567	-0.34	-0.16	Episodic memory;	chr2:206750798	chr2:206783246~206783266:+
KIRC	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	3.47	0.000568	0.18	0.16	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-3.47	0.000569	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
KIRC	cis	rs12701220	0.604	rs34904312	MIMAT0004702	hsa-miR-339-3p	3.47	0.000569	0.22	0.16	Bronchopulmonary dysplasia;	chr7:1096247	chr7:1022955~1022977:-
KIRC	cis	rs8066044	1	rs8066044	MIMAT0004495	hsa-miR-22-5p	3.47	0.000572	0.13	0.16	Sum neutrophil eosinophil counts;	chr17:1464058	chr17:1713952~1713973:-
KIRC	cis	rs1550115	0.57	rs6545730	MIMAT0005797	hsa-miR-1301-3p	3.47	0.000574	0.17	0.16	Coronary artery disease;	chr2:24792205	chr2:25328651~25328674:-
KIRC	cis	rs9527	0.59	rs763914	MIMAT0022727	hsa-miR-1307-5p	3.47	0.000574	0.11	0.16	Arsenic metabolism;	chr10:103081830	chr10:103394341~103394361:-
KIRC	cis	rs990171	0.566	rs1523199	MIMAT0019927	hsa-miR-4772-3p	-3.47	0.000574	-0.2	-0.16	Lymphocyte counts;	chr2:102481732	chr2:102432336~102432357:+
KIRC	cis	rs2295389	0.899	rs4081134	MIMAT0002171	hsa-miR-410-3p	3.47	0.000575	0.13	0.16	Breast cancer;	chr14:100855451	chr14:101065961~101065981:+
KIRC	cis	rs6681460	0.634	rs12143964	MIMAT0014979	hsa-miR-3117-3p	-3.47	0.000577	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66544583	chr1:66628485~66628505:+
KIRC	cis	rs11237982	0.587	rs72944361	MIMAT0004927	hsa-miR-708-3p	3.47	0.000578	0.27	0.16	Verbal declarative memory;	chr11:79677841	chr11:79402032~79402053:-
KIRC	cis	rs9527	0.59	rs10883829	MIMAT0022727	hsa-miR-1307-5p	3.46	0.000579	0.11	0.16	Arsenic metabolism;	chr10:103080878	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs11191544	MIMAT0022727	hsa-miR-1307-5p	3.46	0.000581	0.12	0.16	Arsenic metabolism;	chr10:103067441	chr10:103394341~103394361:-
KIRC	cis	rs12701220	0.894	rs2141274	MIMAT0004702	hsa-miR-339-3p	3.46	0.000582	0.23	0.16	Bronchopulmonary dysplasia;	chr7:995081	chr7:1022955~1022977:-
KIRC	cis	rs2766692	0.843	rs10873515	MIMAT0002176	hsa-miR-485-3p	3.46	0.000583	0.15	0.16	Electroencephalographic traits in alcoholism;	chr14:100300327	chr14:101055464~101055485:+
KIRC	cis	rs74233809	1	rs17115213	MIMAT0005951	hsa-miR-1307-3p	-3.46	0.000583	-0.17	-0.16	Birth weight;	chr10:102921386	chr10:103394301~103394322:-
KIRC	cis	rs11651753	0.561	rs7211859	MIMAT0000253	hsa-miR-10a-5p	3.46	0.000584	0.18	0.16	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1);	chr17:47908916	chr17:48579904~48579926:-
KIRC	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-3.46	0.000584	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
KIRC	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-3.46	0.000584	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
KIRC	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-3.46	0.000584	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
KIRC	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-3.46	0.000584	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
KIRC	cis	rs7072216	0.666	rs2274248	MIMAT0026738	hsa-miR-1287-3p	3.46	0.000586	0.17	0.16	Metabolite levels;	chr10:98388785	chr10:98395232~98395253:-
KIRC	cis	rs482700	0.836	rs532137	MIMAT0003242	hsa-miR-577	-3.46	0.000588	-0.18	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115094562	chr4:114656774~114656794:+
KIRC	cis	rs9527	0.59	rs7910900	MIMAT0022727	hsa-miR-1307-5p	3.46	0.000588	0.12	0.16	Arsenic metabolism;	chr10:103070141	chr10:103394341~103394361:-
KIRC	cis	rs990171	0.566	rs1523198	MIMAT0019927	hsa-miR-4772-3p	-3.46	0.00059	-0.19	-0.16	Lymphocyte counts;	chr2:102482015	chr2:102432336~102432357:+
KIRC	cis	rs2766692	0.81	rs7151517	MIMAT0002176	hsa-miR-485-3p	3.46	0.000595	0.15	0.16	Electroencephalographic traits in alcoholism;	chr14:100300707	chr14:101055464~101055485:+
KIRC	cis	rs74233809	1	rs3781285	MIMAT0022727	hsa-miR-1307-5p	-3.46	0.000596	-0.19	-0.16	Birth weight;	chr10:103065908	chr10:103394341~103394361:-
KIRC	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-3.46	0.000598	-0.17	-0.16	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
KIRC	cis	rs1864585	0.52	rs73200742	MIMAT0003266	hsa-miR-598-3p	-3.46	0.000598	-0.23	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10771846	chr8:11035221~11035242:-
KIRC	cis	rs482700	0.758	rs569105	MIMAT0003242	hsa-miR-577	-3.45	0.000599	-0.18	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115106473	chr4:114656774~114656794:+
KIRC	cis	rs482700	0.836	rs512355	MIMAT0003242	hsa-miR-577	-3.45	0.000599	-0.18	-0.16	Stromal-cell-derived factor 1 alpha levels;	chr4:115108054	chr4:114656774~114656794:+
KIRC	cis	rs8114671	0.647	rs1124511	MIMAT0004772	hsa-miR-499a-3p	-3.45	6e-04	-0.18	-0.16	Height;	chr20:35148894	chr20:34990445~34990466:+
KIRC	cis	rs74233809	1	rs11191514	MIMAT0022727	hsa-miR-1307-5p	-3.45	0.000601	-0.18	-0.16	Birth weight;	chr10:103013607	chr10:103394341~103394361:-
KIRC	cis	rs1950626	0.615	rs12893486	MIMAT0026557	hsa-miR-412-5p	-3.45	0.000604	-0.21	-0.16	Pelvic organ prolapse (moderate/severe);	chr14:100997463	chr14:101065465~101065487:+
KIRC	cis	rs9824310	0.605	rs11710233	MIMAT0004518	hsa-miR-16-2-3p	-3.45	0.00061	-0.11	-0.16	Iron status biomarkers (total iron binding capacity);	chr3:159463390	chr3:160404797~160404818:+
KIRC	cis	rs1864585	0.52	rs17774398	MIMAT0003266	hsa-miR-598-3p	3.45	0.000611	0.23	0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10774986	chr8:11035221~11035242:-
KIRC	cis	rs4851551	0.543	rs17026757	MIMAT0019927	hsa-miR-4772-3p	-3.45	0.000611	-0.32	-0.16	Blood protein levels;	chr2:102197452	chr2:102432336~102432357:+
KIRC	cis	rs74233809	1	rs943037	MIMAT0022727	hsa-miR-1307-5p	-3.45	0.000612	-0.19	-0.16	Birth weight;	chr10:103076162	chr10:103394341~103394361:-
KIRC	cis	rs2766692	0.788	rs2281892	MIMAT0002176	hsa-miR-485-3p	-3.45	0.000614	-0.15	-0.16	Electroencephalographic traits in alcoholism;	chr14:100303601	chr14:101055464~101055485:+
KIRC	cis	rs2106139	1	rs2106139	MIMAT0005950	hsa-miR-1306-3p	-3.45	0.000614	-0.37	-0.16	IgG glycosylation;	chr22:19577734	chr22:20086112~20086129:+
KIRC	cis	rs6555855	0.521	rs888777	MIMAT0003250	hsa-miR-585-3p	3.45	0.000614	0.23	0.16	Menarche (age at onset);	chr5:169285452	chr5:169263616~169263634:-
KIRC	cis	rs6555855	0.521	rs6555854	MIMAT0003250	hsa-miR-585-3p	3.45	0.000614	0.23	0.16	Menarche (age at onset);	chr5:169285510	chr5:169263616~169263634:-
KIRC	cis	rs74233809	1	rs74444347	MIMAT0022727	hsa-miR-1307-5p	-3.45	0.000615	-0.18	-0.16	Birth weight;	chr10:103009518	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs12221335	MIMAT0022727	hsa-miR-1307-5p	-3.45	0.000615	-0.18	-0.16	Birth weight;	chr10:103009635	chr10:103394341~103394361:-
KIRC	cis	rs1018697	0.966	rs11191396	MIMAT0022727	hsa-miR-1307-5p	3.45	0.000617	0.11	0.16	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394341~103394361:-
KIRC	cis	rs1018697	1	rs4919678	MIMAT0022727	hsa-miR-1307-5p	3.45	0.000617	0.11	0.16	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394341~103394361:-
KIRC	cis	rs1018697	1	rs11191397	MIMAT0022727	hsa-miR-1307-5p	3.45	0.000617	0.11	0.16	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.615	rs4919685	MIMAT0022727	hsa-miR-1307-5p	3.44	0.000621	0.12	0.16	Arsenic metabolism;	chr10:102827605	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs79237883	MIMAT0022727	hsa-miR-1307-5p	-3.44	0.000621	-0.19	-0.16	Birth weight;	chr10:103181189	chr10:103394341~103394361:-
KIRC	cis	rs3764400	0.508	rs12601350	MIMAT0000438	hsa-miR-152-3p	3.44	0.000622	0.26	0.16	Body mass index;	chr17:48043057	chr17:48037174~48037194:-
KIRC	cis	rs1984450	0.92	rs73934544	MIMAT0004485	hsa-let-7e-3p	-3.44	0.000627	-0.18	-0.15	Longitudinal alcohol consumption;	chr19:52515675	chr19:51692838~51692859:+
KIRC	cis	rs9462027	0.585	rs205283	MIMAT0022975	hsa-miR-3934-3p	3.44	0.000632	0.19	0.15	Systemic lupus erythematosus;	chr6:34585271	chr6:33698191~33698212:+
KIRC	cis	rs74233809	1	rs11191502	MIMAT0005951	hsa-miR-1307-3p	-3.44	0.000634	-0.16	-0.15	Birth weight;	chr10:103005737	chr10:103394301~103394322:-
KIRC	cis	rs7200543	0.884	rs72789542	MIMAT0000710	hsa-miR-365a-3p	-3.44	0.000635	-0.15	-0.15	Body mass index;Triglyceride levels;Metabolic traits;Glycerophospholipid levels;	chr16:15033678	chr16:14309340~14309361:+
KIRC	cis	rs6133127	0.554	rs6052625	MIMAT0000101	hsa-miR-103a-3p	-3.44	0.000636	-0.1	-0.15	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533214	chr20:3917541~3917563:+
KIRC	cis	rs6133127	0.554	rs6052625	MIMAT0000101_1	hsa-miR-103a-3p	-3.44	0.000636	-0.1	-0.15	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr20:4533214	chr5:168560904~168560926:-
KIRC	cis	rs250677	0.652	rs1422582	MIMAT0000731	hsa-miR-378a-5p	-3.44	0.000638	-0.16	-0.15	Breast cancer;	chr5:149057362	chr5:149732829~149732850:+
KIRC	cis	rs11237982	0.587	rs10899664	MIMAT0004926	hsa-miR-708-5p	3.44	0.000641	0.25	0.15	Verbal declarative memory;	chr11:79678322	chr11:79402077~79402099:-
KIRC	cis	rs9527	0.59	rs7901197	MIMAT0022727	hsa-miR-1307-5p	3.44	0.000642	0.11	0.15	Arsenic metabolism;	chr10:103080676	chr10:103394341~103394361:-
KIRC	cis	rs2564921	0.666	rs62253656	MIMAT0004584	hsa-let-7g-3p	3.44	0.000642	0.09	0.15	Height;	chr3:52989412	chr3:52268280~52268300:-
KIRC	cis	rs6681460	0.649	rs7540195	MIMAT0014979	hsa-miR-3117-3p	3.44	0.000643	0.18	0.15	Presence of antiphospholipid antibodies;	chr1:66536723	chr1:66628485~66628505:+
KIRC	cis	rs953492	0.698	rs61833914	MIMAT0019761	hsa-miR-4677-3p	-3.44	0.000643	-0.16	-0.15	Diastolic blood pressure;	chr1:243276745	chr1:243346225~243346246:+
KIRC	cis	rs9303542	1	rs12948017	MIMAT0000253	hsa-miR-10a-5p	-3.43	0.000644	-0.18	-0.15	Epithelial ovarian cancer;Ovarian cancer;	chr17:48361884	chr17:48579904~48579926:-
KIRC	cis	rs11237982	0.587	rs12578029	MIMAT0004927	hsa-miR-708-3p	3.43	0.000645	0.26	0.15	Verbal declarative memory;	chr11:79681181	chr11:79402032~79402053:-
KIRC	cis	rs9527	0.59	rs3861984	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000651	0.11	0.15	Arsenic metabolism;	chr10:103157223	chr10:103394341~103394361:-
KIRC	cis	rs3764400	0.508	rs55696440	MIMAT0000438	hsa-miR-152-3p	3.43	0.000652	0.26	0.15	Body mass index;	chr17:48193784	chr17:48037174~48037194:-
KIRC	cis	rs9462027	0.959	rs205262	MIMAT0022975	hsa-miR-3934-3p	3.43	0.000652	0.2	0.15	Systemic lupus erythematosus;	chr6:34595387	chr6:33698191~33698212:+
KIRC	cis	rs12701220	0.696	rs12112029	MIMAT0004702	hsa-miR-339-3p	3.43	0.000652	0.22	0.15	Bronchopulmonary dysplasia;	chr7:1098253	chr7:1022955~1022977:-
KIRC	cis	rs1018697	1	rs2150928	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000653	0.11	0.15	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394341~103394361:-
KIRC	cis	rs1018697	1	rs7073114	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000655	0.11	0.15	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs10883830	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000656	0.11	0.15	Arsenic metabolism;	chr10:103091528	chr10:103394341~103394361:-
KIRC	cis	rs9527	0.59	rs11191553	MIMAT0022727	hsa-miR-1307-5p	3.43	0.000656	0.11	0.15	Arsenic metabolism;	chr10:103091639	chr10:103394341~103394361:-
KIRC	cis	rs7072216	0.687	rs10883085	MIMAT0026738	hsa-miR-1287-3p	3.43	0.000659	0.15	0.15	Metabolite levels;	chr10:98395856	chr10:98395232~98395253:-
KIRC	cis	rs74233809	0.892	rs11191447	MIMAT0022727	hsa-miR-1307-5p	-3.43	0.000664	-0.18	-0.15	Birth weight;	chr10:102892566	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs74233296	MIMAT0022727	hsa-miR-1307-5p	-3.43	0.000664	-0.18	-0.15	Birth weight;	chr10:102895593	chr10:103394341~103394361:-
KIRC	cis	rs74233809	1	rs35125602	MIMAT0022727	hsa-miR-1307-5p	-3.43	0.000664	-0.18	-0.15	Birth weight;	chr10:102896282	chr10:103394341~103394361:-
KIRC	cis	rs1018697	1	rs6584525	MIMAT0022727	hsa-miR-1307-5p	3.42	0.000668	0.11	0.15	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394341~103394361:-
KIRC	cis	rs1950626	0.743	rs12887333	MIMAT0026557	hsa-miR-412-5p	-3.42	0.000672	-0.2	-0.15	Pelvic organ prolapse (moderate/severe);	chr14:100996275	chr14:101065465~101065487:+
KIRC	trans	rs854624	0.892	rs2702954	MIMAT0004774	hsa-miR-501-3p	6.26	8.57e-10	0.42	0.27	Blood protein levels;	chr17:36007697	chrX:50009772~50009793:+
KIRC	trans	rs854624	0.792	rs2687497	MIMAT0004774	hsa-miR-501-3p	6.26	8.57e-10	0.42	0.27	Blood protein levels;	chr17:36008126	chrX:50009772~50009793:+
KIRC	trans	rs854624	0.892	rs1734961	MIMAT0004774	hsa-miR-501-3p	-6.21	1.11e-09	-0.4	-0.27	Blood protein levels;	chr17:36008471	chrX:50009772~50009793:+
KIRC	trans	rs16949516	0.59	rs68108118	MIMAT0004774	hsa-miR-501-3p	-6.11	2.08e-09	-0.38	-0.27	Stearic acid (18:0) levels;	chr15:94784144	chrX:50009772~50009793:+
KIRC	trans	rs2341459	0.556	rs13432009	MIMAT0022925	hsa-miR-503-3p	6.08	2.44e-09	0.32	0.27	Height;	chr2:44621719	chrX:134546331~134546353:-
KIRC	trans	rs16949516	1	rs12443304	MIMAT0004774	hsa-miR-501-3p	6.06	2.7e-09	0.37	0.27	Stearic acid (18:0) levels;	chr15:94784866	chrX:50009772~50009793:+
KIRC	trans	rs2341459	0.624	rs6742204	MIMAT0022925	hsa-miR-503-3p	6.02	3.46e-09	0.32	0.26	Height;	chr2:44602002	chrX:134546331~134546353:-
KIRC	trans	rs854625	1	rs854625	MIMAT0004774	hsa-miR-501-3p	-6.01	3.64e-09	-0.39	-0.26	Cerebrospinal fluid biomarker levels;	chr17:36001422	chrX:50009772~50009793:+
KIRC	trans	rs2341459	0.602	rs6737132	MIMAT0022925	hsa-miR-503-3p	5.94	5.33e-09	0.31	0.26	Height;	chr2:44555598	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs6544764	MIMAT0022925	hsa-miR-503-3p	5.92	6.06e-09	0.32	0.26	Height;	chr2:44638500	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.556	rs934777	MIMAT0022925	hsa-miR-503-3p	5.92	6.19e-09	0.31	0.26	Height;	chr2:44618119	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs76774089	MIMAT0000733	hsa-miR-379-5p	-5.92	6.27e-09	-0.22	-0.26	Intelligence (multi-trait analysis);	chr8:70167902	chr14:101022071~101022091:+
KIRC	trans	rs854624	0.892	rs1719194	MIMAT0004774	hsa-miR-501-3p	-5.9	6.85e-09	-0.41	-0.26	Blood protein levels;	chr17:36009014	chrX:50009772~50009793:+
KIRC	trans	rs897080	0.535	rs10168462	MIMAT0022925	hsa-miR-503-3p	5.89	7.31e-09	0.32	0.26	Height;	chr2:44635474	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs10192334	MIMAT0022925	hsa-miR-503-3p	5.89	7.31e-09	0.32	0.26	Height;	chr2:44635596	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs1821859	MIMAT0022925	hsa-miR-503-3p	5.88	7.52e-09	0.31	0.26	Height;	chr2:44641749	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs10504470	MIMAT0000733	hsa-miR-379-5p	5.86	8.49e-09	0.22	0.26	Intelligence (multi-trait analysis);	chr8:70178211	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.556	rs13409374	MIMAT0022925	hsa-miR-503-3p	5.86	8.63e-09	0.31	0.26	Height;	chr2:44622133	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs4832364	MIMAT0000733	hsa-miR-379-5p	-5.86	8.67e-09	-0.22	-0.26	Conduct disorder (symptom count);Conduct disorder;	chr2:83975139	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs1965788	MIMAT0022925	hsa-miR-503-3p	5.85	8.92e-09	0.31	0.26	Height;	chr2:44609133	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs10190107	MIMAT0000733	hsa-miR-379-5p	5.85	9.02e-09	0.22	0.26	Conduct disorder (symptom count);Conduct disorder;	chr2:83973934	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13402904	MIMAT0000733	hsa-miR-379-5p	-5.83	9.99e-09	-0.25	-0.26	Conduct disorder (symptom count);Conduct disorder;	chr2:83966440	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.556	rs10153682	MIMAT0022925	hsa-miR-503-3p	5.82	1.08e-08	0.31	0.26	Height;	chr2:44613959	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs10204480	MIMAT0022925	hsa-miR-503-3p	5.82	1.09e-08	0.31	0.26	Height;	chr2:44637302	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs10168220	MIMAT0000733	hsa-miR-379-5p	-5.81	1.15e-08	-0.24	-0.26	Conduct disorder (symptom count);Conduct disorder;	chr2:84016658	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs78680085	MIMAT0000733	hsa-miR-379-5p	-5.81	1.15e-08	-0.24	-0.26	Conduct disorder (symptom count);Conduct disorder;	chr2:84017801	chr14:101022071~101022091:+
KIRC	trans	rs854624	0.711	rs1608205	MIMAT0004774	hsa-miR-501-3p	5.8	1.18e-08	0.39	0.26	Blood protein levels;	chr17:36009727	chrX:50009772~50009793:+
KIRC	trans	rs2341459	0.624	rs13400118	MIMAT0022925	hsa-miR-503-3p	5.8	1.2e-08	0.31	0.26	Height;	chr2:44644735	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs12615601	MIMAT0022925	hsa-miR-503-3p	5.8	1.22e-08	0.31	0.26	Height;	chr2:44596503	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs12622145	MIMAT0022925	hsa-miR-503-3p	5.79	1.3e-08	0.31	0.25	Height;	chr2:44596848	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.556	rs1119013	MIMAT0022925	hsa-miR-503-3p	5.78	1.31e-08	0.31	0.25	Height;	chr2:44626139	chrX:134546331~134546353:-
KIRC	trans	rs17832777	0.603	rs1959706	MIMAT0000087	hsa-miR-30a-5p	5.78	1.32e-08	0.29	0.25	Chronic obstructive pulmonary disease-related biomarkers;	chr14:56449084	chr6:71403595~71403616:-
KIRC	trans	rs57994514	0.524	rs3793365	MIMAT0000733	hsa-miR-379-5p	5.78	1.33e-08	0.21	0.25	Intelligence (multi-trait analysis);	chr8:70165780	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs6718003	MIMAT0022925	hsa-miR-503-3p	5.78	1.38e-08	0.3	0.25	Height;	chr2:44603053	chrX:134546331~134546353:-
KIRC	trans	rs854624	0.892	rs1608206	MIMAT0004774	hsa-miR-501-3p	5.78	1.38e-08	0.38	0.25	Blood protein levels;	chr17:36009796	chrX:50009772~50009793:+
KIRC	trans	rs2341459	0.624	rs4953125	MIMAT0022925	hsa-miR-503-3p	5.77	1.39e-08	0.31	0.25	Height;	chr2:44643170	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs79508542	MIMAT0000733	hsa-miR-379-5p	-5.77	1.41e-08	-0.22	-0.25	Intelligence (multi-trait analysis);	chr8:70252416	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs4832365	MIMAT0000733	hsa-miR-379-5p	-5.77	1.42e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83999788	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs6714384	MIMAT0000733	hsa-miR-379-5p	-5.77	1.42e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:84001078	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.56	rs12469243	MIMAT0022925	hsa-miR-503-3p	5.76	1.47e-08	0.3	0.25	Height;	chr2:44622974	chrX:134546331~134546353:-
KIRC	trans	rs16949516	0.793	rs12442336	MIMAT0004774	hsa-miR-501-3p	5.76	1.48e-08	0.36	0.25	Stearic acid (18:0) levels;	chr15:94790530	chrX:50009772~50009793:+
KIRC	trans	rs57994514	0.524	rs10504472	MIMAT0000733	hsa-miR-379-5p	-5.76	1.48e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70328243	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.541	rs4953126	MIMAT0022925	hsa-miR-503-3p	5.76	1.49e-08	0.3	0.25	Height;	chr2:44643567	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs56174599	MIMAT0000733	hsa-miR-379-5p	-5.76	1.5e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70286234	chr14:101022071~101022091:+
KIRC	trans	rs16949516	1	rs12442999	MIMAT0004774	hsa-miR-501-3p	-5.76	1.53e-08	-0.36	-0.25	Stearic acid (18:0) levels;	chr15:94787795	chrX:50009772~50009793:+
KIRC	trans	rs13398848	1	rs76942868	MIMAT0000733	hsa-miR-379-5p	-5.75	1.56e-08	-0.22	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83974537	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs1579641	MIMAT0022925	hsa-miR-503-3p	5.75	1.58e-08	0.31	0.25	Height;	chr2:44635000	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs4953128	MIMAT0022925	hsa-miR-503-3p	5.75	1.59e-08	0.3	0.25	Height;	chr2:44648156	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs3887086	MIMAT0000733	hsa-miR-379-5p	-5.75	1.6e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83990815	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs725180	MIMAT0000733	hsa-miR-379-5p	-5.75	1.6e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83991044	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs78494718	MIMAT0000733	hsa-miR-379-5p	-5.75	1.6e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83992396	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs10445928	MIMAT0022925	hsa-miR-503-3p	5.75	1.6e-08	0.3	0.25	Height;	chr2:44605717	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs6737437	MIMAT0022925	hsa-miR-503-3p	5.74	1.63e-08	0.3	0.25	Height;	chr2:44643613	chrX:134546331~134546353:-
KIRC	trans	rs16949516	1	rs8034828	MIMAT0004774	hsa-miR-501-3p	-5.74	1.64e-08	-0.36	-0.25	Stearic acid (18:0) levels;	chr15:94786997	chrX:50009772~50009793:+
KIRC	trans	rs3857067	0.55	rs12646201	MIMAT0016895	hsa-miR-2355-5p	5.74	1.7e-08	0.31	0.25	QT interval;	chr4:94106695	chr2:207110043~207110063:-
KIRC	trans	rs2341459	0.624	rs734016	MIMAT0022925	hsa-miR-503-3p	5.74	1.7e-08	0.3	0.25	Height;	chr2:44641997	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs2138591	MIMAT0022925	hsa-miR-503-3p	5.74	1.7e-08	0.31	0.25	Height;	chr2:44642684	chrX:134546331~134546353:-
KIRC	trans	rs11082098	0.85	rs4800037	MIMAT0000447	hsa-miR-134-5p	-5.74	1.72e-08	-0.2	-0.25	Pit-and-Fissure caries;Smooth-surface caries;	chr18:38617083	chr14:101054694~101054715:+
KIRC	trans	rs57994514	0.524	rs75596384	MIMAT0000733	hsa-miR-379-5p	-5.73	1.73e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70154957	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs34317066	MIMAT0022925	hsa-miR-503-3p	5.73	1.79e-08	0.3	0.25	Height;	chr2:44634122	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs77493063	MIMAT0000733	hsa-miR-379-5p	-5.72	1.83e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70227701	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs6724077	MIMAT0000733	hsa-miR-379-5p	-5.72	1.84e-08	-0.25	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83850744	chr14:101022071~101022091:+
KIRC	trans	rs897080	0.513	rs7590333	MIMAT0022925	hsa-miR-503-3p	5.71	1.93e-08	0.3	0.25	Height;	chr2:44614123	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.581	rs4953115	MIMAT0022925	hsa-miR-503-3p	5.71	1.94e-08	0.3	0.25	Height;	chr2:44609949	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs1837118	MIMAT0022925	hsa-miR-503-3p	5.71	1.94e-08	0.3	0.25	Height;	chr2:44612494	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.56	rs6758854	MIMAT0022925	hsa-miR-503-3p	5.7	2.1e-08	0.3	0.25	Height;	chr2:44606311	chrX:134546331~134546353:-
KIRC	trans	rs1039002	1	rs1039002	MIMAT0002817	hsa-miR-495-3p	-5.7	2.11e-08	-0.32	-0.25	Bipolar disorder;	chr6:165741969	chr14:101033804~101033825:+
KIRC	trans	rs3857067	0.509	rs72663769	MIMAT0016895	hsa-miR-2355-5p	5.69	2.16e-08	0.31	0.25	QT interval;	chr4:94096565	chr2:207110043~207110063:-
KIRC	trans	rs11082098	0.557	rs4800035	MIMAT0000447	hsa-miR-134-5p	-5.69	2.2e-08	-0.21	-0.25	Pit-and-Fissure caries;Smooth-surface caries;	chr18:38616951	chr14:101054694~101054715:+
KIRC	trans	rs57994514	0.524	rs55812701	MIMAT0000733	hsa-miR-379-5p	-5.69	2.25e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70231849	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs10165552	MIMAT0022925	hsa-miR-503-3p	5.69	2.27e-08	0.3	0.25	Height;	chr2:44558286	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs6713725	MIMAT0022925	hsa-miR-503-3p	5.68	2.27e-08	0.3	0.25	Height;	chr2:44601987	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs116730477	MIMAT0000733	hsa-miR-379-5p	-5.68	2.29e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70270567	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs10164919	MIMAT0022925	hsa-miR-503-3p	5.68	2.29e-08	0.3	0.25	Height;	chr2:44647949	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs77931642	MIMAT0000733	hsa-miR-379-5p	-5.68	2.31e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70230723	chr14:101022071~101022091:+
KIRC	trans	rs57994514	0.524	rs10957517	MIMAT0000733	hsa-miR-379-5p	-5.68	2.38e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70213200	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7578721	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83962576	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7578957	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83962807	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7566660	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83962934	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7608359	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83962980	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10200157	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83964101	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10176974	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83964176	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13424336	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83965186	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs75970785	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83965781	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13402815	MIMAT0000733	hsa-miR-379-5p	-5.67	2.4e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83966365	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs2015420	MIMAT0022925	hsa-miR-503-3p	5.67	2.41e-08	0.3	0.25	Height;	chr2:44610532	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs12615693	MIMAT0022925	hsa-miR-503-3p	5.67	2.45e-08	0.3	0.25	Height;	chr2:44626746	chrX:134546331~134546353:-
KIRC	trans	rs298235	1	rs12694629	MIMAT0000430	hsa-miR-138-5p	5.67	2.5e-08	0.53	0.25	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis;	chr2:156455635	chr16:56858527~56858549:+
KIRC	trans	rs298235	1	rs12694629	MIMAT0000430_1	hsa-miR-138-5p	5.67	2.5e-08	0.53	0.25	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis;	chr2:156455635	chr3:44114234~44114256:+
KIRC	trans	rs4877691	1	rs11139535	MIMAT0000692	hsa-miR-30e-5p	-5.67	2.5e-08	-0.14	-0.25	Airway imaging phenotypes;	chr9:82304577	chr1:40754371~40754392:+
KIRC	trans	rs13398848	1	rs78101110	MIMAT0000733	hsa-miR-379-5p	-5.66	2.54e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:84010455	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs77196789	MIMAT0000733	hsa-miR-379-5p	-5.66	2.54e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:84014213	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13398848	MIMAT0000733	hsa-miR-379-5p	-5.66	2.54e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:84018044	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10496302	MIMAT0000733	hsa-miR-379-5p	-5.66	2.55e-08	-0.22	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83983071	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10496303	MIMAT0000733	hsa-miR-379-5p	-5.66	2.55e-08	-0.22	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83983122	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs6727871	MIMAT0022925	hsa-miR-503-3p	5.66	2.56e-08	0.3	0.25	Height;	chr2:44593405	chrX:134546331~134546353:-
KIRC	trans	rs3857067	0.55	rs72663751	MIMAT0016895	hsa-miR-2355-5p	5.66	2.58e-08	0.3	0.25	QT interval;	chr4:94080643	chr2:207110043~207110063:-
KIRC	trans	rs3857067	0.53	rs72663756	MIMAT0016895	hsa-miR-2355-5p	5.66	2.58e-08	0.3	0.25	QT interval;	chr4:94082347	chr2:207110043~207110063:-
KIRC	trans	rs2341459	0.581	rs7561661	MIMAT0022925	hsa-miR-503-3p	5.66	2.59e-08	0.3	0.25	Height;	chr2:44562199	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs4484075	MIMAT0022925	hsa-miR-503-3p	5.66	2.63e-08	0.3	0.25	Height;	chr2:44607023	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs10165993	MIMAT0000733	hsa-miR-379-5p	-5.66	2.65e-08	-0.21	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83973756	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7601959	MIMAT0000733	hsa-miR-379-5p	-5.65	2.75e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83873421	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.602	rs4953109	MIMAT0022925	hsa-miR-503-3p	5.64	2.85e-08	0.3	0.25	Height;	chr2:44578192	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs4832348	MIMAT0000733	hsa-miR-379-5p	-5.64	2.93e-08	-0.23	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83860621	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs17032420	MIMAT0022925	hsa-miR-503-3p	5.64	2.98e-08	0.3	0.25	Height;	chr2:44598574	chrX:134546331~134546353:-
KIRC	trans	rs897080	0.513	rs13403533	MIMAT0022925	hsa-miR-503-3p	5.64	2.98e-08	0.3	0.25	Height;	chr2:44599034	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs3931848	MIMAT0022925	hsa-miR-503-3p	5.64	2.98e-08	0.3	0.25	Height;	chr2:44599477	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs7582708	MIMAT0022925	hsa-miR-503-3p	5.63	2.98e-08	0.3	0.25	Height;	chr2:44578872	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs4953122	MIMAT0022925	hsa-miR-503-3p	5.63	2.99e-08	0.3	0.25	Height;	chr2:44634653	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs6707653	MIMAT0022925	hsa-miR-503-3p	5.63	3.01e-08	0.3	0.25	Height;	chr2:44648833	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs28475496	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83920536	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs6742327	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83924990	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs76703208	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83927756	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13383734	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83945182	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs11896470	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83946064	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs4832357	MIMAT0000733	hsa-miR-379-5p	-5.63	3.12e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83953980	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.515	rs12616170	MIMAT0022925	hsa-miR-503-3p	5.62	3.16e-08	0.3	0.25	Height;	chr2:44537177	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs7566018	MIMAT0000733	hsa-miR-379-5p	-5.62	3.16e-08	-0.23	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83971321	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs114901495	MIMAT0000733	hsa-miR-379-5p	-5.62	3.23e-08	-0.23	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83998137	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs6751281	MIMAT0022925	hsa-miR-503-3p	5.62	3.24e-08	0.3	0.25	Height;	chr2:44597465	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs6710978	MIMAT0022925	hsa-miR-503-3p	5.62	3.25e-08	0.3	0.25	Height;	chr2:44649098	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.581	rs13424763	MIMAT0022925	hsa-miR-503-3p	5.62	3.3e-08	0.29	0.25	Height;	chr2:44559442	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs4832064	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83897660	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13382450	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83902746	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs11890751	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83903678	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs76834527	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83903824	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs13392658	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83905369	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs7558026	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83907309	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs6737097	MIMAT0000733	hsa-miR-379-5p	-5.62	3.31e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83950063	chr14:101022071~101022091:+
KIRC	trans	rs11082098	0.85	rs4800034	MIMAT0000447	hsa-miR-134-5p	-5.61	3.35e-08	-0.19	-0.25	Pit-and-Fissure caries;Smooth-surface caries;	chr18:38616865	chr14:101054694~101054715:+
KIRC	trans	rs2341459	0.602	rs12987925	MIMAT0022925	hsa-miR-503-3p	5.61	3.42e-08	0.3	0.25	Height;	chr2:44634467	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs62132285	MIMAT0022925	hsa-miR-503-3p	5.61	3.44e-08	0.3	0.25	Height;	chr2:44593102	chrX:134546331~134546353:-
KIRC	trans	rs13398848	1	rs11890845	MIMAT0000733	hsa-miR-379-5p	-5.61	3.45e-08	-0.23	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83903852	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs6729292	MIMAT0022925	hsa-miR-503-3p	5.6	3.58e-08	0.3	0.25	Height;	chr2:44581320	chrX:134546331~134546353:-
KIRC	trans	rs6861497	0.966	rs899043	MIMAT0004497	hsa-miR-24-2-5p	5.6	3.59e-08	0.21	0.25	QRS duration;	chr5:102099781	chr19:13836326~13836347:-
KIRC	trans	rs10230207	0.58	rs2024353	MIMAT0000443	hsa-miR-125a-5p	5.59	3.73e-08	0.2	0.25	Intracranial aneurysm;	chr7:19539253	chr19:51693268~51693291:+
KIRC	trans	rs2341459	0.624	rs13389981	MIMAT0022925	hsa-miR-503-3p	5.59	3.89e-08	0.3	0.25	Height;	chr2:44598929	chrX:134546331~134546353:-
KIRC	trans	rs10230207	0.648	rs6965709	MIMAT0000443	hsa-miR-125a-5p	-5.58	3.94e-08	-0.19	-0.25	Intracranial aneurysm;	chr7:19532964	chr19:51693268~51693291:+
KIRC	trans	rs13398848	1	rs6547518	MIMAT0000733	hsa-miR-379-5p	-5.58	4.07e-08	-0.24	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83892586	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs7419527	MIMAT0022925	hsa-miR-503-3p	-5.58	4.1e-08	-0.29	-0.25	Height;	chr2:44595010	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs4953102	MIMAT0022925	hsa-miR-503-3p	5.57	4.18e-08	0.3	0.25	Height;	chr2:44563383	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs7568327	MIMAT0022925	hsa-miR-503-3p	5.57	4.19e-08	0.3	0.25	Height;	chr2:44608499	chrX:134546331~134546353:-
KIRC	trans	rs12080794	1	rs11121323	MIMAT0001620	hsa-miR-200a-5p	5.57	4.21e-08	0.2	0.25	Response to antidepressant treatment (citalopram);	chr1:9096012	chr1:1167878~1167899:+
KIRC	trans	rs13398848	1	rs74864343	MIMAT0000733	hsa-miR-379-5p	-5.57	4.32e-08	-0.23	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:84017467	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10168676	MIMAT0000733	hsa-miR-379-5p	-5.56	4.42e-08	-0.21	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83974130	chr14:101022071~101022091:+
KIRC	trans	rs13398848	1	rs10192434	MIMAT0000733	hsa-miR-379-5p	-5.56	4.42e-08	-0.21	-0.25	Conduct disorder (symptom count);Conduct disorder;	chr2:83974132	chr14:101022071~101022091:+
KIRC	trans	rs897080	0.535	rs17032481	MIMAT0022925	hsa-miR-503-3p	5.56	4.48e-08	0.3	0.25	Height;	chr2:44645207	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.602	rs4953100	MIMAT0022925	hsa-miR-503-3p	5.56	4.49e-08	0.29	0.25	Height;	chr2:44562914	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.624	rs4953105	MIMAT0022925	hsa-miR-503-3p	5.56	4.52e-08	0.3	0.25	Height;	chr2:44564520	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs16936884	MIMAT0000733	hsa-miR-379-5p	-5.56	4.54e-08	-0.21	-0.25	Intelligence (multi-trait analysis);	chr8:70290780	chr14:101022071~101022091:+
KIRC	trans	rs57994514	0.524	rs75137497	MIMAT0000733	hsa-miR-379-5p	-5.55	4.61e-08	-0.2	-0.25	Intelligence (multi-trait analysis);	chr8:70398869	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.624	rs4953107	MIMAT0022925	hsa-miR-503-3p	5.55	4.63e-08	0.3	0.25	Height;	chr2:44569974	chrX:134546331~134546353:-
KIRC	trans	rs57994514	0.524	rs12544983	MIMAT0000733	hsa-miR-379-5p	-5.55	4.64e-08	-0.2	-0.25	Intelligence (multi-trait analysis);	chr8:70380412	chr14:101022071~101022091:+
KIRC	trans	rs2341459	0.512	rs10195185	MIMAT0022925	hsa-miR-503-3p	5.55	4.7e-08	0.29	0.25	Height;	chr2:44611852	chrX:134546331~134546353:-
KIRC	trans	rs2341459	0.581	rs4953103	MIMAT0022925	hsa-miR-503-3p	5.55	4.71e-08	0.3	0.25	Height;	chr2:44564254	chrX:134546331~134546353:-